data_1c99_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c99 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.843 0.354 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.13 -49.39 65.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -63.74 -30.61 71.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.55 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.529 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -76.68 -48.33 19.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.783 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.72 -15.69 62.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.05 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 27.3 ttt -82.05 -57.49 3.38 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.765 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.529 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 7.0 p-10 -68.68 -41.56 79.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.979 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 55.1 tp -60.1 -39.39 86.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 35.4 tp -67.48 -57.4 6.58 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.108 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 8.6 m-30 -50.85 -51.99 45.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 109.742 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.404 ' HE1' ' HB2' ' A' ' 11' ' ' MET . 45.7 ttm -60.43 -38.98 85.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.817 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.07 -35.49 77.1 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.423 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -64.32 -37.32 87.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.03 -54.52 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.29 -49.59 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.999 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.568 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -57.5 -46.02 84.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.081 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 85.5 mmm -65.24 -41.56 94.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.525 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -67.25 -54.33 20.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.868 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.452 HD11 ' C ' ' A' ' 19' ' ' LEU . 3.6 pp -59.67 -42.65 93.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . -68.89 -30.58 69.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.717 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -67.74 -41.89 82.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.893 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 26' ' ' ILE . 67.2 mt -64.45 -56.7 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.931 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.72 98.74 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.425 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -60.62 -45.26 94.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.65 -46.81 88.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.754 ' O ' HG13 ' A' ' 30' ' ' ILE . 40.8 mm -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.458 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.74 -48.3 68.34 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.113 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 24' ' ' ALA . 36.2 pt -49.48 -46.77 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 117.541 0.67 . . . . 0.0 109.331 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -65.43 -36.79 93.06 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.118 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.754 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.2 mt -59.73 -71.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 110.68 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 35' ' ' PHE . 5.9 tt -68.26 -30.94 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -59.71 -47.93 88.55 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.996 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.01 61.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.295 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 17.9 ptpt -60.51 -53.85 52.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 111.66 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.67 ' HB2' HD22 ' A' ' 31' ' ' LEU . 12.7 t80 -64.05 -48.33 76.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.29 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 2.0 tm? -60.19 -37.68 80.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -61.01 -55.39 33.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.757 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.8 -56.01 27.68 Favored Glycine 0 C--O 1.235 0.196 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 45' ' ' LEU . . . -55.8 -48.02 76.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.286 0.565 . . . . 0.0 110.418 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.571 ' CA ' HD22 ' A' ' 49' ' ' LEU . . . -70.66 -15.87 62.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.589 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 6.4 tpm_? -81.58 -28.41 33.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 90.9 mm-40 -101.85 106.93 49.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.623 ' O ' HG13 ' A' ' 46' ' ' ILE . 5.0 Cg_exo -44.83 -22.72 0.72 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.854 2.369 . . . . 0.0 113.974 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -82.69 -7.2 59.66 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 4.3 mp -108.45 19.36 19.9 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 43' ' ' PRO . 32.1 mt -54.8 -45.55 99.65 Favored Pre-proline 0 C--O 1.225 -0.229 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.145 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 15.4 Cg_exo -67.39 -20.83 47.97 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.803 1.669 . . . . 0.0 110.255 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 27.4 tp -69.44 -38.64 77.92 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD22 ' CA ' ' A' ' 40' ' ' ALA . 51.9 mt -44.29 -62.9 1.0 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.679 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -67.4 -46.36 73.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.6 m -55.73 -46.06 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.77 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.614 ' O ' HG21 ' A' ' 55' ' ' ILE . 16.4 pt20 -70.08 -36.31 74.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.19 -57.45 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.14 -41.64 99.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.202 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 52' ' ' GLN . 11.0 tp -63.23 -50.17 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.698 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.444 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 61.0 t -65.59 -42.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.4 ttm -71.83 -40.82 68.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.279 0.561 . . . . 0.0 110.327 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -68.7 -44.33 71.2 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.357 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 88.4 mt -63.56 -40.57 97.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.166 0.483 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.45 -41.39 73.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.425 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 40.7 m-20 -81.19 -9.01 59.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.62 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -66.14 -27.55 68.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.667 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 72.4 mt -62.24 -59.66 12.33 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 16.3 Cg_exo -68.79 -26.38 32.5 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.264 1.309 . . . . 0.0 110.74 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.7 tpt -69.29 -31.7 70.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.494 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 51.8 mt -79.15 -44.92 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.908 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.644 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.26 -53.13 32.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 110.306 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 97.1 t -64.71 -46.99 90.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -54.5 -50.77 55.67 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.702 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.6 pp -62.79 -42.33 99.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.301 0.572 . . . . 0.0 110.34 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.602 ' N ' HD13 ' A' ' 70' ' ' LEU . . . -58.49 -56.38 25.57 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.845 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 3.9 pp -71.59 -28.46 63.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 21.4 t80 -57.91 -40.24 79.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 109.654 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.515 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 46.4 t -94.02 -32.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.817 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.534 ' HA ' ' HB1' ' A' ' 79' ' ' ALA . 88.3 mmm -75.03 -76.04 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.237 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 28.0 m-85 -63.93 -29.0 70.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 73' ' ' TYR . . . -96.21 -51.85 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 55.7 t -88.04 -6.49 10.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.66 0.267 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 6' ' ' MET . 42.7 tt0 -61.62 -53.9 50.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -65.68 -32.77 74.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.552 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -77.26 -31.14 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.688 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.43 -29.47 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.28 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 66.0 mtm -80.23 -49.16 11.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.561 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 57.5 p-10 -67.94 -40.13 83.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.255 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.563 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 3.1 tm? -64.13 -30.04 71.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 2.1 tm? -68.15 -61.62 1.77 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -50.53 -49.57 55.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.728 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.65 -43.04 99.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -55.25 -42.88 74.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.856 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' MET . . . -56.77 -44.33 81.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.974 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.63 44.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.132 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.38 -62.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.088 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.52 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.1 mpp? -47.57 -47.3 28.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.709 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.603 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -62.32 -45.09 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.935 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.441 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -66.69 -49.99 51.58 Favored Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.027 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 3.4 pp -60.61 -41.69 95.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.095 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -70.34 -32.14 69.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 17' ' ' MET . . . -67.05 -44.14 80.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.1 mt -63.55 -57.61 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.408 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.22 -51.4 58.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.743 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -59.55 -41.32 89.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -62.01 -47.01 86.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.726 ' O ' HG12 ' A' ' 30' ' ' ILE . 36.7 mm -56.71 -60.02 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.29 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.42 -45.91 74.75 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.178 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.8 tp -51.37 -46.66 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.09 -39.39 97.55 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.739 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.726 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.9 mm -58.01 -69.61 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 2.5 tm? -76.31 -44.55 36.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -61.64 -38.35 95.73 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.458 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.21 -51.97 45.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.589 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -58.13 -50.07 74.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.36 0.6 . . . . 0.0 110.168 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.32 -41.54 97.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.754 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.42 ' CD1' HD23 ' A' ' 49' ' ' LEU . 58.7 tp -63.79 -41.36 97.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.421 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 47.9 mt-10 -59.52 -53.48 57.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.601 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.97 -61.32 7.11 Favored Glycine 0 C--O 1.239 0.427 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.951 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -49.92 -46.14 51.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.564 ' N ' HD22 ' A' ' 49' ' ' LEU . . . -72.44 -25.83 61.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.629 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 55.3 ttp180 -67.8 -25.24 65.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -96.85 95.54 2.26 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.098 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 99.4 Cg_exo -38.38 -25.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.46 2.773 . . . . 0.0 114.356 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -79.87 -1.42 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 5.4 mp -121.04 14.91 11.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 26.9 mm -52.48 -45.15 95.65 Favored Pre-proline 0 N--CA 1.464 0.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.308 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 9.4 Cg_exo -70.24 -21.0 31.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.813 1.675 . . . . 0.0 110.714 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 30.1 tp -67.31 -38.96 85.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 40' ' ' ALA . 38.9 mt -47.0 -64.59 0.74 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.829 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.017 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.67 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 46.8 m -58.58 -42.9 89.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.695 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -84.84 -34.79 22.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.949 0.404 . . . . 0.0 110.366 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.5 t80 -51.93 -50.6 60.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.908 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 1.2 p90 -63.41 -35.47 80.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.836 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 51' ' ' THR . 55.0 mt -66.21 -63.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.24 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.6 t -54.62 -40.45 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.638 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.7 ttt -71.2 -39.0 72.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 0.0 110.564 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -66.22 -45.91 83.28 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.343 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -57.08 -43.33 82.03 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 109.804 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.28 -51.42 59.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.438 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.33 -13.68 62.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.58 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.496 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.77 -33.77 70.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 53.5 mt -60.69 -66.28 1.63 Allowed Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.598 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 22.0 Cg_exo -56.94 -25.31 61.69 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 120.055 1.055 . . . . 0.0 111.061 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.11 70.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 62' ' ' ALA . 70.2 mt -77.49 -43.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.26 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.32 -51.24 54.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.17 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.2 t -69.62 -30.53 45.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.269 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.52 -50.84 29.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.775 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.7 pp -62.35 -42.61 99.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.993 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' CD1' ' A' ' 70' ' ' LEU . . . -61.55 -52.53 50.51 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.515 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pp -64.04 -30.57 71.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 111.145 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -53.03 -48.54 67.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.266 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -89.75 -31.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.397 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -80.5 -69.08 0.62 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -59.2 -23.04 61.93 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.04 -54.49 5.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.67 -17.43 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.399 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.469 ' H1 ' ' H ' ' A' ' 2' ' ' GLU . 4.2 mpp? . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.469 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 47.8 mt-10 -66.2 -45.9 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.693 0.282 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.65 -45.84 90.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 8' ' ' LEU . 96.6 mt -66.19 -44.74 83.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.608 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -63.2 -36.32 83.23 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.46 ' O ' ' HD1' ' A' ' 10' ' ' TYR . 56.4 ttm -64.22 -69.73 0.26 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.794 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -52.98 -40.65 63.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.526 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 54.7 tp -65.62 -31.01 71.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.762 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HA ' HD21 ' A' ' 9' ' ' LEU . 2.3 tm? -68.6 -52.9 26.5 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.326 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' HD1' ' O ' ' A' ' 6' ' ' MET . 31.3 m-85 -59.69 -42.59 93.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.009 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -63.3 -37.76 88.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.08 -37.4 84.87 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.474 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -60.22 -46.24 90.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.57 72.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.91 -51.52 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.319 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.32 -51.61 66.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 84.6 mtp -62.5 -41.9 99.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.401 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -68.66 -53.85 18.2 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.567 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 20' ' ' ALA . 3.5 pp -58.04 -45.39 87.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.241 0.544 . . . . 0.0 109.892 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' N ' ' CD1' ' A' ' 19' ' ' LEU . . . -66.37 -32.18 73.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.371 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.557 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -68.86 -41.06 78.92 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.508 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 18' ' ' GLY . 92.6 mt -62.26 -57.79 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.777 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -47.76 89.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.446 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -56.42 -42.67 78.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.9 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -61.62 -58.08 9.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.197 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.827 ' O ' HG12 ' A' ' 30' ' ' ILE . 33.8 mm -44.4 -56.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.34 -38.33 87.12 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.766 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.9 HG21 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -56.13 -44.03 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.25 -36.4 89.66 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.546 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.827 HG12 ' O ' ' A' ' 26' ' ' ILE . 42.5 mm -59.63 -69.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.441 0.162 . . . . 0.0 110.81 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.579 HD21 ' HD3' ' A' ' 34' ' ' LYS . 3.0 tm? -74.59 -45.6 44.11 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.658 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -62.59 -44.11 98.03 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.3 -0.953 . . . . 0.0 110.886 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -60.75 -49.22 81.05 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.853 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HD3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.44 -53.98 49.42 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.058 0.456 . . . . 0.0 110.587 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.25 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 6.8 mp -53.28 -34.65 58.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.925 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 16.3 tp10 -56.77 -61.28 2.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 109.944 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -54.32 -47.31 69.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.19 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.819 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.26 -34.97 77.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.148 0.499 . . . . 0.0 110.009 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' A' ' 49' ' ' LEU . . . -70.99 -22.87 62.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.616 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 4.5 tmm_? -92.34 -19.39 22.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.763 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.911 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 65.3 mt-30 -61.21 -177.01 0.12 Allowed Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.911 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 73.6 Cg_exo -48.81 -71.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.154 2.569 . . . . 0.0 113.375 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.6 t70 -146.09 46.94 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.893 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.819 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -84.56 13.22 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 111.131 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 29.4 mm -52.56 -45.51 95.9 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.635 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 35.3 Cg_endo -68.16 -23.43 39.47 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 120.874 1.05 . . . . 0.0 110.698 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.668 ' O ' ' HG3' ' A' ' 52' ' ' GLN . 35.6 tp -67.8 -38.72 83.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 77.8 mt -43.91 -61.42 1.45 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.743 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.617 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 39.7 ptt180 -63.02 -49.53 74.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.148 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 55' ' ' ILE . 97.6 m -46.83 -48.8 20.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.668 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 40.7 mt-30 -69.3 -33.43 73.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.987 0.423 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.02 -54.19 47.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' HD1' ' O ' ' A' ' 50' ' ' ARG . 31.6 m-85 -65.15 -44.45 88.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.638 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 51' ' ' THR . 36.8 mm -63.86 -56.99 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.78 -48.19 89.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.4 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 26.5 ttt -68.73 -35.53 77.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.216 0.532 . . . . 0.0 110.576 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.61 -45.08 60.8 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.07 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 80.2 mt -61.98 -42.5 99.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 -50.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.391 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.4 ' OD2' ' HG2' ' A' ' 57' ' ' MET . 28.6 m-20 -69.13 -16.04 63.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.636 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.73 -33.72 68.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.389 . . . . 0.0 110.506 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 70.9 mt -57.6 -66.11 1.45 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.577 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -60.13 -24.94 78.53 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.261 1.307 . . . . 0.0 110.839 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.414 ' HB3' ' HE1' ' A' ' 65' ' ' MET . 79.0 mmm -71.67 -31.6 66.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.495 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 58.4 mt -75.51 -46.47 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.513 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.55 -54.65 18.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.53 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 72' ' ' LEU . 58.1 t -67.13 -40.87 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.338 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.52 -41.61 99.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.876 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.89 -46.21 72.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.411 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -63.4 -44.67 96.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.683 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 68' ' ' VAL . 85.4 mt -73.68 -30.37 62.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.967 0.413 . . . . 0.0 110.273 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.447 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 92.8 t80 -58.27 -47.44 83.59 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 6.4 p -78.64 -34.0 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.43 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.477 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -70.07 -74.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.411 ' CE2' HD23 ' A' ' 72' ' ' LEU . 31.1 m-85 -56.89 -29.58 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -93.48 -54.3 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 78' ' ' VAL . 14.8 t -92.08 -10.03 9.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.79 -55.78 13.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.04 -40.35 76.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.614 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.588 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 82.4 mt -70.32 -45.39 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 3.9 m120 -71.19 -13.96 62.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.118 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.457 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 28.0 ttt -82.89 -59.05 2.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 10.5 p-10 -67.39 -42.38 83.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.099 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' C ' ' A' ' 8' ' ' LEU . 3.4 tm? -59.97 -34.15 72.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.57 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 51.2 tp -68.43 -63.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.132 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 5.8 m-85 -53.64 -42.57 67.94 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.183 0.516 . . . . 0.0 109.935 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -66.31 -36.29 82.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.409 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -63.77 -31.25 72.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.743 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -68.08 -33.08 73.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -54.65 17.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.06 -41.94 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.762 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 15.2 mmt -62.03 -50.8 70.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.765 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.5 mmm -66.51 -39.65 88.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.566 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.642 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -69.65 -49.84 34.43 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -59.41 -47.28 86.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' N ' ' CD1' ' A' ' 19' ' ' LEU . . . -66.58 -33.0 74.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.734 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -67.14 -42.26 84.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 18' ' ' GLY . 75.1 mt -62.25 -60.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.87 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.77 -45.88 90.53 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.808 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -62.32 -40.79 97.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.589 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.454 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -63.55 -43.88 95.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.212 0.53 . . . . 0.0 110.275 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.81 ' O ' HG13 ' A' ' 30' ' ' ILE . 79.4 mt -58.24 -61.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.174 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' HA2' HD13 ' A' ' 30' ' ' ILE . . . -67.16 -42.32 91.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.156 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.7 tp -54.87 -46.75 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.475 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.21 -36.43 92.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.65 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.81 HG13 ' O ' ' A' ' 26' ' ' ILE . 72.3 mt -61.88 -72.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.521 0.201 . . . . 0.0 110.856 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.3 tm? -71.39 -42.06 68.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -65.18 -44.05 94.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.793 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.59 -38.04 95.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.418 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 18.8 ptpt -71.99 -47.88 48.91 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.6 t80 -63.91 -49.44 72.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CD2' ' C ' ' A' ' 36' ' ' LEU . 5.1 tt -56.24 -51.44 68.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.271 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 34' ' ' LYS . 12.6 pt-20 -57.26 -51.65 68.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.862 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -54.02 -53.7 35.54 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.77 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -64.62 -42.32 95.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.093 0.473 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 36' ' ' LEU . . . -57.0 -30.82 64.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.575 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 97.2 mtt180 -82.3 -37.82 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 109.706 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.765 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . 3.1 tp-100 -44.86 127.97 5.27 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.352 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -32.78 -33.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 124.755 3.637 . . . . 0.0 115.879 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -141.02 29.3 1.86 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.765 ' HB2' ' HB3' ' A' ' 42' ' ' GLN . 8.6 mp -114.38 6.98 16.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 111.563 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.3 mp -48.61 -47.29 71.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.704 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 79.3 Cg_endo -78.92 -16.69 12.55 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.867 1.711 . . . . 0.0 111.174 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 40.4 tp -69.52 -30.74 68.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -47.48 -59.21 3.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.556 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.507 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 86.7 mtm180 -72.06 -42.54 66.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 110.196 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.652 ' O ' HG12 ' A' ' 55' ' ' ILE . 28.0 m -52.74 -39.61 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 18.3 pt20 -84.59 -33.82 23.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.6 -49.7 75.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.231 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -73.2 -30.09 63.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 51' ' ' THR . 38.7 mm -69.69 -56.75 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.262 0.553 . . . . 0.0 109.843 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' HD13 ' A' ' 59' ' ' LEU . 41.1 t -61.57 -39.23 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.302 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.75 -34.26 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.537 . . . . 0.0 110.204 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.03 63.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.352 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.601 HD13 HG21 ' A' ' 60' ' ' VAL . 3.7 pp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.133 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.601 HG21 HD13 ' A' ' 59' ' ' LEU . 99.7 t -78.16 -51.25 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -69.04 -12.77 61.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.51 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.591 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.48 -33.32 69.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.696 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 70.3 mt -60.85 -64.92 2.52 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.285 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 35.1 Cg_exo -55.71 -26.5 56.54 Favored 'Trans proline' 0 C--N 1.359 1.092 0 CA-C-N 120.123 1.08 . . . . 0.0 110.845 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.14 -30.85 66.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.633 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 62' ' ' ALA . 80.0 mt -76.73 -44.59 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.457 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.06 -58.42 4.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.3 t -63.52 -39.53 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.192 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -64.67 -47.5 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.735 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 2.1 tm? -60.7 -44.74 96.19 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.37 58.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.172 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 4.2 pp -69.34 -26.06 64.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 11.7 t80 -54.68 -47.35 73.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 109.628 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 13.4 p -90.6 -28.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.675 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.57 ' HG3' ' CD2' ' A' ' 9' ' ' LEU . 94.2 mmm -82.14 -74.99 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 72' ' ' LEU . 15.5 m-30 -58.53 -28.79 65.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.378 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 -55.08 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 48.1 t -87.75 -2.75 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.158 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.94 -51.35 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.5 -38.28 86.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.7 -32.62 68.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.12 -30.94 62.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 10' ' ' TYR . 51.5 ttm -77.42 -46.22 23.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.746 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.41 -46.57 69.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.369 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.514 HD11 ' C ' ' A' ' 8' ' ' LEU . 3.4 tm? -59.98 -32.26 70.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.483 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 61.2 tp -64.87 -58.23 6.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.778 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 6' ' ' MET . 9.1 m-30 -47.38 -54.3 11.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.521 0.676 . . . . 0.0 109.839 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -61.45 -38.56 87.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.721 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.82 -33.7 74.61 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.83 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.6 -52.57 51.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.078 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.48 -44.45 96.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.303 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.619 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.48 -55.42 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.773 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.2 mmm -58.68 -42.21 88.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.579 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.652 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -68.72 -53.98 17.32 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.695 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 16' ' ' MET . 3.4 pp -57.72 -44.07 85.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 110.196 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 16' ' ' MET . . . -67.89 -32.44 72.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.45 86.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 18' ' ' GLY . 47.4 mm -62.37 -64.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.576 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.31 -50.51 46.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.677 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.22 -42.09 85.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.852 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -56.95 -59.52 4.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 22' ' ' ILE . 1.9 mp -53.72 -57.46 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.16 97.32 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.896 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.852 HG21 ' O ' ' A' ' 25' ' ' ALA . 6.0 tp -58.13 -43.67 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.03 -35.84 92.64 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.599 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -60.39 -72.3 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.611 0.244 . . . . 0.0 110.762 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD2' ' HD2' ' A' ' 34' ' ' LYS . 3.2 tm? -69.02 -41.55 77.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.107 0.48 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -60.21 -43.24 98.64 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.834 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.87 -48.48 80.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.077 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -62.77 -50.87 69.33 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.893 0.377 . . . . 0.0 110.922 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 15.3 t80 -62.66 -49.23 75.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.514 HD12 HD23 ' A' ' 49' ' ' LEU . 2.4 tm? -61.46 -37.18 82.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.796 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -58.79 -57.93 10.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.13 -56.78 18.51 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.245 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -50.29 -25.24 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.133 0.492 . . . . 0.0 111.255 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.72 ' HB1' HD23 ' A' ' 49' ' ' LEU . . . -92.86 -33.21 14.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.242 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 9.1 mmp_? -63.96 -25.04 67.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.26 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 10.9 mm100 -100.44 117.2 63.39 Favored Pre-proline 0 N--CA 1.435 -1.225 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.073 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 42' ' ' GLN . 9.7 Cg_endo -56.05 -7.44 1.74 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.008 2.472 . . . . 0.0 113.787 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -98.69 -25.39 14.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.53 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 mm? -92.16 11.56 25.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 13.9 mt -53.98 -44.24 97.97 Favored Pre-proline 0 C--O 1.225 -0.222 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.107 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 13.0 Cg_exo -68.83 -21.44 38.11 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.708 1.605 . . . . 0.0 110.694 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 48.4 tp -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.72 HD23 ' HB1' ' A' ' 40' ' ' ALA . 69.1 mt -45.54 -63.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.449 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 47' ' ' PRO . 58.8 mtm-85 -67.6 -41.15 84.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.143 0.496 . . . . 0.0 110.305 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.86 ' O ' HG13 ' A' ' 55' ' ' ILE . 42.1 m -60.01 -39.68 86.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.076 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -81.25 -29.89 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.059 0.457 . . . . 0.0 110.155 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -61.22 -57.32 12.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.746 ' CE1' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -69.4 -34.58 74.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.86 HG13 ' O ' ' A' ' 51' ' ' THR . 33.6 mt -71.27 -56.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.658 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 52' ' ' GLN . 59.5 t -62.83 -37.34 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.499 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.412 ' CE ' HG12 ' A' ' 28' ' ' ILE . 61.3 tpp -73.69 -39.29 64.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.231 0.539 . . . . 0.0 110.386 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.96 -44.78 66.0 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.76 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 93.4 mt -60.21 -39.21 85.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.145 0.498 . . . . 0.0 110.071 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -42.3 77.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.656 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 41.0 m-20 -79.32 -13.09 59.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.648 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' O ' HD12 ' A' ' 66' ' ' ILE . . . -67.12 -21.89 65.82 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.311 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 66.8 mt -65.13 -56.19 21.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.565 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 2.8 Cg_exo -77.94 -26.32 6.75 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.846 1.697 . . . . 0.0 110.979 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.413 ' HB2' ' HE1' ' A' ' 65' ' ' MET . 50.6 tpp -70.69 -31.71 68.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 62' ' ' ALA . 1.2 mp -81.55 -44.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.771 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.8 48.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 109.984 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 74.6 t -67.98 -43.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.284 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.14 -43.08 99.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.989 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 2.5 tm? -63.87 -46.22 85.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 109.783 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.41 -55.52 30.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.493 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 3.9 pp -68.2 -28.15 67.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.452 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 87.4 t80 -52.54 -45.62 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.284 0.564 . . . . 0.0 109.711 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.6 p -93.0 -29.08 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.547 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 24.1 mmt -82.34 -70.04 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.321 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 10' ' ' TYR . 7.9 m-85 -61.21 -28.52 69.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 73' ' ' TYR . . . -98.76 -58.9 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 111.839 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 49.7 t -83.82 -2.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.06 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.851 0.357 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.566 ' HE1' HD13 ' A' ' 4' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.586 0.231 . . . . 0.0 111.544 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.534 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 50.0 mt-10 -66.32 -53.44 36.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.203 0.525 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . 0.416 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 75.2 m-20 -63.02 -31.73 72.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.792 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.566 HD13 ' HE1' ' A' ' 1' ' ' MET . 79.7 mt -72.54 -50.86 22.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.35 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' A' ' 2' ' ' GLU . 11.4 p-10 -69.67 -17.99 63.53 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.649 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.527 ' HG3' ' CZ ' ' A' ' 10' ' ' TYR . 10.3 tpt -85.9 -47.08 9.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.346 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 2.3 p30 -72.65 -40.68 66.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 60.3 mt -61.99 -32.7 73.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.512 HD12 ' HG3' ' A' ' 75' ' ' MET . 7.3 tt -70.26 -48.57 56.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 6' ' ' MET . 11.0 m-30 -48.58 -54.64 13.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.813 0.816 . . . . 0.0 109.105 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 ttm -63.61 -38.59 91.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.123 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -60.77 -33.07 72.4 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.915 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.68 80.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.04 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.38 55.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.499 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.09 -47.1 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -59.08 -45.65 90.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.84 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 15.3 mmt -65.2 -42.75 93.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.15 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.677 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -70.14 -50.19 29.46 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.733 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 4.0 pp -60.03 -44.88 94.32 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.095 0.474 . . . . 0.0 109.938 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.561 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -65.68 -38.42 89.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.332 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 17' ' ' MET . . . -61.76 -45.19 94.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.537 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.1 mm -60.55 -61.6 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -52.93 42.63 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.933 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 20' ' ' ALA . . . -56.8 -41.61 78.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.807 0.337 . . . . 0.0 110.693 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -61.95 -44.32 97.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.725 ' O ' HG13 ' A' ' 30' ' ' ILE . 66.0 mt -59.37 -55.76 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.756 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 30' ' ' ILE . . . -64.66 -50.39 59.08 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.012 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 29' ' ' GLY . 2.9 pp -48.92 -46.86 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.518 ' N ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.52 -39.3 96.21 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.725 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.3 mt -57.92 -72.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.635 0.255 . . . . 0.0 111.073 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.457 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 61.2 tp -73.51 -40.26 64.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -59.27 -39.44 94.63 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.62 -50.37 59.33 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.953 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -60.9 -52.41 65.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.169 0.509 . . . . 0.0 110.657 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.37 -52.88 63.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 47.6 tp -58.86 -36.04 73.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.151 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.83 -58.54 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.565 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -56.57 -56.31 25.29 Favored Glycine 0 C--O 1.242 0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.115 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.48 -16.16 53.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.335 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.682 ' HA ' HD22 ' A' ' 49' ' ' LEU . . . -95.94 -23.58 16.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.611 0.243 . . . . 0.0 110.831 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.571 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 16.0 ptm180 -86.31 -15.11 41.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -96.91 93.62 1.48 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.339 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 78.0 Cg_exo -38.06 -25.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.729 2.953 . . . . 0.0 114.729 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.28 2.81 42.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -116.02 18.97 15.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 22.8 mt -52.66 -45.92 96.23 Favored Pre-proline 0 C--O 1.224 -0.266 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.541 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 14.5 Cg_exo -67.82 -22.43 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.563 1.509 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 25.4 tp -68.74 -37.27 79.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.682 HD22 ' HA ' ' A' ' 40' ' ' ALA . 63.9 mt -45.45 -65.45 0.54 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.34 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.07 -42.09 85.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.931 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.485 ' O ' HG12 ' A' ' 55' ' ' ILE . 50.6 m -58.58 -39.51 80.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.456 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 20.7 pt20 -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.054 0.454 . . . . 0.0 110.218 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -59.16 -52.43 65.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.806 ' CE1' HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.09 -33.44 63.63 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.451 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.806 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.3 mm -69.76 -54.72 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.311 0.577 . . . . 0.0 110.063 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.892 ' HA ' HD13 ' A' ' 59' ' ' LEU . 59.8 t -64.53 -36.97 78.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.119 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HE2' ' CD1' ' A' ' 28' ' ' ILE . 24.6 mmt -82.24 -29.51 31.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 0.0 110.433 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HB1' ' A' ' 62' ' ' ALA . . . -81.21 -37.81 17.06 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.909 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.892 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -71.19 -21.41 62.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.829 0.814 . . . . 0.0 109.931 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 56' ' ' VAL . 78.3 t -88.19 -44.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.694 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -74.23 -22.15 59.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.74 -29.39 66.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.32 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.592 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 1.8 mp -58.15 -70.39 0.39 Allowed Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.114 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 25.6 Cg_exo -57.39 -27.38 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 120.787 0.992 . . . . 0.0 111.007 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.419 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 47.7 tpp -71.06 -30.33 66.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.166 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 62' ' ' ALA . 68.7 mt -79.31 -44.03 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.505 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.97 -56.8 6.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 0.0 109.947 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.584 ' O ' HD11 ' A' ' 72' ' ' LEU . 86.2 t -63.12 -44.0 99.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.061 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -58.31 -46.69 92.59 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.339 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.483 ' N ' HD21 ' A' ' 70' ' ' LEU . 4.4 mm? -65.93 -46.18 79.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.842 0.321 . . . . 0.0 110.99 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -62.48 -52.71 47.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.807 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 68' ' ' VAL . 5.7 mp -65.89 -32.26 73.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.945 0.402 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 94.1 t80 -54.2 -46.74 72.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.361 0.6 . . . . 0.0 109.727 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.611 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 49.1 t -86.3 -30.79 6.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.614 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.536 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 21.8 mmt -75.44 -74.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.501 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 20.2 m-85 -62.37 -27.64 69.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.78 -49.17 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 52.8 t -91.72 -6.24 10.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.047 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 111.242 179.676 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.952 0.406 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 6' ' ' MET . 56.0 mt-10 -62.09 -52.08 65.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.83 -46.23 85.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.699 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.471 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 84.3 mt -68.93 -33.29 73.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.775 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -70.7 -28.22 64.58 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.409 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.568 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 26.5 mmt -80.58 -53.11 6.85 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.092 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.9 p30 -64.13 -39.64 94.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.129 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 57.1 tp -63.4 -28.06 69.72 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.875 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 2.1 tm? -69.11 -65.5 0.7 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.158 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -51.83 -37.76 53.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.526 0.679 . . . . 0.0 109.451 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.39 73.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.672 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -65.29 -31.94 73.34 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.774 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.1 79.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.76 44.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.6 -47.31 93.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.781 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -58.36 -47.46 83.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.145 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.403 ' CE ' HG22 ' A' ' 68' ' ' VAL . 21.1 mmt -67.72 -37.62 82.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.614 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.76 -53.37 16.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.051 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 HD13 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.06 -42.58 94.83 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.213 0.53 . . . . 0.0 109.767 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -67.84 -31.77 71.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.337 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.02 82.81 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.178 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 18' ' ' GLY . 43.4 mm -63.93 -61.63 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.585 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.04 -49.72 61.69 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.514 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.623 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.5 -42.18 87.06 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 110.63 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.78 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -59.63 -61.6 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.676 ' O ' HG12 ' A' ' 30' ' ' ILE . 2.1 mp -51.29 -52.63 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.04 77.21 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.258 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.78 HG21 ' O ' ' A' ' 25' ' ' ALA . 5.5 tp -57.13 -44.95 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.96 -40.23 95.22 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.96 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 26' ' ' ILE . 36.6 mm -55.03 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.565 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 35' ' ' PHE . 7.9 tt -68.2 -26.87 65.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.984 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -58.77 -45.08 95.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.257 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.86 -52.38 50.81 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.06 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 14.6 ptmm? -60.55 -51.1 70.87 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.195 0.521 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB2' HD22 ' A' ' 31' ' ' LEU . 15.4 t80 -63.01 -48.94 76.63 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.713 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 53.0 tp -65.07 -36.27 83.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.05 -63.09 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.069 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.82 -49.47 67.98 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.553 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -53.8 -37.78 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.549 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . . . -81.91 -22.49 36.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -64.92 -34.06 77.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 44' ' ' ASP . 68.1 mt-30 -57.81 123.38 63.16 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.12 1.71 0.58 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.73 2.287 . . . . 0.0 112.757 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.506 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.9 t0 -130.23 34.09 4.25 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 120.84 0.353 . . . . 0.0 110.334 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.703 ' HG ' ' HA ' ' A' ' 40' ' ' ALA . 2.6 tm? -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.51 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.587 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.4 mp -30.09 -58.64 0.29 Allowed Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 81.8 Cg_endo -77.66 -27.67 5.94 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.237 1.291 . . . . 0.0 110.938 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 23.0 tp -66.21 -21.52 66.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -56.41 -56.98 14.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.46 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.525 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 54.0 mtp85 -75.5 -34.88 60.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.141 0.496 . . . . 0.0 110.169 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.914 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 59.7 m -64.72 -33.33 75.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.45 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 2.8 pt20 -81.43 -36.91 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.413 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 12.2 t80 -55.52 -55.42 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.695 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.914 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 3.8 p90 -72.89 -38.5 66.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.493 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.554 HG12 ' CE1' ' A' ' 54' ' ' PHE . 21.1 mm -61.25 -59.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 110.335 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 60' ' ' VAL . 40.7 t -60.64 -50.0 82.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.124 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.67 -34.69 76.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.206 0.527 . . . . 0.0 110.571 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.31 -42.81 48.58 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.589 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' A' ' 60' ' ' VAL . 4.6 pp -66.88 -33.68 76.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.45 0.625 . . . . 0.0 109.881 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG21 ' CD1' ' A' ' 59' ' ' LEU . 59.5 t -76.76 -49.8 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.039 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.43 -17.61 63.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.074 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.595 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.4 -34.26 68.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.626 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 52.0 mt -59.32 -69.02 0.59 Allowed Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.297 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 24.5 Cg_exo -53.49 -26.47 36.42 Favored 'Trans proline' 0 C--N 1.356 0.926 0 CA-C-N 119.845 0.98 . . . . 0.0 110.842 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.15 -30.69 66.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 62' ' ' ALA . 81.8 mt -77.99 -43.26 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.724 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.91 -58.49 3.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.858 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 59.8 t -62.33 -40.1 86.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.7 -49.72 75.51 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.064 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.83 -41.59 82.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.0 111.196 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.448 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -65.92 -48.01 69.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.173 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 9' ' ' LEU . 74.0 mt -70.76 -34.76 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 88.4 t80 -54.78 -46.77 74.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.198 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 8.3 p -84.27 -27.22 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.529 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.875 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -78.04 -74.71 0.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.53 -27.85 64.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -93.5 -56.57 2.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 27.1 t -87.63 -8.56 10.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.629 ' HB1' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 111.183 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -58.05 -67.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -59.65 -32.8 70.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.433 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 80.6 mt -67.99 -40.86 83.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.237 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 21.6 p30 -70.42 -33.79 71.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.568 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.448 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 60.7 mtm -68.82 -56.11 9.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.766 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -63.23 -44.11 96.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 3.2 tm? -60.7 -29.51 69.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 5.9 tt -69.23 -60.85 2.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.668 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -51.31 -45.31 62.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.303 0.573 . . . . 0.0 109.495 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.81 -40.21 91.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.698 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -57.99 -32.4 67.86 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.299 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -67.24 -37.8 84.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.28 50.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.99 -41.17 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.01 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.7 mmm -61.03 -50.66 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.917 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 26.3 mmt -65.88 -39.58 90.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.646 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.66 -51.2 26.53 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -61.0 -44.76 96.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' N ' ' CD1' ' A' ' 19' ' ' LEU . . . -66.14 -32.18 73.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.262 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.03 86.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.392 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.6 mm -63.39 -60.52 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.771 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.1 92.88 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.617 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -59.62 -47.15 86.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 110.72 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 28' ' ' ILE . . . -59.0 -53.12 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 110.932 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.78 ' O ' HG12 ' A' ' 30' ' ' ILE . 70.0 mt -51.78 -59.08 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.42 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.52 -44.44 92.95 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.393 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -49.25 -47.52 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.84 -40.44 98.4 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.911 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 26' ' ' ILE . 45.9 mm -56.45 -74.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 68.7 tp -67.21 -44.07 80.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -52.88 -43.76 61.06 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.557 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.04 -55.24 29.22 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 5.2 ptpp? -57.48 -52.06 66.93 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 120.965 0.412 . . . . 0.0 111.308 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.439 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 t80 -62.43 -54.38 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.459 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 53.5 tp -52.8 -39.58 62.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.316 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -64.3 0.96 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.1 27.13 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.039 -1.076 . . . . 0.0 111.572 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.545 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -58.54 -31.21 67.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.591 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -71.64 -29.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.981 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -87.62 -16.88 33.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.89 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.64 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 60.9 mt-30 -70.71 167.82 24.84 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.673 0.749 . . . . 0.0 111.229 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 58.4 Cg_endo -80.17 12.34 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.112 3.208 . . . . 0.0 113.081 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 p-10 -125.22 -83.87 0.64 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.87 ' O ' HD11 ' A' ' 48' ' ' LEU . 3.7 tt 69.87 -51.53 0.63 Allowed 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 6.8 mt -44.92 -50.29 26.27 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.344 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 57.9 Cg_endo -72.93 -23.74 18.34 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.444 1.429 . . . . 0.0 111.741 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.87 HD11 ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -66.22 -37.38 85.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 31.9 mt -48.61 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.82 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -74.95 -34.91 62.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 81.3 m -66.49 -31.76 72.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.13 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.587 ' NE2' HD21 ' A' ' 48' ' ' LEU . 62.1 mt-30 -98.43 -36.42 9.96 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.868 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.75 -46.3 90.2 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.37 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -76.08 -42.59 46.9 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.895 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 51' ' ' THR . 47.0 mm -69.41 -46.34 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.502 ' O ' HG21 ' A' ' 60' ' ' VAL . 95.7 t -67.19 -42.44 88.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.666 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -67.49 -40.86 85.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.432 0.634 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.29 68.7 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.639 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.537 HD13 HG21 ' A' ' 60' ' ' VAL . 4.6 pp -65.87 -23.83 66.74 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.449 0.625 . . . . 0.0 110.649 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 59' ' ' LEU . 88.6 t -83.52 -53.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.41 0.624 . . . . 0.0 109.507 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' MET . 59.4 m-20 -62.97 -20.16 64.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.833 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -54.85 -35.41 63.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.567 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 60.8 mt -58.73 -66.56 1.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.888 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.567 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -59.5 -22.97 68.85 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.295 1.33 . . . . 0.0 111.08 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.426 ' HE3' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -72.7 -32.05 65.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 62' ' ' ALA . 65.5 mt -74.85 -46.65 40.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.741 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.92 -57.25 6.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.323 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 62.7 t -64.68 -34.39 69.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.382 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.11 -50.65 44.46 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.613 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.2 -43.21 96.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.494 0.664 . . . . 0.0 109.769 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.479 ' CA ' HD13 ' A' ' 9' ' ' LEU . . . -60.62 -59.46 10.2 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 76' ' ' PHE . 4.7 pp -61.02 -27.51 68.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.104 0.478 . . . . 0.0 110.954 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 89.2 t80 -58.56 -45.0 89.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.171 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 38.8 t -90.92 -32.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.963 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 mpp? -86.72 -69.67 0.66 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.777 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 9.6 m-85 -58.49 -27.2 64.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -98.59 -62.15 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 22.4 t -83.57 1.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.166 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.824 0.345 . . . . 0.0 111.225 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 4.2 mpp? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 6' ' ' MET . 16.9 tp10 -64.73 -44.81 88.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.903 0.383 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -58.32 -55.31 36.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.444 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.542 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -68.64 -35.86 77.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.771 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 1' ' ' MET . 63.4 m-20 -73.06 -22.38 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.875 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 49.7 mtm -82.01 -51.54 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.537 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 53.1 p-10 -71.7 -37.84 70.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.098 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 3.0 tm? -65.27 -33.72 76.64 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 75' ' ' MET . 3.4 tm? -70.91 -55.94 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.763 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -51.05 -53.45 33.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.742 0.782 . . . . 0.0 109.65 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -38.03 84.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.64 -33.7 75.55 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -66.93 -38.74 86.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.06 68.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -51.66 65.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.433 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.596 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -59.17 -55.51 33.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.773 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . 0.629 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 81.1 mtp -62.72 -41.3 99.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.387 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.594 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.24 -52.05 34.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 16' ' ' MET . 4.0 pp -59.42 -44.99 92.76 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.625 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . -67.05 -30.07 70.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.52 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 17' ' ' MET . . . -68.76 -38.83 80.37 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.175 0.512 . . . . 0.0 109.664 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 18' ' ' GLY . 49.1 mm -62.83 -58.32 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.732 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.2 -47.4 90.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.31 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.618 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -57.5 -38.73 75.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -67.14 -44.01 80.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.697 ' O ' HG13 ' A' ' 30' ' ' ILE . 32.9 mm -58.71 -52.32 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.306 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 30' ' ' ILE . . . -66.9 -48.32 61.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.938 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 24' ' ' ALA . 38.5 pt -51.86 -46.78 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -62.24 -37.04 93.9 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 26' ' ' ILE . 65.5 mt -58.17 -77.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.91 -47.6 74.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.127 0.489 . . . . 0.0 110.853 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -54.42 -48.73 63.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.365 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.06 90.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.662 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.689 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 44.8 mmtm -59.59 -64.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 110.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -62.28 -40.16 95.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 109.692 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 49' ' ' LEU . 34.1 tp -57.61 -40.86 80.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.63 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.58 -56.58 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -58.22 -54.55 36.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.042 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -56.05 -25.6 45.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.534 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . . . -83.34 -37.08 23.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.828 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 41.0 ptt180 -85.05 -6.28 59.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.432 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.903 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 58.8 tp60 -71.85 -108.57 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 71.7 Cg_endo -101.48 -68.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.737 0 CA-C-N 122.381 1.886 . . . . 0.0 112.835 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 46' ' ' ILE . 3.0 p30 -158.95 36.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.976 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 74.7 mt -74.77 16.13 0.31 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.506 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 37.9 mt -46.99 -44.31 46.99 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.306 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.3 Cg_endo -70.99 -29.25 18.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.08 1.187 . . . . 0.0 110.159 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 51.2 tp -64.0 -33.06 74.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 26.4 mt -47.93 -67.52 0.27 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.759 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -61.69 -46.25 90.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.02 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.724 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.6 m -55.94 -39.57 71.91 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -85.32 -26.02 26.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -60.64 -54.01 50.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE1' ' O ' ' A' ' 51' ' ' THR . 2.9 p90 -68.29 -30.14 69.07 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.716 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 51' ' ' THR . 36.5 mm -66.45 -58.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 60' ' ' VAL . 78.7 t -55.61 -46.39 79.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.222 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.453 ' HA ' ' CG2' ' A' ' 28' ' ' ILE . 62.4 ttp -69.47 -33.16 72.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -71.49 -42.67 55.25 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.978 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.501 HD13 ' CG2' ' A' ' 60' ' ' VAL . 4.4 pp -65.17 -29.13 69.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.142 0.471 . . . . 0.0 110.198 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 56' ' ' VAL . 98.1 t -78.01 -48.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 46.9 m-20 -73.27 -8.72 57.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.299 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -61.72 -30.69 70.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 56.2 mt -62.0 -62.21 6.25 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 31.0 Cg_exo -60.9 -25.42 81.33 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.044 1.051 . . . . 0.0 110.424 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -70.02 -31.1 68.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.29 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 62' ' ' ALA . 74.1 mt -78.24 -45.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.623 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -56.29 13.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.088 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 43.8 t -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.034 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 72' ' ' LEU . . . -59.52 -45.43 95.58 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.127 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.04 -44.53 88.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 109.791 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -64.33 -45.78 92.48 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.525 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 75' ' ' MET . 4.0 pp -66.76 -32.71 74.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.371 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.417 ' N ' HD13 ' A' ' 72' ' ' LEU . 92.7 t80 -54.98 -47.03 75.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 47.1 t -86.03 -30.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.445 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.658 ' HG3' ' HG ' ' A' ' 9' ' ' LEU . 20.9 mmt -73.21 -76.13 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.29 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.475 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 27.1 m-85 -60.78 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -92.96 -59.84 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 94.6 t -82.55 -6.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.062 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.117 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.843 0.354 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.13 -49.39 65.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -63.74 -30.61 71.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.55 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.529 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -76.68 -48.33 19.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.783 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.72 -15.69 62.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.05 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 27.3 ttt -82.05 -57.49 3.38 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.765 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.529 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 7.0 p-10 -68.68 -41.56 79.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.979 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 55.1 tp -60.1 -39.39 86.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.523 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 35.4 tp -67.48 -57.4 6.58 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.108 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 8.6 m-30 -50.85 -51.99 45.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 109.742 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.404 ' HE1' ' HB2' ' A' ' 11' ' ' MET . 45.7 ttm -60.43 -38.98 85.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.817 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.07 -35.49 77.1 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.423 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.489 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -64.32 -37.32 87.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.03 -54.52 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.29 -49.59 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.999 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.568 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -57.5 -46.02 84.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.081 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.489 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 85.5 mmm -65.24 -41.56 94.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.525 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -67.25 -54.33 20.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.868 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.452 HD11 ' C ' ' A' ' 19' ' ' LEU . 3.6 pp -59.67 -42.65 93.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . -68.89 -30.58 69.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.717 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -67.74 -41.89 82.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.893 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 26' ' ' ILE . 67.2 mt -64.45 -56.7 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.931 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.72 98.74 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.425 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -60.62 -45.26 94.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.65 -46.81 88.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.754 ' O ' HG13 ' A' ' 30' ' ' ILE . 40.8 mm -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.458 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.74 -48.3 68.34 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.113 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 24' ' ' ALA . 36.2 pt -49.48 -46.77 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 117.541 0.67 . . . . 0.0 109.331 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.5 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -65.43 -36.79 93.06 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.118 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.754 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.2 mt -59.73 -71.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 110.68 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 35' ' ' PHE . 5.9 tt -68.26 -30.94 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -59.71 -47.93 88.55 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.996 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.01 61.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.295 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 17.9 ptpt -60.51 -53.85 52.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 111.66 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.67 ' HB2' HD22 ' A' ' 31' ' ' LEU . 12.7 t80 -64.05 -48.33 76.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.29 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 2.0 tm? -60.19 -37.68 80.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -61.01 -55.39 33.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.757 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.8 -56.01 27.68 Favored Glycine 0 C--O 1.235 0.196 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.531 ' HA ' ' CD2' ' A' ' 45' ' ' LEU . . . -55.8 -48.02 76.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.286 0.565 . . . . 0.0 110.418 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.571 ' CA ' HD22 ' A' ' 49' ' ' LEU . . . -70.66 -15.87 62.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.589 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 6.4 tpm_? -81.58 -28.41 33.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 90.9 mm-40 -101.85 106.93 49.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.623 ' O ' HG13 ' A' ' 46' ' ' ILE . 5.0 Cg_exo -44.83 -22.72 0.72 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.854 2.369 . . . . 0.0 113.974 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -82.69 -7.2 59.66 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.531 ' CD2' ' HA ' ' A' ' 39' ' ' ALA . 4.3 mp -108.45 19.36 19.9 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.623 HG13 ' O ' ' A' ' 43' ' ' PRO . 32.1 mt -54.8 -45.55 99.65 Favored Pre-proline 0 C--O 1.225 -0.229 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.145 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 15.4 Cg_exo -67.39 -20.83 47.97 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.803 1.669 . . . . 0.0 110.255 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.59 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 27.4 tp -69.44 -38.64 77.92 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD22 ' CA ' ' A' ' 40' ' ' ALA . 51.9 mt -44.29 -62.9 1.0 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.679 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -67.4 -46.36 73.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.6 m -55.73 -46.06 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.77 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.614 ' O ' HG21 ' A' ' 55' ' ' ILE . 16.4 pt20 -70.08 -36.31 74.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.19 -57.45 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.14 -41.64 99.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.202 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.614 HG21 ' O ' ' A' ' 52' ' ' GLN . 11.0 tp -63.23 -50.17 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.698 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.444 ' N ' ' CG2' ' A' ' 55' ' ' ILE . 61.0 t -65.59 -42.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.4 ttm -71.83 -40.82 68.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.279 0.561 . . . . 0.0 110.327 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -68.7 -44.33 71.2 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.357 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 88.4 mt -63.56 -40.57 97.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.166 0.483 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 73.4 t -71.45 -41.39 73.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.425 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 40.7 m-20 -81.19 -9.01 59.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.62 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -66.14 -27.55 68.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.667 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 72.4 mt -62.24 -59.66 12.33 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 16.3 Cg_exo -68.79 -26.38 32.5 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.264 1.309 . . . . 0.0 110.74 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.7 tpt -69.29 -31.7 70.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.494 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 51.8 mt -79.15 -44.92 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.908 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.644 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.26 -53.13 32.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 110.306 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.6 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 97.1 t -64.71 -46.99 90.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -54.5 -50.77 55.67 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.702 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.6 pp -62.79 -42.33 99.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.301 0.572 . . . . 0.0 110.34 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.602 ' N ' HD13 ' A' ' 70' ' ' LEU . . . -58.49 -56.38 25.57 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.845 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 3.9 pp -71.59 -28.46 63.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.605 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 21.4 t80 -57.91 -40.24 79.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 109.654 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.515 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 46.4 t -94.02 -32.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.817 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.534 ' HA ' ' HB1' ' A' ' 79' ' ' ALA . 88.3 mmm -75.03 -76.04 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.237 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.453 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 28.0 m-85 -63.93 -29.0 70.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.605 ' HB2' ' O ' ' A' ' 73' ' ' TYR . . . -96.21 -51.85 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 55.7 t -88.04 -6.49 10.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.66 0.267 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 6' ' ' MET . 42.7 tt0 -61.62 -53.9 50.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -65.68 -32.77 74.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.552 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -77.26 -31.14 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.688 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.43 -29.47 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.28 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 66.0 mtm -80.23 -49.16 11.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.561 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 57.5 p-10 -67.94 -40.13 83.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.255 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.563 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 3.1 tm? -64.13 -30.04 71.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 9' ' ' LEU . 2.1 tm? -68.15 -61.62 1.77 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -50.53 -49.57 55.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.728 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.65 -43.04 99.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -55.25 -42.88 74.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.856 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' MET . . . -56.77 -44.33 81.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.974 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.63 44.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.132 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.38 -62.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.088 179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.52 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.1 mpp? -47.57 -47.3 28.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.709 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.603 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 0.0 OUTLIER -62.32 -45.09 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.935 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.441 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -66.69 -49.99 51.58 Favored Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.027 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 3.4 pp -60.61 -41.69 95.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.095 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -70.34 -32.14 69.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB1' ' O ' ' A' ' 17' ' ' MET . . . -67.05 -44.14 80.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.502 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.1 mt -63.55 -57.61 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.408 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.22 -51.4 58.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.743 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -59.55 -41.32 89.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -62.01 -47.01 86.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.726 ' O ' HG12 ' A' ' 30' ' ' ILE . 36.7 mm -56.71 -60.02 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.29 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.42 -45.91 74.75 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.178 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.529 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.8 tp -51.37 -46.66 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.09 -39.39 97.55 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.739 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.726 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.9 mm -58.01 -69.61 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 34' ' ' LYS . 2.5 tm? -76.31 -44.55 36.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -61.64 -38.35 95.73 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.458 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.21 -51.97 45.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.589 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -58.13 -50.07 74.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.36 0.6 . . . . 0.0 110.168 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -61.32 -41.54 97.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.754 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.42 ' CD1' HD23 ' A' ' 49' ' ' LEU . 58.7 tp -63.79 -41.36 97.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.421 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 47.9 mt-10 -59.52 -53.48 57.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.601 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.97 -61.32 7.11 Favored Glycine 0 C--O 1.239 0.427 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.951 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -49.92 -46.14 51.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.564 ' N ' HD22 ' A' ' 49' ' ' LEU . . . -72.44 -25.83 61.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.629 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.529 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 55.3 ttp180 -67.8 -25.24 65.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -96.85 95.54 2.26 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.098 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 99.4 Cg_exo -38.38 -25.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.46 2.773 . . . . 0.0 114.356 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -79.87 -1.42 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 5.4 mp -121.04 14.91 11.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.543 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 26.9 mm -52.48 -45.15 95.65 Favored Pre-proline 0 N--CA 1.464 0.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.308 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 9.4 Cg_exo -70.24 -21.0 31.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.813 1.675 . . . . 0.0 110.714 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 30.1 tp -67.31 -38.96 85.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD22 ' N ' ' A' ' 40' ' ' ALA . 38.9 mt -47.0 -64.59 0.74 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.829 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.017 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.67 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 46.8 m -58.58 -42.9 89.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.695 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -84.84 -34.79 22.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.949 0.404 . . . . 0.0 110.366 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.5 t80 -51.93 -50.6 60.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.908 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.67 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 1.2 p90 -63.41 -35.47 80.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.836 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.571 HG13 ' O ' ' A' ' 51' ' ' THR . 55.0 mt -66.21 -63.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.24 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 22.6 t -54.62 -40.45 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.638 -178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.7 ttt -71.2 -39.0 72.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 0.0 110.564 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -66.22 -45.91 83.28 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.343 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -57.08 -43.33 82.03 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 109.804 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 50.6 t -66.28 -51.42 59.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.438 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.33 -13.68 62.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.58 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.496 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.77 -33.77 70.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.672 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 53.5 mt -60.69 -66.28 1.63 Allowed Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.598 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.672 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 22.0 Cg_exo -56.94 -25.31 61.69 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 120.055 1.055 . . . . 0.0 111.061 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.11 70.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 62' ' ' ALA . 70.2 mt -77.49 -43.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.26 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.32 -51.24 54.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.17 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.2 t -69.62 -30.53 45.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.269 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.52 -50.84 29.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.775 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.7 pp -62.35 -42.61 99.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.993 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.514 ' N ' ' CD1' ' A' ' 70' ' ' LEU . . . -61.55 -52.53 50.51 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.515 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 4.1 pp -64.04 -30.57 71.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 111.145 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -53.03 -48.54 67.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.266 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -89.75 -31.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.397 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -80.5 -69.08 0.62 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -59.2 -23.04 61.93 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.04 -54.49 5.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.67 -17.43 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.399 -178.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.469 ' H1 ' ' H ' ' A' ' 2' ' ' GLU . 4.2 mpp? . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.469 ' H ' ' H1 ' ' A' ' 1' ' ' MET . 47.8 mt-10 -66.2 -45.9 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.693 0.282 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.65 -45.84 90.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 8' ' ' LEU . 96.6 mt -66.19 -44.74 83.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.608 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -63.2 -36.32 83.23 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.46 ' O ' ' HD1' ' A' ' 10' ' ' TYR . 56.4 ttm -64.22 -69.73 0.26 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.794 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -52.98 -40.65 63.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.526 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 54.7 tp -65.62 -31.01 71.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.762 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HA ' HD21 ' A' ' 9' ' ' LEU . 2.3 tm? -68.6 -52.9 26.5 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.326 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' HD1' ' O ' ' A' ' 6' ' ' MET . 31.3 m-85 -59.69 -42.59 93.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.009 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.7 ttt -63.3 -37.76 88.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.608 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.08 -37.4 84.87 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.474 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -60.22 -46.24 90.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.57 72.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 38.8 t -64.91 -51.52 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.319 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.608 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.32 -51.61 66.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.559 ' HG2' ' HB2' ' A' ' 64' ' ' PRO . 84.6 mtp -62.5 -41.9 99.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.401 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.483 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -68.66 -53.85 18.2 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.567 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.484 ' CD1' ' N ' ' A' ' 20' ' ' ALA . 3.5 pp -58.04 -45.39 87.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.241 0.544 . . . . 0.0 109.892 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' N ' ' CD1' ' A' ' 19' ' ' LEU . . . -66.37 -32.18 73.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.371 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.557 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -68.86 -41.06 78.92 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.508 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 18' ' ' GLY . 92.6 mt -62.26 -57.79 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.777 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -47.76 89.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.446 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -56.42 -42.67 78.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.9 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -61.62 -58.08 9.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.197 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.827 ' O ' HG12 ' A' ' 30' ' ' ILE . 33.8 mm -44.4 -56.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.34 -38.33 87.12 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.766 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.9 HG21 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -56.13 -44.03 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.25 -36.4 89.66 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.546 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.827 HG12 ' O ' ' A' ' 26' ' ' ILE . 42.5 mm -59.63 -69.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.441 0.162 . . . . 0.0 110.81 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.579 HD21 ' HD3' ' A' ' 34' ' ' LYS . 3.0 tm? -74.59 -45.6 44.11 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.658 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.562 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -62.59 -44.11 98.03 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.3 -0.953 . . . . 0.0 110.886 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -60.75 -49.22 81.05 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.853 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' HD3' HD21 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.44 -53.98 49.42 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.058 0.456 . . . . 0.0 110.587 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.25 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 6.8 mp -53.28 -34.65 58.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.925 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 16.3 tp10 -56.77 -61.28 2.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 109.944 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.523 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -54.32 -47.31 69.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.19 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.819 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.26 -34.97 77.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.148 0.499 . . . . 0.0 110.009 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' A' ' 49' ' ' LEU . . . -70.99 -22.87 62.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.616 ' HD2' ' O ' ' A' ' 41' ' ' ARG . 4.5 tmm_? -92.34 -19.39 22.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.763 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.911 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 65.3 mt-30 -61.21 -177.01 0.12 Allowed Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.911 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 73.6 Cg_exo -48.81 -71.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.154 2.569 . . . . 0.0 113.375 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.401 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.6 t70 -146.09 46.94 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.893 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.819 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -84.56 13.22 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 111.131 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.614 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 29.4 mm -52.56 -45.51 95.9 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.635 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 35.3 Cg_endo -68.16 -23.43 39.47 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 120.874 1.05 . . . . 0.0 110.698 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.668 ' O ' ' HG3' ' A' ' 52' ' ' GLN . 35.6 tp -67.8 -38.72 83.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 77.8 mt -43.91 -61.42 1.45 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.743 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.617 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 39.7 ptt180 -63.02 -49.53 74.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.148 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.464 ' O ' HG12 ' A' ' 55' ' ' ILE . 97.6 m -46.83 -48.8 20.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.668 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 40.7 mt-30 -69.3 -33.43 73.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.987 0.423 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.02 -54.19 47.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' HD1' ' O ' ' A' ' 50' ' ' ARG . 31.6 m-85 -65.15 -44.45 88.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.638 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 51' ' ' THR . 36.8 mm -63.86 -56.99 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.1 t -60.78 -48.19 89.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.4 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 26.5 ttt -68.73 -35.53 77.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.216 0.532 . . . . 0.0 110.576 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -69.61 -45.08 60.8 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.07 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 80.2 mt -61.98 -42.5 99.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.65 -50.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.391 179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.4 ' OD2' ' HG2' ' A' ' 57' ' ' MET . 28.6 m-20 -69.13 -16.04 63.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.636 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.73 -33.72 68.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.389 . . . . 0.0 110.506 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 70.9 mt -57.6 -66.11 1.45 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.577 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -60.13 -24.94 78.53 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.261 1.307 . . . . 0.0 110.839 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.414 ' HB3' ' HE1' ' A' ' 65' ' ' MET . 79.0 mmm -71.67 -31.6 66.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.495 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 58.4 mt -75.51 -46.47 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.513 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.55 -54.65 18.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.53 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' A' ' 72' ' ' LEU . 58.1 t -67.13 -40.87 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.338 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.52 -41.61 99.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.876 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 5.2 tt -67.89 -46.21 72.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.411 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -63.4 -44.67 96.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.683 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 68' ' ' VAL . 85.4 mt -73.68 -30.37 62.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.967 0.413 . . . . 0.0 110.273 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.447 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 92.8 t80 -58.27 -47.44 83.59 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.485 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 6.4 p -78.64 -34.0 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.43 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.477 ' O ' ' N ' ' A' ' 79' ' ' ALA . 0.1 OUTLIER -70.07 -74.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.411 ' CE2' HD23 ' A' ' 72' ' ' LEU . 31.1 m-85 -56.89 -29.58 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -93.48 -54.3 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 78' ' ' VAL . 14.8 t -92.08 -10.03 9.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.79 -55.78 13.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.04 -40.35 76.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.614 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.588 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 82.4 mt -70.32 -45.39 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.512 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 3.9 m120 -71.19 -13.96 62.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.118 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.457 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 28.0 ttt -82.89 -59.05 2.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 10.5 p-10 -67.39 -42.38 83.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.099 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD11 ' C ' ' A' ' 8' ' ' LEU . 3.4 tm? -59.97 -34.15 72.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.57 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 51.2 tp -68.43 -63.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.132 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.457 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 5.8 m-85 -53.64 -42.57 67.94 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.183 0.516 . . . . 0.0 109.935 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 tmm? -66.31 -36.29 82.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.409 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -63.77 -31.25 72.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.743 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -68.08 -33.08 73.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -54.65 17.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.4 t -62.06 -41.94 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.762 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.449 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 15.2 mmt -62.03 -50.8 70.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.765 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.415 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.5 mmm -66.51 -39.65 88.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.566 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.642 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -69.65 -49.84 34.43 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.465 ' CD1' ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -59.41 -47.28 86.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' N ' ' CD1' ' A' ' 19' ' ' LEU . . . -66.58 -33.0 74.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.734 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.411 ' O ' ' HB1' ' A' ' 25' ' ' ALA . . . -67.14 -42.26 84.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.642 HG13 ' O ' ' A' ' 18' ' ' GLY . 75.1 mt -62.25 -60.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.87 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.77 -45.88 90.53 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.808 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -62.32 -40.79 97.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.589 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.454 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -63.55 -43.88 95.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.212 0.53 . . . . 0.0 110.275 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.81 ' O ' HG13 ' A' ' 30' ' ' ILE . 79.4 mt -58.24 -61.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.174 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' HA2' HD13 ' A' ' 30' ' ' ILE . . . -67.16 -42.32 91.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.156 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 32' ' ' GLY . 8.7 tp -54.87 -46.75 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.475 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.21 -36.43 92.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.65 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.81 HG13 ' O ' ' A' ' 26' ' ' ILE . 72.3 mt -61.88 -72.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.521 0.201 . . . . 0.0 110.856 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 3.3 tm? -71.39 -42.06 68.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -65.18 -44.05 94.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.793 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.59 -38.04 95.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.418 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.518 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 18.8 ptpt -71.99 -47.88 48.91 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.6 t80 -63.91 -49.44 72.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.464 ' CD2' ' C ' ' A' ' 36' ' ' LEU . 5.1 tt -56.24 -51.44 68.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.271 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 34' ' ' LYS . 12.6 pt-20 -57.26 -51.65 68.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.862 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -54.02 -53.7 35.54 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.77 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -64.62 -42.32 95.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.093 0.473 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 36' ' ' LEU . . . -57.0 -30.82 64.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.575 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.506 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 97.2 mtt180 -82.3 -37.82 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 109.706 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.765 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . 3.1 tp-100 -44.86 127.97 5.27 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.352 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -32.78 -33.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 124.755 3.637 . . . . 0.0 115.879 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -141.02 29.3 1.86 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.765 ' HB2' ' HB3' ' A' ' 42' ' ' GLN . 8.6 mp -114.38 6.98 16.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 111.563 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.3 mp -48.61 -47.29 71.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.704 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.443 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 79.3 Cg_endo -78.92 -16.69 12.55 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.867 1.711 . . . . 0.0 111.174 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.543 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 40.4 tp -69.52 -30.74 68.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -47.48 -59.21 3.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.556 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.507 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 86.7 mtm180 -72.06 -42.54 66.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 110.196 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.652 ' O ' HG12 ' A' ' 55' ' ' ILE . 28.0 m -52.74 -39.61 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 18.3 pt20 -84.59 -33.82 23.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.6 -49.7 75.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.231 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -73.2 -30.09 63.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 51' ' ' THR . 38.7 mm -69.69 -56.75 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.262 0.553 . . . . 0.0 109.843 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.486 ' O ' HD13 ' A' ' 59' ' ' LEU . 41.1 t -61.57 -39.23 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.302 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.75 -34.26 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.537 . . . . 0.0 110.204 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.03 63.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.352 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.601 HD13 HG21 ' A' ' 60' ' ' VAL . 3.7 pp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.133 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.601 HG21 HD13 ' A' ' 59' ' ' LEU . 99.7 t -78.16 -51.25 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -69.04 -12.77 61.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.51 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.591 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.48 -33.32 69.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.696 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 70.3 mt -60.85 -64.92 2.52 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.285 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.696 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 35.1 Cg_exo -55.71 -26.5 56.54 Favored 'Trans proline' 0 C--N 1.359 1.092 0 CA-C-N 120.123 1.08 . . . . 0.0 110.845 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.14 -30.85 66.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.633 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 62' ' ' ALA . 80.0 mt -76.73 -44.59 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.457 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.06 -58.42 4.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.528 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.3 t -63.52 -39.53 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.192 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -64.67 -47.5 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.735 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.403 ' C ' ' CD1' ' A' ' 70' ' ' LEU . 2.1 tm? -60.7 -44.74 96.19 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.37 58.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.172 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 4.2 pp -69.34 -26.06 64.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 11.7 t80 -54.68 -47.35 73.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 109.628 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.603 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 13.4 p -90.6 -28.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.675 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.57 ' HG3' ' CD2' ' A' ' 9' ' ' LEU . 94.2 mmm -82.14 -74.99 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.498 ' CD2' ' HB2' ' A' ' 72' ' ' LEU . 15.5 m-30 -58.53 -28.79 65.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.378 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -96.96 -55.08 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 48.1 t -87.75 -2.75 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.158 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.94 -51.35 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.5 -38.28 86.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.7 -32.62 68.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.12 -30.94 62.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 10' ' ' TYR . 51.5 ttm -77.42 -46.22 23.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.746 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.41 -46.57 69.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.369 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.514 HD11 ' C ' ' A' ' 8' ' ' LEU . 3.4 tm? -59.98 -32.26 70.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.483 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 61.2 tp -64.87 -58.23 6.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.778 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 6' ' ' MET . 9.1 m-30 -47.38 -54.3 11.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.521 0.676 . . . . 0.0 109.839 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -61.45 -38.56 87.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.721 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.619 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.82 -33.7 74.61 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.83 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.442 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.6 -52.57 51.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.078 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.48 -44.45 96.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.303 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.619 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.48 -55.42 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.773 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.2 mmm -58.68 -42.21 88.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.579 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.652 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -68.72 -53.98 17.32 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.695 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 16' ' ' MET . 3.4 pp -57.72 -44.07 85.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 110.196 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 16' ' ' MET . . . -67.89 -32.44 72.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.09 -40.45 86.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.652 HG12 ' O ' ' A' ' 18' ' ' GLY . 47.4 mm -62.37 -64.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.576 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.31 -50.51 46.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.677 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.614 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.22 -42.09 85.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.852 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -56.95 -59.52 4.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.489 HD11 ' O ' ' A' ' 22' ' ' ILE . 1.9 mp -53.72 -57.46 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.16 97.32 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.896 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.852 HG21 ' O ' ' A' ' 25' ' ' ALA . 6.0 tp -58.13 -43.67 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.03 -35.84 92.64 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.599 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.468 HD11 ' N ' ' A' ' 30' ' ' ILE . 1.5 mp -60.39 -72.3 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.611 0.244 . . . . 0.0 110.762 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 ' CD2' ' HD2' ' A' ' 34' ' ' LYS . 3.2 tm? -69.02 -41.55 77.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.107 0.48 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -60.21 -43.24 98.64 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.834 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.87 -48.48 80.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.077 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.624 ' HZ1' ' HB3' ' A' ' 34' ' ' LYS . 1.0 OUTLIER -62.77 -50.87 69.33 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.893 0.377 . . . . 0.0 110.922 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 15.3 t80 -62.66 -49.23 75.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.514 HD12 HD23 ' A' ' 49' ' ' LEU . 2.4 tm? -61.46 -37.18 82.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.796 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -58.79 -57.93 10.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.13 -56.78 18.51 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.245 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.516 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -50.29 -25.24 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.133 0.492 . . . . 0.0 111.255 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.72 ' HB1' HD23 ' A' ' 49' ' ' LEU . . . -92.86 -33.21 14.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.242 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.648 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 9.1 mmp_? -63.96 -25.04 67.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.26 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 43' ' ' PRO . 10.9 mm100 -100.44 117.2 63.39 Favored Pre-proline 0 N--CA 1.435 -1.225 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.073 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 42' ' ' GLN . 9.7 Cg_endo -56.05 -7.44 1.74 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.008 2.472 . . . . 0.0 113.787 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -98.69 -25.39 14.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.53 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.535 ' O ' ' HB3' ' A' ' 48' ' ' LEU . 2.8 mm? -92.16 11.56 25.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 13.9 mt -53.98 -44.24 97.97 Favored Pre-proline 0 C--O 1.225 -0.222 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.107 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 13.0 Cg_exo -68.83 -21.44 38.11 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.708 1.605 . . . . 0.0 110.694 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.535 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 48.4 tp -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.72 HD23 ' HB1' ' A' ' 40' ' ' ALA . 69.1 mt -45.54 -63.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.449 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' A' ' 47' ' ' PRO . 58.8 mtm-85 -67.6 -41.15 84.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.143 0.496 . . . . 0.0 110.305 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.86 ' O ' HG13 ' A' ' 55' ' ' ILE . 42.1 m -60.01 -39.68 86.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.076 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.488 ' HG3' ' O ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -81.25 -29.89 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.059 0.457 . . . . 0.0 110.155 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -61.22 -57.32 12.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.746 ' CE1' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -69.4 -34.58 74.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.86 HG13 ' O ' ' A' ' 51' ' ' THR . 33.6 mt -71.27 -56.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.658 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 52' ' ' GLN . 59.5 t -62.83 -37.34 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.499 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.412 ' CE ' HG12 ' A' ' 28' ' ' ILE . 61.3 tpp -73.69 -39.29 64.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.231 0.539 . . . . 0.0 110.386 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.96 -44.78 66.0 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.76 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 93.4 mt -60.21 -39.21 85.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.145 0.498 . . . . 0.0 110.071 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.1 t -70.64 -42.3 77.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.745 179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.656 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 41.0 m-20 -79.32 -13.09 59.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.648 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' O ' HD12 ' A' ' 66' ' ' ILE . . . -67.12 -21.89 65.82 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.311 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.63 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 66.8 mt -65.13 -56.19 21.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.565 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 2.8 Cg_exo -77.94 -26.32 6.75 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.846 1.697 . . . . 0.0 110.979 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.413 ' HB2' ' HE1' ' A' ' 65' ' ' MET . 50.6 tpp -70.69 -31.71 68.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.592 HD12 ' O ' ' A' ' 62' ' ' ALA . 1.2 mp -81.55 -44.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.771 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.8 48.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 109.984 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 74.6 t -67.98 -43.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.284 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.14 -43.08 99.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.989 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 66' ' ' ILE . 2.5 tm? -63.87 -46.22 85.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 109.783 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.41 -55.52 30.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.493 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 3.9 pp -68.2 -28.15 67.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.452 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.502 ' O ' ' HB2' ' A' ' 77' ' ' ALA . 87.4 t80 -52.54 -45.62 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.284 0.564 . . . . 0.0 109.711 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.6 p -93.0 -29.08 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.547 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 24.1 mmt -82.34 -70.04 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.321 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 10' ' ' TYR . 7.9 m-85 -61.21 -28.52 69.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 73' ' ' TYR . . . -98.76 -58.9 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 111.839 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 49.7 t -83.82 -2.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.06 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.851 0.357 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' HE1' HD13 ' A' ' 4' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.586 0.231 . . . . 0.0 111.544 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.534 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 50.0 mt-10 -66.32 -53.44 36.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.203 0.525 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . 0.416 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 75.2 m-20 -63.02 -31.73 72.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.792 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.566 HD13 ' HE1' ' A' ' 1' ' ' MET . 79.7 mt -72.54 -50.86 22.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.35 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' A' ' 2' ' ' GLU . 11.4 p-10 -69.67 -17.99 63.53 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.649 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.527 ' HG3' ' CZ ' ' A' ' 10' ' ' TYR . 10.3 tpt -85.9 -47.08 9.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.346 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 2.3 p30 -72.65 -40.68 66.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 60.3 mt -61.99 -32.7 73.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 HD12 ' HG3' ' A' ' 75' ' ' MET . 7.3 tt -70.26 -48.57 56.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 6' ' ' MET . 11.0 m-30 -48.58 -54.64 13.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.813 0.816 . . . . 0.0 109.105 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 ttm -63.61 -38.59 91.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.123 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.594 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -60.77 -33.07 72.4 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.915 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.68 80.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.04 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.38 55.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.499 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.4 t -63.09 -47.1 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.594 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -59.08 -45.65 90.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.84 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.517 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 15.3 mmt -65.2 -42.75 93.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.15 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.677 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -70.14 -50.19 29.46 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.733 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 4.0 pp -60.03 -44.88 94.32 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.095 0.474 . . . . 0.0 109.938 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.561 ' O ' ' HB1' ' A' ' 24' ' ' ALA . . . -65.68 -38.42 89.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.332 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 17' ' ' MET . . . -61.76 -45.19 94.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.537 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.1 mm -60.55 -61.6 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -52.93 42.63 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.933 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 20' ' ' ALA . . . -56.8 -41.61 78.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.807 0.337 . . . . 0.0 110.693 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.514 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -61.95 -44.32 97.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.725 ' O ' HG13 ' A' ' 30' ' ' ILE . 66.0 mt -59.37 -55.76 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.756 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.437 ' O ' ' HB ' ' A' ' 30' ' ' ILE . . . -64.66 -50.39 59.08 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.012 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.518 ' CD1' ' N ' ' A' ' 29' ' ' GLY . 2.9 pp -48.92 -46.86 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.518 ' N ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.52 -39.3 96.21 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.725 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.3 mt -57.92 -72.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.635 0.255 . . . . 0.0 111.073 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.457 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 61.2 tp -73.51 -40.26 64.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -59.27 -39.44 94.63 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.62 -50.37 59.33 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.953 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -60.9 -52.41 65.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.169 0.509 . . . . 0.0 110.657 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.37 -52.88 63.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 47.6 tp -58.86 -36.04 73.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.151 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.83 -58.54 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.565 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -56.57 -56.31 25.29 Favored Glycine 0 C--O 1.242 0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.115 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.48 -16.16 53.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.335 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.682 ' HA ' HD22 ' A' ' 49' ' ' LEU . . . -95.94 -23.58 16.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.611 0.243 . . . . 0.0 110.831 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.571 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 16.0 ptm180 -86.31 -15.11 41.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -96.91 93.62 1.48 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.339 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 78.0 Cg_exo -38.06 -25.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.729 2.953 . . . . 0.0 114.729 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -85.28 2.81 42.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -116.02 18.97 15.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 22.8 mt -52.66 -45.92 96.23 Favored Pre-proline 0 C--O 1.224 -0.266 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.541 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 14.5 Cg_exo -67.82 -22.43 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.563 1.509 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.492 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 25.4 tp -68.74 -37.27 79.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD22 ' HA ' ' A' ' 40' ' ' ALA . 63.9 mt -45.45 -65.45 0.54 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.34 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.07 -42.09 85.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.931 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.485 ' O ' HG12 ' A' ' 55' ' ' ILE . 50.6 m -58.58 -39.51 80.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.456 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 20.7 pt20 -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.054 0.454 . . . . 0.0 110.218 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -59.16 -52.43 65.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.806 ' CE1' HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.09 -33.44 63.63 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.451 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.806 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.3 mm -69.76 -54.72 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.311 0.577 . . . . 0.0 110.063 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.892 ' HA ' HD13 ' A' ' 59' ' ' LEU . 59.8 t -64.53 -36.97 78.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.119 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HE2' ' CD1' ' A' ' 28' ' ' ILE . 24.6 mmt -82.24 -29.51 31.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 0.0 110.433 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.473 ' O ' ' HB1' ' A' ' 62' ' ' ALA . . . -81.21 -37.81 17.06 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.909 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.892 HD13 ' HA ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -71.19 -21.41 62.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.829 0.814 . . . . 0.0 109.931 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.576 HG22 ' O ' ' A' ' 56' ' ' VAL . 78.3 t -88.19 -44.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.694 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -74.23 -22.15 59.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.644 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.74 -29.39 66.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.32 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.592 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 1.8 mp -58.15 -70.39 0.39 Allowed Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.114 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.592 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 25.6 Cg_exo -57.39 -27.38 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 120.787 0.992 . . . . 0.0 111.007 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.419 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 47.7 tpp -71.06 -30.33 66.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.166 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.644 HG13 ' O ' ' A' ' 62' ' ' ALA . 68.7 mt -79.31 -44.03 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.505 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.97 -56.8 6.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 0.0 109.947 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.584 ' O ' HD11 ' A' ' 72' ' ' LEU . 86.2 t -63.12 -44.0 99.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.061 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -58.31 -46.69 92.59 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.339 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.483 ' N ' HD21 ' A' ' 70' ' ' LEU . 4.4 mm? -65.93 -46.18 79.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.842 0.321 . . . . 0.0 110.99 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -62.48 -52.71 47.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.807 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.584 HD11 ' O ' ' A' ' 68' ' ' VAL . 5.7 mp -65.89 -32.26 73.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.945 0.402 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.518 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 94.1 t80 -54.2 -46.74 72.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.361 0.6 . . . . 0.0 109.727 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.611 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 49.1 t -86.3 -30.79 6.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.614 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.536 ' HB2' ' HA ' ' A' ' 72' ' ' LEU . 21.8 mmt -75.44 -74.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.501 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 20.2 m-85 -62.37 -27.64 69.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -98.78 -49.17 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.611 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 52.8 t -91.72 -6.24 10.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.047 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 111.242 179.676 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.952 0.406 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 6' ' ' MET . 56.0 mt-10 -62.09 -52.08 65.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.83 -46.23 85.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.699 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.471 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 84.3 mt -68.93 -33.29 73.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.775 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -70.7 -28.22 64.58 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.409 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.568 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 26.5 mmt -80.58 -53.11 6.85 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.092 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.9 p30 -64.13 -39.64 94.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.129 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 57.1 tp -63.4 -28.06 69.72 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.875 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 2.1 tm? -69.11 -65.5 0.7 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.158 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -51.83 -37.76 53.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.526 0.679 . . . . 0.0 109.451 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.39 73.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.672 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -65.29 -31.94 73.34 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.774 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.1 79.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.76 44.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.6 -47.31 93.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.781 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.496 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -58.36 -47.46 83.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.145 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.403 ' CE ' HG22 ' A' ' 68' ' ' VAL . 21.1 mmt -67.72 -37.62 82.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.614 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.76 -53.37 16.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.051 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 HD13 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.06 -42.58 94.83 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.213 0.53 . . . . 0.0 109.767 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' N ' HD13 ' A' ' 19' ' ' LEU . . . -67.84 -31.77 71.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.337 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.07 -40.02 82.81 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.178 179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.614 HG12 ' O ' ' A' ' 18' ' ' GLY . 43.4 mm -63.93 -61.63 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.585 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.04 -49.72 61.69 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.514 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.623 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.5 -42.18 87.06 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 110.63 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.78 ' O ' HG21 ' A' ' 28' ' ' ILE . . . -59.63 -61.6 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.676 ' O ' HG12 ' A' ' 30' ' ' ILE . 2.1 mp -51.29 -52.63 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.04 77.21 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.258 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.78 HG21 ' O ' ' A' ' 25' ' ' ALA . 5.5 tp -57.13 -44.95 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.96 -40.23 95.22 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.96 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 26' ' ' ILE . 36.6 mm -55.03 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.565 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 35' ' ' PHE . 7.9 tt -68.2 -26.87 65.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.984 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -58.77 -45.08 95.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.257 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.86 -52.38 50.81 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.06 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 14.6 ptmm? -60.55 -51.1 70.87 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.195 0.521 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.456 ' HB2' HD22 ' A' ' 31' ' ' LEU . 15.4 t80 -63.01 -48.94 76.63 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.713 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 53.0 tp -65.07 -36.27 83.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.05 -63.09 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.069 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.82 -49.47 67.98 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.553 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -53.8 -37.78 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.549 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.703 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . . . -81.91 -22.49 36.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -64.92 -34.06 77.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' C ' ' H ' ' A' ' 44' ' ' ASP . 68.1 mt-30 -57.81 123.38 63.16 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.12 1.71 0.58 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.73 2.287 . . . . 0.0 112.757 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.506 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.9 t0 -130.23 34.09 4.25 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 120.84 0.353 . . . . 0.0 110.334 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.703 ' HG ' ' HA ' ' A' ' 40' ' ' ALA . 2.6 tm? -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.51 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' O ' ' HB3' ' A' ' 49' ' ' LEU . 4.4 mp -30.09 -58.64 0.29 Allowed Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 81.8 Cg_endo -77.66 -27.67 5.94 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.237 1.291 . . . . 0.0 110.938 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.552 ' O ' ' HG2' ' A' ' 52' ' ' GLN . 23.0 tp -66.21 -21.52 66.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.587 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -56.41 -56.98 14.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.46 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.525 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 54.0 mtp85 -75.5 -34.88 60.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.141 0.496 . . . . 0.0 110.169 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.914 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 59.7 m -64.72 -33.33 75.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.45 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.552 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 2.8 pt20 -81.43 -36.91 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.413 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 12.2 t80 -55.52 -55.42 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.695 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.914 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 3.8 p90 -72.89 -38.5 66.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.493 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.554 HG12 ' CE1' ' A' ' 54' ' ' PHE . 21.1 mm -61.25 -59.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 110.335 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.408 ' O ' HG21 ' A' ' 60' ' ' VAL . 40.7 t -60.64 -50.0 82.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.124 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.67 -34.69 76.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.206 0.527 . . . . 0.0 110.571 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.31 -42.81 48.58 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.589 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' A' ' 60' ' ' VAL . 4.6 pp -66.88 -33.68 76.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.45 0.625 . . . . 0.0 109.881 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG21 ' CD1' ' A' ' 59' ' ' LEU . 59.5 t -76.76 -49.8 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.039 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.43 -17.61 63.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.074 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.595 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.4 -34.26 68.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.626 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 52.0 mt -59.32 -69.02 0.59 Allowed Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.297 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 24.5 Cg_exo -53.49 -26.47 36.42 Favored 'Trans proline' 0 C--N 1.356 0.926 0 CA-C-N 119.845 0.98 . . . . 0.0 110.842 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.15 -30.69 66.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.595 HG13 ' O ' ' A' ' 62' ' ' ALA . 81.8 mt -77.99 -43.26 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.724 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.91 -58.49 3.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.858 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.452 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 59.8 t -62.33 -40.1 86.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.7 -49.72 75.51 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.064 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.83 -41.59 82.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.0 111.196 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.448 ' O ' HG11 ' A' ' 74' ' ' VAL . . . -65.92 -48.01 69.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.173 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.483 HD22 HD13 ' A' ' 9' ' ' LEU . 74.0 mt -70.76 -34.76 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 69' ' ' GLY . 88.4 t80 -54.78 -46.77 74.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.198 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.561 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 8.3 p -84.27 -27.22 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.529 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.875 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -78.04 -74.71 0.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.53 -27.85 64.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -93.5 -56.57 2.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.561 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 27.1 t -87.63 -8.56 10.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.629 ' HB1' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 111.183 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -58.05 -67.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -59.65 -32.8 70.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.433 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 80.6 mt -67.99 -40.86 83.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.237 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.511 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 21.6 p30 -70.42 -33.79 71.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.568 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.448 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 60.7 mtm -68.82 -56.11 9.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.766 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -63.23 -44.11 96.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.487 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 3.2 tm? -60.7 -29.51 69.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 5' ' ' ASN . 5.9 tt -69.23 -60.85 2.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.668 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -51.31 -45.31 62.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.303 0.573 . . . . 0.0 109.495 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.81 -40.21 91.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.698 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -57.99 -32.4 67.86 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.299 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -67.24 -37.8 84.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.28 50.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.99 -41.17 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.01 178.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.7 mmm -61.03 -50.66 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.917 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 26.3 mmt -65.88 -39.58 90.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.646 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.571 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.66 -51.2 26.53 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -61.0 -44.76 96.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' N ' ' CD1' ' A' ' 19' ' ' LEU . . . -66.14 -32.18 73.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.262 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.03 86.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.392 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.571 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.6 mm -63.39 -60.52 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.771 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.1 92.88 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.617 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.509 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -59.62 -47.15 86.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 110.72 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 28' ' ' ILE . . . -59.0 -53.12 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 110.932 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.78 ' O ' HG12 ' A' ' 30' ' ' ILE . 70.0 mt -51.78 -59.08 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.42 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.52 -44.44 92.95 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.393 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.641 HG23 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -49.25 -47.52 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.84 -40.44 98.4 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.911 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.78 HG12 ' O ' ' A' ' 26' ' ' ILE . 45.9 mm -56.45 -74.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.498 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 68.7 tp -67.21 -44.07 80.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -52.88 -43.76 61.06 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.557 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.04 -55.24 29.22 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.276 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 5.2 ptpp? -57.48 -52.06 66.93 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 120.965 0.412 . . . . 0.0 111.308 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 t80 -62.43 -54.38 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.459 ' CB ' ' O ' ' A' ' 32' ' ' GLY . 53.5 tp -52.8 -39.58 62.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.316 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.96 -64.3 0.96 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.1 27.13 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.039 -1.076 . . . . 0.0 111.572 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.545 ' HB2' ' HG ' ' A' ' 48' ' ' LEU . . . -58.54 -31.21 67.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.591 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -71.64 -29.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.981 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -87.62 -16.88 33.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.89 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.64 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 60.9 mt-30 -70.71 167.82 24.84 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.673 0.749 . . . . 0.0 111.229 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 58.4 Cg_endo -80.17 12.34 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.112 3.208 . . . . 0.0 113.081 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 p-10 -125.22 -83.87 0.64 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.87 ' O ' HD11 ' A' ' 48' ' ' LEU . 3.7 tt 69.87 -51.53 0.63 Allowed 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.562 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 6.8 mt -44.92 -50.29 26.27 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.344 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 57.9 Cg_endo -72.93 -23.74 18.34 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.444 1.429 . . . . 0.0 111.741 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.87 HD11 ' O ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -66.22 -37.38 85.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 31.9 mt -48.61 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.82 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -74.95 -34.91 62.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 81.3 m -66.49 -31.76 72.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.13 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.587 ' NE2' HD21 ' A' ' 48' ' ' LEU . 62.1 mt-30 -98.43 -36.42 9.96 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.868 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.75 -46.3 90.2 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.37 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -76.08 -42.59 46.9 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.895 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.44 ' CG1' ' O ' ' A' ' 51' ' ' THR . 47.0 mm -69.41 -46.34 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.502 ' O ' HG21 ' A' ' 60' ' ' VAL . 95.7 t -67.19 -42.44 88.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.666 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -67.49 -40.86 85.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.432 0.634 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.29 68.7 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.639 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.537 HD13 HG21 ' A' ' 60' ' ' VAL . 4.6 pp -65.87 -23.83 66.74 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.449 0.625 . . . . 0.0 110.649 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.537 HG21 HD13 ' A' ' 59' ' ' LEU . 88.6 t -83.52 -53.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.41 0.624 . . . . 0.0 109.507 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 65' ' ' MET . 59.4 m-20 -62.97 -20.16 64.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.833 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.549 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -54.85 -35.41 63.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.567 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 60.8 mt -58.73 -66.56 1.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.888 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.567 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -59.5 -22.97 68.85 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.295 1.33 . . . . 0.0 111.08 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.426 ' HE3' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -72.7 -32.05 65.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.336 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 62' ' ' ALA . 65.5 mt -74.85 -46.65 40.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.741 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.92 -57.25 6.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.323 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.435 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 62.7 t -64.68 -34.39 69.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.382 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.11 -50.65 44.46 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.613 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.2 -43.21 96.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.494 0.664 . . . . 0.0 109.769 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.479 ' CA ' HD13 ' A' ' 9' ' ' LEU . . . -60.62 -59.46 10.2 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 76' ' ' PHE . 4.7 pp -61.02 -27.51 68.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.104 0.478 . . . . 0.0 110.954 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.417 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 89.2 t80 -58.56 -45.0 89.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.171 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.548 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 38.8 t -90.92 -32.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.963 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 mpp? -86.72 -69.67 0.66 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.777 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 9.6 m-85 -58.49 -27.2 64.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -98.59 -62.15 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.548 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 22.4 t -83.57 1.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.166 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.824 0.345 . . . . 0.0 111.225 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HB3' ' ND2' ' A' ' 5' ' ' ASN . 4.2 mpp? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 6' ' ' MET . 16.9 tp10 -64.73 -44.81 88.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.903 0.383 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -58.32 -55.31 36.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.444 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.542 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -68.64 -35.86 77.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.771 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.483 ' ND2' ' HB3' ' A' ' 1' ' ' MET . 63.4 m-20 -73.06 -22.38 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.875 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 49.7 mtm -82.01 -51.54 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.537 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 53.1 p-10 -71.7 -37.84 70.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.098 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.476 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 3.0 tm? -65.27 -33.72 76.64 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.658 ' HG ' ' HG3' ' A' ' 75' ' ' MET . 3.4 tm? -70.91 -55.94 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.763 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -51.05 -53.45 33.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.742 0.782 . . . . 0.0 109.65 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -38.03 84.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.596 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.64 -33.7 75.55 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -66.93 -38.74 86.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.06 68.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.27 -51.66 65.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.433 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.596 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -59.17 -55.51 33.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.773 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . 0.629 ' O ' ' HB1' ' A' ' 21' ' ' ALA . 81.1 mtp -62.72 -41.3 99.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.387 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.594 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.24 -52.05 34.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 16' ' ' MET . 4.0 pp -59.42 -44.99 92.76 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.625 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' O ' ' CB ' ' A' ' 24' ' ' ALA . . . -67.05 -30.07 70.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.52 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.629 ' HB1' ' O ' ' A' ' 17' ' ' MET . . . -68.76 -38.83 80.37 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.175 0.512 . . . . 0.0 109.664 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.594 HG12 ' O ' ' A' ' 18' ' ' GLY . 49.1 mm -62.83 -58.32 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.732 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.2 -47.4 90.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.31 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.618 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -57.5 -38.73 75.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.562 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -67.14 -44.01 80.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.697 ' O ' HG13 ' A' ' 30' ' ' ILE . 32.9 mm -58.71 -52.32 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.306 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 30' ' ' ILE . . . -66.9 -48.32 61.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.938 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 24' ' ' ALA . 38.5 pt -51.86 -46.78 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.528 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -62.24 -37.04 93.9 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.697 HG13 ' O ' ' A' ' 26' ' ' ILE . 65.5 mt -58.17 -77.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.91 -47.6 74.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.127 0.489 . . . . 0.0 110.853 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -54.42 -48.73 63.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.365 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.06 90.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.662 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.689 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 44.8 mmtm -59.59 -64.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 110.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -62.28 -40.16 95.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 109.692 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 49' ' ' LEU . 34.1 tp -57.61 -40.86 80.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.63 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.58 -56.58 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.411 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -58.22 -54.55 36.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.042 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.647 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -56.05 -25.6 45.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.534 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.583 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . . . -83.34 -37.08 23.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.828 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.411 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 41.0 ptt180 -85.05 -6.28 59.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.432 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.903 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 58.8 tp60 -71.85 -108.57 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.903 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 71.7 Cg_endo -101.48 -68.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.737 0 CA-C-N 122.381 1.886 . . . . 0.0 112.835 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.482 ' C ' ' H ' ' A' ' 46' ' ' ILE . 3.0 p30 -158.95 36.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.976 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.647 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 74.7 mt -74.77 16.13 0.31 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.506 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 37.9 mt -46.99 -44.31 46.99 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.306 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.3 Cg_endo -70.99 -29.25 18.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.08 1.187 . . . . 0.0 110.159 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.514 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 51.2 tp -64.0 -33.06 74.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.603 ' HB2' ' O ' ' A' ' 46' ' ' ILE . 26.4 mt -47.93 -67.52 0.27 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.759 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -61.69 -46.25 90.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.02 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.724 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.6 m -55.94 -39.57 71.91 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -85.32 -26.02 26.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 110.124 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -60.64 -54.01 50.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE1' ' O ' ' A' ' 51' ' ' THR . 2.9 p90 -68.29 -30.14 69.07 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.716 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.724 HG12 ' O ' ' A' ' 51' ' ' THR . 36.5 mm -66.45 -58.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 60' ' ' VAL . 78.7 t -55.61 -46.39 79.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.222 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.453 ' HA ' ' CG2' ' A' ' 28' ' ' ILE . 62.4 ttp -69.47 -33.16 72.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -71.49 -42.67 55.25 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.978 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.501 HD13 ' CG2' ' A' ' 60' ' ' VAL . 4.4 pp -65.17 -29.13 69.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.142 0.471 . . . . 0.0 110.198 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 56' ' ' VAL . 98.1 t -78.01 -48.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.481 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 46.9 m-20 -73.27 -8.72 57.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.299 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -61.72 -30.69 70.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.686 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 56.2 mt -62.0 -62.21 6.25 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.686 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 31.0 Cg_exo -60.9 -25.42 81.33 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.044 1.051 . . . . 0.0 110.424 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -70.02 -31.1 68.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.29 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 62' ' ' ALA . 74.1 mt -78.24 -45.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.623 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -56.29 13.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.088 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 43.8 t -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.034 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 72' ' ' LEU . . . -59.52 -45.43 95.58 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.127 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -65.04 -44.53 88.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 109.791 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -64.33 -45.78 92.48 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.525 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.535 ' HA ' ' HB2' ' A' ' 75' ' ' MET . 4.0 pp -66.76 -32.71 74.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.371 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.417 ' N ' HD13 ' A' ' 72' ' ' LEU . 92.7 t80 -54.98 -47.03 75.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 47.1 t -86.03 -30.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.445 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.658 ' HG3' ' HG ' ' A' ' 9' ' ' LEU . 20.9 mmt -73.21 -76.13 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.29 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.475 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 27.1 m-85 -60.78 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 73' ' ' TYR . . . -92.96 -59.84 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.512 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 94.6 t -82.55 -6.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.062 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.613 ' HB1' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.117 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.843 0.354 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.13 -49.39 65.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -63.74 -30.61 71.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.55 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.531 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -76.68 -48.33 19.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.783 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -71.72 -15.69 62.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.05 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.458 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 27.3 ttt -82.05 -57.49 3.38 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.765 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 7.0 p-10 -68.68 -41.56 79.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.979 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 55.1 tp -60.1 -39.39 86.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 75' ' ' MET . 35.4 tp -67.48 -57.4 6.58 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.108 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 8.6 m-30 -50.85 -51.99 45.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 109.742 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.7 ttm -60.43 -38.98 85.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.07 -35.49 77.1 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.423 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -64.32 -37.32 87.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.03 -54.52 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 19' ' ' LEU . 52.6 t -61.29 -49.59 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.999 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -57.5 -46.02 84.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.081 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 85.5 mmm -65.24 -41.56 94.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.525 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -67.25 -54.33 20.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.868 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.6 pp -59.67 -42.65 93.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.611 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -68.89 -30.58 69.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.717 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.74 -41.89 82.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.893 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 26' ' ' ILE . 67.2 mt -64.45 -56.7 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.931 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.72 98.74 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.425 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.637 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -60.62 -45.26 94.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.65 -46.81 88.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.756 ' O ' HG13 ' A' ' 30' ' ' ILE . 40.8 mm -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.458 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -65.74 -48.3 68.34 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.113 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 24' ' ' ALA . 36.2 pt -49.48 -46.77 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 117.541 0.67 . . . . 0.0 109.331 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.526 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -65.43 -36.79 93.06 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.118 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.756 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.2 mt -59.73 -71.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 110.68 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 31' ' ' LEU . 5.9 tt -68.26 -30.94 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -59.71 -47.93 88.55 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.996 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.01 61.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.295 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 17.9 ptpt -60.51 -53.85 52.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 111.66 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.434 ' HB2' HD23 ' A' ' 31' ' ' LEU . 12.7 t80 -64.05 -48.33 76.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.29 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 36' ' ' LEU . 2.0 tm? -60.19 -37.68 80.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -61.01 -55.39 33.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.757 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.8 -56.01 27.68 Favored Glycine 0 C--O 1.235 0.196 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -55.8 -48.02 76.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.286 0.565 . . . . 0.0 110.418 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.626 ' CA ' HD21 ' A' ' 49' ' ' LEU . . . -70.66 -15.87 62.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.589 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 6.4 tpm_? -81.58 -28.41 33.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.633 ' CB ' HD13 ' A' ' 45' ' ' LEU . 90.9 mm-40 -101.85 106.93 49.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.63 ' O ' HG13 ' A' ' 46' ' ' ILE . 5.0 Cg_exo -44.83 -22.72 0.72 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.854 2.369 . . . . 0.0 113.974 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.606 ' C ' HD12 ' A' ' 45' ' ' LEU . 37.9 t70 -82.69 -7.2 59.66 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 42' ' ' GLN . 4.3 mp -108.45 19.36 19.9 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 43' ' ' PRO . 32.1 mt -54.8 -45.55 99.65 Favored Pre-proline 0 C--O 1.225 -0.229 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.145 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 15.4 Cg_exo -67.39 -20.83 47.97 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.803 1.669 . . . . 0.0 110.255 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 39' ' ' ALA . 27.4 tp -69.44 -38.64 77.92 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.626 HD21 ' CA ' ' A' ' 40' ' ' ALA . 51.9 mt -44.29 -62.9 1.0 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.679 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -67.4 -46.36 73.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.6 m -55.73 -46.06 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.77 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.736 ' HA ' HG22 ' A' ' 55' ' ' ILE . 16.4 pt20 -70.08 -36.31 74.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.19 -57.45 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.14 -41.64 99.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.202 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.736 HG22 ' HA ' ' A' ' 52' ' ' GLN . 11.0 tp -63.23 -50.17 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.698 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 60' ' ' VAL . 61.0 t -65.59 -42.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.4 ttm -71.83 -40.82 68.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.279 0.561 . . . . 0.0 110.327 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -68.7 -44.33 71.2 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.357 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 88.4 mt -63.56 -40.57 97.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.166 0.483 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 56' ' ' VAL . 73.4 t -71.45 -41.39 73.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.425 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 40.7 m-20 -81.19 -9.01 59.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.62 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -66.14 -27.55 68.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 72.4 mt -62.24 -59.66 12.33 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 16.3 Cg_exo -68.79 -26.38 32.5 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.264 1.309 . . . . 0.0 110.74 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.7 tpt -69.29 -31.7 70.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.494 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 62' ' ' ALA . 51.8 mt -79.15 -44.92 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.908 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.26 -53.13 32.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 110.306 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 97.1 t -64.71 -46.99 90.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -54.5 -50.77 55.67 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.702 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.6 pp -62.79 -42.33 99.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.301 0.572 . . . . 0.0 110.34 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -58.49 -56.38 25.57 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.845 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -71.59 -28.46 63.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.732 ' N ' HD12 ' A' ' 72' ' ' LEU . 21.4 t80 -57.91 -40.24 79.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 109.654 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 46.4 t -94.02 -32.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.817 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.845 ' HG3' HD23 ' A' ' 9' ' ' LEU . 88.3 mmm -75.03 -76.04 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.237 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 28.0 m-85 -63.93 -29.0 70.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.21 -51.85 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 78' ' ' VAL . 55.7 t -88.04 -6.49 10.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.66 0.267 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 6' ' ' MET . 42.7 tt0 -61.62 -53.9 50.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -65.68 -32.77 74.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -77.26 -31.14 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.688 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -77.43 -29.47 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.28 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 66.0 mtm -80.23 -49.16 11.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.561 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 57.5 p-10 -67.94 -40.13 83.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.255 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.1 tm? -64.13 -30.04 71.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.1 tm? -68.15 -61.62 1.77 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -50.53 -49.57 55.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.728 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.65 -43.04 99.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -55.25 -42.88 74.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.856 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' MET . . . -56.77 -44.33 81.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.974 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.63 44.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.132 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 HD23 ' A' ' 19' ' ' LEU . 48.9 t -58.38 -62.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.088 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.1 mpp? -47.57 -47.3 28.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.709 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -62.32 -45.09 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.935 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -66.69 -49.99 51.58 Favored Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.027 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 3.4 pp -60.61 -41.69 95.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.095 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -70.34 -32.14 69.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . -67.05 -44.14 80.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.1 mt -63.55 -57.61 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.408 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.22 -51.4 58.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.743 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.55 -41.32 89.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -62.01 -47.01 86.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.749 ' O ' HG12 ' A' ' 30' ' ' ILE . 36.7 mm -56.71 -60.02 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.29 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.42 -45.91 74.75 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.178 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.8 tp -51.37 -46.66 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.09 -39.39 97.55 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.739 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.9 mm -58.01 -69.61 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD22 ' HD3' ' A' ' 34' ' ' LYS . 2.5 tm? -76.31 -44.55 36.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -61.64 -38.35 95.73 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.458 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.21 -51.97 45.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.589 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.742 ' HD3' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -58.13 -50.07 74.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.36 0.6 . . . . 0.0 110.168 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 5.8 t80 -61.32 -41.54 97.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.754 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 49' ' ' LEU . 58.7 tp -63.79 -41.36 97.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.421 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 47.9 mt-10 -59.52 -53.48 57.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.601 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.97 -61.32 7.11 Favored Glycine 0 C--O 1.239 0.427 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.951 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -49.92 -46.14 51.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.636 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -72.44 -25.83 61.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.629 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 55.3 ttp180 -67.8 -25.24 65.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.59 ' CB ' HD13 ' A' ' 45' ' ' LEU . 72.6 mt-30 -96.85 95.54 2.26 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.098 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 99.4 Cg_exo -38.38 -25.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.46 2.773 . . . . 0.0 114.356 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.664 ' C ' HD12 ' A' ' 45' ' ' LEU . 58.2 m-20 -79.87 -1.42 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.772 HD23 ' CD2' ' A' ' 48' ' ' LEU . 5.4 mp -121.04 14.91 11.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 26.9 mm -52.48 -45.15 95.65 Favored Pre-proline 0 N--CA 1.464 0.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.308 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 9.4 Cg_exo -70.24 -21.0 31.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.813 1.675 . . . . 0.0 110.714 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.772 ' CD2' HD23 ' A' ' 45' ' ' LEU . 30.1 tp -67.31 -38.96 85.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 36' ' ' LEU . 38.9 mt -47.0 -64.59 0.74 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.829 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.017 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.689 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 46.8 m -58.58 -42.9 89.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.695 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -84.84 -34.79 22.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.949 0.404 . . . . 0.0 110.366 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.5 t80 -51.93 -50.6 60.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.908 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 1.2 p90 -63.41 -35.47 80.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.836 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 51' ' ' THR . 55.0 mt -66.21 -63.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.24 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.6 t -54.62 -40.45 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.638 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.7 ttt -71.2 -39.0 72.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 0.0 110.564 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -66.22 -45.91 83.28 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.343 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -57.08 -43.33 82.03 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 109.804 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 56' ' ' VAL . 50.6 t -66.28 -51.42 59.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.438 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.33 -13.68 62.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.58 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.77 -33.77 70.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.746 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 53.5 mt -60.69 -66.28 1.63 Allowed Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.598 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 22.0 Cg_exo -56.94 -25.31 61.69 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 120.055 1.055 . . . . 0.0 111.061 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.11 70.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 62' ' ' ALA . 70.2 mt -77.49 -43.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.26 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.546 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.32 -51.24 54.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.17 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.2 t -69.62 -30.53 45.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.269 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.52 -50.84 29.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.775 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 71' ' ' GLY . 3.7 pp -62.35 -42.61 99.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.993 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.854 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -61.55 -52.53 50.51 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.515 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.1 pp -64.04 -30.57 71.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 111.145 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 72' ' ' LEU . 89.2 t80 -53.03 -48.54 67.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.266 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.1 t -89.75 -31.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.397 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.893 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -80.5 -69.08 0.62 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -59.2 -23.04 61.93 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -79.04 -54.49 5.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 74' ' ' VAL . 13.8 p -115.67 -17.43 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.399 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.2 -45.9 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.693 0.282 . . . . 0.0 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.65 -45.84 90.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 8' ' ' LEU . 96.6 mt -66.19 -44.74 83.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.608 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 56.3 m-20 -63.2 -36.32 83.23 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.471 ' O ' ' HD1' ' A' ' 10' ' ' TYR . 56.4 ttm -64.22 -69.73 0.26 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.794 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -52.98 -40.65 63.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.526 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 54.7 tp -65.62 -31.01 71.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.762 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.591 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.3 tm? -68.6 -52.9 26.5 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.326 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 6' ' ' MET . 31.3 m-85 -59.69 -42.59 93.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.009 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 25.7 ttt -63.3 -37.76 88.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.08 -37.4 84.87 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.474 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -60.22 -46.24 90.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.57 72.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 19' ' ' LEU . 38.8 t -64.91 -51.52 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.733 ' CE ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.32 -51.61 66.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.684 ' CG ' HG21 ' A' ' 68' ' ' VAL . 84.6 mtp -62.5 -41.9 99.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.401 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -68.66 -53.85 18.2 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.567 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.5 pp -58.04 -45.39 87.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.241 0.544 . . . . 0.0 109.892 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.786 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.37 -32.18 73.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.371 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.86 -41.06 78.92 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.508 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 18' ' ' GLY . 92.6 mt -62.26 -57.79 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.777 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -47.76 89.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.446 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -56.42 -42.67 78.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.875 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -61.62 -58.08 9.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.197 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.854 ' O ' HG12 ' A' ' 30' ' ' ILE . 33.8 mm -44.4 -56.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.34 -38.33 87.12 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.766 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -56.13 -44.03 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.25 -36.4 89.66 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.546 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.854 HG12 ' O ' ' A' ' 26' ' ' ILE . 42.5 mm -59.63 -69.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.441 0.162 . . . . 0.0 110.81 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.0 tm? -74.59 -45.6 44.11 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.658 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -62.59 -44.11 98.03 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.3 -0.953 . . . . 0.0 110.886 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -60.75 -49.22 81.05 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.853 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.44 -53.98 49.42 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.058 0.456 . . . . 0.0 110.587 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CE1' ' NE2' ' A' ' 52' ' ' GLN . 5.0 t80 -57.25 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 32' ' ' GLY . 6.8 mp -53.28 -34.65 58.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.925 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 16.3 tp10 -56.77 -61.28 2.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 109.944 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -54.32 -47.31 69.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.19 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.26 -34.97 77.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.148 0.499 . . . . 0.0 110.009 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.99 -22.87 62.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 4.5 tmm_? -92.34 -19.39 22.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.763 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.951 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 65.3 mt-30 -61.21 -177.01 0.12 Allowed Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 73.6 Cg_exo -48.81 -71.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.154 2.569 . . . . 0.0 113.375 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.6 t70 -146.09 46.94 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.893 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -84.56 13.22 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 111.131 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 29.4 mm -52.56 -45.51 95.9 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.635 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 35.3 Cg_endo -68.16 -23.43 39.47 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 120.874 1.05 . . . . 0.0 110.698 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 45' ' ' LEU . 35.6 tp -67.8 -38.72 83.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 40' ' ' ALA . 77.8 mt -43.91 -61.42 1.45 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.743 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.621 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 39.7 ptt180 -63.02 -49.53 74.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.148 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 55' ' ' ILE . 97.6 m -46.83 -48.8 20.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 28.3 mt-30 -69.3 -33.43 73.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.987 0.423 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.02 -54.19 47.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' HD1' ' O ' ' A' ' 50' ' ' ARG . 31.6 m-85 -65.15 -44.45 88.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.638 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 51' ' ' THR . 36.8 mm -63.86 -56.99 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 60' ' ' VAL . 39.1 t -60.78 -48.19 89.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.426 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 26.5 ttt -68.73 -35.53 77.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.216 0.532 . . . . 0.0 110.576 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -69.61 -45.08 60.8 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.07 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 80.2 mt -61.98 -42.5 99.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' VAL . 60.4 t -69.65 -50.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.391 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 57' ' ' MET . 28.6 m-20 -69.13 -16.04 63.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.636 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.73 -33.72 68.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.389 . . . . 0.0 110.506 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 70.9 mt -57.6 -66.11 1.45 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 17.4 Cg_endo -60.13 -24.94 78.53 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.261 1.307 . . . . 0.0 110.839 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 79.0 mmm -71.67 -31.6 66.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.495 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 58.4 mt -75.51 -46.47 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.513 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.55 -54.65 18.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.53 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG21 ' CG ' ' A' ' 17' ' ' MET . 58.1 t -67.13 -40.87 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.338 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.52 -41.61 99.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.876 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 70' ' ' LEU . 5.2 tt -67.89 -46.21 72.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -44.67 96.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.683 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 85.4 mt -73.68 -30.37 62.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.967 0.413 . . . . 0.0 110.273 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.867 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.8 t80 -58.27 -47.44 83.59 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG13 ' SD ' ' A' ' 75' ' ' MET . 6.4 p -78.64 -34.0 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.43 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.546 ' SD ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -70.07 -74.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.453 ' CE2' HD22 ' A' ' 72' ' ' LEU . 31.1 m-85 -56.89 -29.58 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.48 -54.3 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.8 t -92.08 -10.03 9.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.79 -55.78 13.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.04 -40.35 76.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.614 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.589 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 82.4 mt -70.32 -45.39 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 55.2 m-20 -71.19 -13.96 62.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.118 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.485 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 28.0 ttt -82.89 -59.05 2.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 10.5 p-10 -67.39 -42.38 83.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.099 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.97 -34.15 72.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 75' ' ' MET . 51.2 tp -68.43 -63.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.132 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 5.8 m-85 -53.64 -42.57 67.94 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.183 0.516 . . . . 0.0 109.935 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 15' ' ' VAL . 9.6 tmm? -66.31 -36.29 82.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.409 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -63.77 -31.25 72.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.743 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -68.08 -33.08 73.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -54.65 17.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 50.4 t -62.06 -41.94 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.762 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 15.2 mmt -62.03 -50.8 70.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.765 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.55 ' SD ' HG21 ' A' ' 68' ' ' VAL . 89.5 mmm -66.51 -39.65 88.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.566 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -69.65 -49.84 34.43 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -59.41 -47.28 86.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.793 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.58 -33.0 74.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.734 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.14 -42.26 84.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 18' ' ' GLY . 75.1 mt -62.25 -60.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.87 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.77 -45.88 90.53 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.808 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -62.32 -40.79 97.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.589 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -63.55 -43.88 95.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.212 0.53 . . . . 0.0 110.275 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.825 ' O ' HG13 ' A' ' 30' ' ' ILE . 79.4 mt -58.24 -61.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.174 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -67.16 -42.32 91.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.156 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.646 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.7 tp -54.87 -46.75 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.475 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.21 -36.43 92.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.65 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.825 HG13 ' O ' ' A' ' 26' ' ' ILE . 72.3 mt -61.88 -72.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.521 0.201 . . . . 0.0 110.856 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.3 tm? -71.39 -42.06 68.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -65.18 -44.05 94.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.793 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.59 -38.04 95.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.418 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 18.8 ptpt -71.99 -47.88 48.91 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.6 t80 -63.91 -49.44 72.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 49' ' ' LEU . 5.1 tt -56.24 -51.44 68.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.271 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' LYS . 12.6 pt-20 -57.26 -51.65 68.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.862 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -54.02 -53.7 35.54 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.77 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 45' ' ' LEU . . . -64.62 -42.32 95.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.093 0.473 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' HD23 ' A' ' 36' ' ' LEU . . . -57.0 -30.82 64.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.575 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 97.2 mtt180 -82.3 -37.82 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 109.706 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.793 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . 27.9 tp60 -44.86 127.97 5.27 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.352 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -32.78 -33.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 124.755 3.637 . . . . 0.0 115.879 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' C ' HD12 ' A' ' 45' ' ' LEU . 56.4 m-20 -141.02 29.3 1.86 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.793 ' HB2' ' HB3' ' A' ' 42' ' ' GLN . 8.6 mp -114.38 6.98 16.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 111.563 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.3 mp -48.61 -47.29 71.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.704 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 79.3 Cg_endo -78.92 -16.69 12.55 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.867 1.711 . . . . 0.0 111.174 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' HG ' HE21 ' A' ' 52' ' ' GLN . 40.4 tp -69.52 -30.74 68.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.711 HD13 HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -47.48 -59.21 3.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.556 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 86.7 mtm180 -72.06 -42.54 66.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 110.196 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 55' ' ' ILE . 28.0 m -52.74 -39.61 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.591 HE21 ' HG ' ' A' ' 48' ' ' LEU . 4.8 pt20 -84.59 -33.82 23.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.545 ' HD2' HD12 ' A' ' 36' ' ' LEU . 11.0 t80 -57.6 -49.7 75.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.231 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.564 ' CE1' HG12 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -73.2 -30.09 63.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 51' ' ' THR . 38.7 mm -69.69 -56.75 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.262 0.553 . . . . 0.0 109.843 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.646 HG12 ' CD1' ' A' ' 28' ' ' ILE . 41.1 t -61.57 -39.23 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.302 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.75 -34.26 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.537 . . . . 0.0 110.204 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.03 63.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.352 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.133 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.657 ' N ' HD12 ' A' ' 59' ' ' LEU . 99.7 t -78.16 -51.25 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -69.04 -12.77 61.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.51 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.48 -33.32 69.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.76 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 70.3 mt -60.85 -64.92 2.52 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.285 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 35.1 Cg_exo -55.71 -26.5 56.54 Favored 'Trans proline' 0 C--N 1.359 1.092 0 CA-C-N 120.123 1.08 . . . . 0.0 110.845 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.14 -30.85 66.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.633 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' ALA . 80.0 mt -76.73 -44.59 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.457 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.06 -58.42 4.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.55 HG21 ' SD ' ' A' ' 17' ' ' MET . 60.3 t -63.52 -39.53 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.192 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -64.67 -47.5 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.735 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.708 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.1 tm? -60.7 -44.74 96.19 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.37 58.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.172 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.2 pp -69.34 -26.06 64.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.943 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.7 t80 -54.68 -47.35 73.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 109.628 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 13.4 p -90.6 -28.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.675 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.659 ' HG3' HD21 ' A' ' 9' ' ' LEU . 94.2 mmm -82.14 -74.99 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 72' ' ' LEU . 15.5 m-30 -58.53 -28.79 65.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.378 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.943 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.96 -55.08 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 48.1 t -87.75 -2.75 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.158 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.94 -51.35 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.5 -38.28 86.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.7 -32.62 68.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.12 -30.94 62.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 10' ' ' TYR . 51.5 ttm -77.42 -46.22 23.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.746 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.41 -46.57 69.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.369 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.662 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.98 -32.26 70.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 61.2 tp -64.87 -58.23 6.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.778 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 6' ' ' MET . 9.1 m-30 -47.38 -54.3 11.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.521 0.676 . . . . 0.0 109.839 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -61.45 -38.56 87.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.721 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.82 -33.7 74.61 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.83 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.6 -52.57 51.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.078 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 43.6 t -60.48 -44.45 96.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.303 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.48 -55.42 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.773 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.2 mmm -58.68 -42.21 88.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.579 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -68.72 -53.98 17.32 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.695 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.4 pp -57.72 -44.07 85.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 110.196 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.89 -32.44 72.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -67.09 -40.45 86.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.838 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 18' ' ' GLY . 47.4 mm -62.37 -64.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.576 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.31 -50.51 46.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.677 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.22 -42.09 85.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.863 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -56.95 -59.52 4.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HD13 ' A' ' 30' ' ' ILE . 1.9 mp -53.72 -57.46 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.16 97.32 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.896 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 25' ' ' ALA . 6.0 tp -58.13 -43.67 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.03 -35.84 92.64 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.599 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 26' ' ' ILE . 1.5 mp -60.39 -72.3 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.611 0.244 . . . . 0.0 110.762 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 34' ' ' LYS . 3.2 tm? -69.02 -41.55 77.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.107 0.48 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -60.21 -43.24 98.64 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.834 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.87 -48.48 80.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.077 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.74 ' HD2' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -62.77 -50.87 69.33 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.893 0.377 . . . . 0.0 110.922 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 15.3 t80 -62.66 -49.23 75.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 49' ' ' LEU . 2.4 tm? -61.46 -37.18 82.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.796 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -58.79 -57.93 10.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.13 -56.78 18.51 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.245 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -50.29 -25.24 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.133 0.492 . . . . 0.0 111.255 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.656 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -92.86 -33.21 14.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.242 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 9.1 mmp_? -63.96 -25.04 67.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.26 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' CB ' HD23 ' A' ' 45' ' ' LEU . 10.9 mm100 -100.44 117.2 63.39 Favored Pre-proline 0 N--CA 1.435 -1.225 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.073 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 42' ' ' GLN . 9.7 Cg_endo -56.05 -7.44 1.74 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.008 2.472 . . . . 0.0 113.787 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -98.69 -25.39 14.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.53 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.863 HD12 HD22 ' A' ' 48' ' ' LEU . 2.8 mm? -92.16 11.56 25.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 13.9 mt -53.98 -44.24 97.97 Favored Pre-proline 0 C--O 1.225 -0.222 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.107 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 13.0 Cg_exo -68.83 -21.44 38.11 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.708 1.605 . . . . 0.0 110.694 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD22 HD12 ' A' ' 45' ' ' LEU . 48.4 tp -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 36' ' ' LEU . 69.1 mt -45.54 -63.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.449 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 47' ' ' PRO . 58.8 mtm-85 -67.6 -41.15 84.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.143 0.496 . . . . 0.0 110.305 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.843 ' O ' HG13 ' A' ' 55' ' ' ILE . 42.1 m -60.01 -39.68 86.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.076 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.701 ' OE1' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.25 -29.89 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.059 0.457 . . . . 0.0 110.155 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -61.22 -57.32 12.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.78 ' CE1' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -69.4 -34.58 74.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.843 HG13 ' O ' ' A' ' 51' ' ' THR . 33.6 mt -71.27 -56.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.658 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 60' ' ' VAL . 59.5 t -62.83 -37.34 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.499 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.434 ' CE ' HG12 ' A' ' 28' ' ' ILE . 61.3 tpp -73.69 -39.29 64.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.231 0.539 . . . . 0.0 110.386 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.96 -44.78 66.0 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.76 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 93.4 mt -60.21 -39.21 85.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.145 0.498 . . . . 0.0 110.071 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 56' ' ' VAL . 58.1 t -70.64 -42.3 77.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.745 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.687 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 41.0 m-20 -79.32 -13.09 59.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.648 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.712 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -67.12 -21.89 65.82 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.311 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 66.8 mt -65.13 -56.19 21.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.565 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 2.8 Cg_exo -77.94 -26.32 6.75 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.846 1.697 . . . . 0.0 110.979 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 50.6 tpp -70.69 -31.71 68.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 62' ' ' ALA . 1.2 mp -81.55 -44.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.771 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.8 48.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 109.984 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 74.6 t -67.98 -43.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.284 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.14 -43.08 99.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.989 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -63.87 -46.22 85.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 109.783 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.41 -55.52 30.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.493 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -68.2 -28.15 67.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.452 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.798 ' N ' HD12 ' A' ' 72' ' ' LEU . 87.4 t80 -52.54 -45.62 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.284 0.564 . . . . 0.0 109.711 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.6 p -93.0 -29.08 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.547 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 24.1 mmt -82.34 -70.04 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.321 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 10' ' ' TYR . 7.9 m-85 -61.21 -28.52 69.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.76 -58.9 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 111.839 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.7 t -83.82 -2.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.06 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.851 0.357 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.586 0.231 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.554 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 50.0 mt-10 -66.32 -53.44 36.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.203 0.525 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.416 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 75.2 m-20 -63.02 -31.73 72.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.792 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 79.7 mt -72.54 -50.86 22.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.35 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 2' ' ' GLU . 11.4 p-10 -69.67 -17.99 63.53 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.649 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 10' ' ' TYR . 10.3 tpt -85.9 -47.08 9.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.346 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.3 p30 -72.65 -40.68 66.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 60.3 mt -61.99 -32.7 73.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.688 HD13 ' HG3' ' A' ' 75' ' ' MET . 7.3 tt -70.26 -48.57 56.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 6' ' ' MET . 11.0 m-30 -48.58 -54.64 13.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.813 0.816 . . . . 0.0 109.105 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 ttm -63.61 -38.59 91.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.123 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -60.77 -33.07 72.4 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.915 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.68 80.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.04 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.38 55.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.499 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 19' ' ' LEU . 45.4 t -63.09 -47.1 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -59.08 -45.65 90.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.84 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.3 mmt -65.2 -42.75 93.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.7 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -70.14 -50.19 29.46 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.733 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.03 -44.88 94.32 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.095 0.474 . . . . 0.0 109.938 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.645 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -65.68 -38.42 89.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.332 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.19 94.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.1 mm -60.55 -61.6 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -52.93 42.63 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.933 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -56.8 -41.61 78.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.807 0.337 . . . . 0.0 110.693 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -61.95 -44.32 97.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HG13 ' A' ' 30' ' ' ILE . 66.0 mt -59.37 -55.76 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.756 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.569 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -64.66 -50.39 59.08 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.012 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 29' ' ' GLY . 2.9 pp -48.92 -46.86 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 28' ' ' ILE . . . -60.52 -39.3 96.21 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.3 mt -57.92 -72.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.635 0.255 . . . . 0.0 111.073 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.7 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.2 tp -73.51 -40.26 64.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -59.27 -39.44 94.63 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.62 -50.37 59.33 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.953 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.7 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.9 -52.41 65.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.169 0.509 . . . . 0.0 110.657 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.37 -52.88 63.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 47.6 tp -58.86 -36.04 73.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.151 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.83 -58.54 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -56.57 -56.31 25.29 Favored Glycine 0 C--O 1.242 0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.115 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.726 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -62.48 -16.16 53.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.335 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -95.94 -23.58 16.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.611 0.243 . . . . 0.0 110.831 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.608 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 16.0 ptm180 -86.31 -15.11 41.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.635 ' CB ' HD23 ' A' ' 45' ' ' LEU . 73.7 mt-30 -96.91 93.62 1.48 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.339 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 78.0 Cg_exo -38.06 -25.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.729 2.953 . . . . 0.0 114.729 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.633 ' C ' HD22 ' A' ' 45' ' ' LEU . 10.8 p-10 -85.28 2.81 42.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.901 HD12 HD22 ' A' ' 48' ' ' LEU . 3.4 mm? -116.02 18.97 15.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 22.8 mt -52.66 -45.92 96.23 Favored Pre-proline 0 C--O 1.224 -0.266 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.541 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 14.5 Cg_exo -67.82 -22.43 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.563 1.509 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.901 HD22 HD12 ' A' ' 45' ' ' LEU . 25.4 tp -68.74 -37.27 79.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 40' ' ' ALA . 63.9 mt -45.45 -65.45 0.54 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.34 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.07 -42.09 85.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.931 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 55' ' ' ILE . 50.6 m -58.58 -39.51 80.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.456 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.507 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.4 pt20 -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.054 0.454 . . . . 0.0 110.218 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -59.16 -52.43 65.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.821 ' CE1' HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.09 -33.44 63.63 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.451 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.821 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.3 mm -69.76 -54.72 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.311 0.577 . . . . 0.0 110.063 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' HD12 ' A' ' 59' ' ' LEU . 59.8 t -64.53 -36.97 78.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.119 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.551 ' CE ' HD13 ' A' ' 28' ' ' ILE . 24.6 mmt -82.24 -29.51 31.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 0.0 110.433 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -81.21 -37.81 17.06 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.909 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -71.19 -21.41 62.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.829 0.814 . . . . 0.0 109.931 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 59' ' ' LEU . 78.3 t -88.19 -44.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.694 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -74.23 -22.15 59.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.74 -29.39 66.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.32 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.67 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 1.8 mp -58.15 -70.39 0.39 Allowed Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.114 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 25.6 Cg_exo -57.39 -27.38 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 120.787 0.992 . . . . 0.0 111.007 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.449 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 47.7 tpp -71.06 -30.33 66.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.166 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.804 ' O ' HD23 ' A' ' 70' ' ' LEU . 68.7 mt -79.31 -44.03 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.505 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.97 -56.8 6.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 0.0 109.947 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.816 HG12 HD22 ' A' ' 72' ' ' LEU . 86.2 t -63.12 -44.0 99.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.061 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -58.31 -46.69 92.59 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.339 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 66' ' ' ILE . 4.4 mm? -65.93 -46.18 79.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.842 0.321 . . . . 0.0 110.99 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -62.48 -52.71 47.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.807 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.816 HD22 HG12 ' A' ' 68' ' ' VAL . 5.7 mp -65.89 -32.26 73.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.945 0.402 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.835 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 94.1 t80 -54.2 -46.74 72.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.361 0.6 . . . . 0.0 109.727 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 49.1 t -86.3 -30.79 6.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.614 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.688 ' HG3' HD13 ' A' ' 9' ' ' LEU . 21.8 mmt -75.44 -74.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 20.2 m-85 -62.37 -27.64 69.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.78 -49.17 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 52.8 t -91.72 -6.24 10.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.047 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 111.242 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.952 0.406 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 6' ' ' MET . 56.0 mt-10 -62.09 -52.08 65.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.83 -46.23 85.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.699 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 84.3 mt -68.93 -33.29 73.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.775 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -70.7 -28.22 64.58 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.409 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 26.5 mmt -80.58 -53.11 6.85 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.092 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.9 p30 -64.13 -39.64 94.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.129 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 57.1 tp -63.4 -28.06 69.72 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.905 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 2.1 tm? -69.11 -65.5 0.7 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.158 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -51.83 -37.76 53.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.526 0.679 . . . . 0.0 109.451 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.39 73.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.672 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -65.29 -31.94 73.34 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.774 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.1 79.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.76 44.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 19' ' ' LEU . 42.4 t -61.6 -47.31 93.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.781 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -58.36 -47.46 83.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.145 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 21.1 mmt -67.72 -37.62 82.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.76 -53.37 16.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.051 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.06 -42.58 94.83 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.213 0.53 . . . . 0.0 109.767 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.84 -31.77 71.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.337 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.07 -40.02 82.81 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.178 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 18' ' ' GLY . 43.4 mm -63.93 -61.63 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.585 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.04 -49.72 61.69 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.514 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.5 -42.18 87.06 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 110.63 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.63 -61.6 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 30' ' ' ILE . 2.1 mp -51.29 -52.63 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.04 77.21 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.258 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.971 HD11 HG12 ' A' ' 56' ' ' VAL . 5.5 tp -57.13 -44.95 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.96 -40.23 95.22 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.96 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.701 HG12 ' O ' ' A' ' 26' ' ' ILE . 36.6 mm -55.03 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.565 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 35' ' ' PHE . 7.9 tt -68.2 -26.87 65.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.984 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -58.77 -45.08 95.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.257 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.86 -52.38 50.81 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.06 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 14.6 ptmm? -60.55 -51.1 70.87 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.195 0.521 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.62 ' HB2' HD23 ' A' ' 31' ' ' LEU . 15.4 t80 -63.01 -48.94 76.63 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.713 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.497 HD13 ' OE1' ' A' ' 52' ' ' GLN . 53.0 tp -65.07 -36.27 83.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.05 -63.09 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.069 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.82 -49.47 67.98 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.553 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.649 ' O ' HD23 ' A' ' 45' ' ' LEU . . . -53.8 -37.78 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.549 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . . . -81.91 -22.49 36.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -64.92 -34.06 77.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 36.3 mt-30 -57.81 123.38 63.16 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.12 1.71 0.58 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.73 2.287 . . . . 0.0 112.757 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.9 t0 -130.23 34.09 4.25 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 120.84 0.353 . . . . 0.0 110.334 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.923 HD22 ' HB3' ' A' ' 48' ' ' LEU . 2.6 tm? -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.51 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.862 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.4 mp -30.09 -58.64 0.29 Allowed Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 81.8 Cg_endo -77.66 -27.67 5.94 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.237 1.291 . . . . 0.0 110.938 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.923 ' HB3' HD22 ' A' ' 45' ' ' LEU . 23.0 tp -66.21 -21.52 66.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -56.41 -56.98 14.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.46 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 54.0 mtp85 -75.5 -34.88 60.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.141 0.496 . . . . 0.0 110.169 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.934 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 59.7 m -64.72 -33.33 75.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.45 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 2.8 pt20 -81.43 -36.91 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 12.2 t80 -55.52 -55.42 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.695 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.934 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 3.8 p90 -72.89 -38.5 66.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.493 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 54' ' ' PHE . 21.1 mm -61.25 -59.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 110.335 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.971 HG12 HD11 ' A' ' 28' ' ' ILE . 40.7 t -60.64 -50.0 82.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.124 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.67 -34.69 76.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.206 0.527 . . . . 0.0 110.571 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -72.31 -42.81 48.58 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.589 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.6 pp -66.88 -33.68 76.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.45 0.625 . . . . 0.0 109.881 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 56' ' ' VAL . 59.5 t -76.76 -49.8 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.039 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.43 -17.61 63.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.074 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.4 -34.26 68.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 52.0 mt -59.32 -69.02 0.59 Allowed Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.297 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 24.5 Cg_exo -53.49 -26.47 36.42 Favored 'Trans proline' 0 C--N 1.356 0.926 0 CA-C-N 119.845 0.98 . . . . 0.0 110.842 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.15 -30.69 66.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 62' ' ' ALA . 81.8 mt -77.99 -43.26 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.724 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.91 -58.49 3.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.858 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.512 HG12 HD12 ' A' ' 72' ' ' LEU . 59.8 t -62.33 -40.1 86.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.7 -49.72 75.51 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.064 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.83 -41.59 82.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.0 111.196 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.92 -48.01 69.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.173 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 76' ' ' PHE . 74.0 mt -70.76 -34.76 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.93 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 88.4 t80 -54.78 -46.77 74.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.198 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 75' ' ' MET . 8.3 p -84.27 -27.22 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.529 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.905 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -78.04 -74.71 0.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 72' ' ' LEU . 20.3 m-85 -58.53 -27.85 64.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.5 -56.57 2.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 27.1 t -87.63 -8.56 10.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 111.183 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -58.05 -67.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -59.65 -32.8 70.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.441 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 80.6 mt -67.99 -40.86 83.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.237 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 21.6 p30 -70.42 -33.79 71.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.568 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.448 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 60.7 mtm -68.82 -56.11 9.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.766 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -63.23 -44.11 96.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.2 tm? -60.7 -29.51 69.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.605 HD11 ' CA ' ' A' ' 71' ' ' GLY . 5.9 tt -69.23 -60.85 2.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.668 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -51.31 -45.31 62.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.303 0.573 . . . . 0.0 109.495 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.81 -40.21 91.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.698 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -57.99 -32.4 67.86 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.299 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -67.24 -37.8 84.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.28 50.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 19' ' ' LEU . 48.5 t -63.99 -41.17 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.01 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.7 mmm -61.03 -50.66 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.917 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 26.3 mmt -65.88 -39.58 90.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.646 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.66 -51.2 26.53 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -61.0 -44.76 96.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.14 -32.18 73.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.262 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -66.89 -42.03 86.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.6 mm -63.39 -60.52 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.771 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.1 92.88 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.617 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -59.62 -47.15 86.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 110.72 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.0 -53.12 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 110.932 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.804 ' O ' HG12 ' A' ' 30' ' ' ILE . 70.0 mt -51.78 -59.08 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.42 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.52 -44.44 92.95 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.393 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -49.25 -47.52 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.84 -40.44 98.4 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.911 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.804 HG12 ' O ' ' A' ' 26' ' ' ILE . 45.9 mm -56.45 -74.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 68.7 tp -67.21 -44.07 80.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -52.88 -43.76 61.06 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.557 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -62.04 -55.24 29.22 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.276 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 5.2 ptpp? -57.48 -52.06 66.93 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 120.965 0.412 . . . . 0.0 111.308 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.539 ' CD1' ' NE2' ' A' ' 52' ' ' GLN . 1.1 t80 -62.43 -54.38 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.703 ' CD1' HD11 ' A' ' 48' ' ' LEU . 53.5 tp -52.8 -39.58 62.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.316 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -57.96 -64.3 0.96 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.1 27.13 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.039 -1.076 . . . . 0.0 111.572 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -58.54 -31.21 67.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.591 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . . . -71.64 -29.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.981 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -87.62 -16.88 33.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.89 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 35.0 mt-30 -70.71 167.82 24.84 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.673 0.749 . . . . 0.0 111.229 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 58.4 Cg_endo -80.17 12.34 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.112 3.208 . . . . 0.0 113.081 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 p-10 -125.22 -83.87 0.64 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 45' ' ' LEU . 3.7 tt 69.87 -51.53 0.63 Allowed 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.55 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 6.8 mt -44.92 -50.29 26.27 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.344 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 57.9 Cg_endo -72.93 -23.74 18.34 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.444 1.429 . . . . 0.0 111.741 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.22 -37.38 85.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.027 ' N ' HD13 ' A' ' 48' ' ' LEU . 31.9 mt -48.61 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.82 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -74.95 -34.91 62.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 81.3 m -66.49 -31.76 72.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.13 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.581 ' OE1' HD23 ' A' ' 48' ' ' LEU . 23.6 mt-30 -98.43 -36.42 9.96 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.868 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.75 -46.3 90.2 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.37 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -76.08 -42.59 46.9 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.895 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD23 ' A' ' 59' ' ' LEU . 47.0 mm -69.41 -46.34 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 60' ' ' VAL . 95.7 t -67.19 -42.44 88.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.666 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -67.49 -40.86 85.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.432 0.634 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.29 68.7 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.639 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 55' ' ' ILE . 4.6 pp -65.87 -23.83 66.74 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.449 0.625 . . . . 0.0 110.649 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 56' ' ' VAL . 88.6 t -83.52 -53.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.41 0.624 . . . . 0.0 109.507 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 65' ' ' MET . 59.4 m-20 -62.97 -20.16 64.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.833 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -54.85 -35.41 63.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.578 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 60.8 mt -58.73 -66.56 1.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.888 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -59.5 -22.97 68.85 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.295 1.33 . . . . 0.0 111.08 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -72.7 -32.05 65.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 62' ' ' ALA . 65.5 mt -74.85 -46.65 40.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.741 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.92 -57.25 6.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.323 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG12 HD23 ' A' ' 72' ' ' LEU . 62.7 t -64.68 -34.39 69.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.382 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.11 -50.65 44.46 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.613 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.2 -43.21 96.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.494 0.664 . . . . 0.0 109.769 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.605 ' CA ' HD11 ' A' ' 9' ' ' LEU . . . -60.62 -59.46 10.2 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 68' ' ' VAL . 4.7 pp -61.02 -27.51 68.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.104 0.478 . . . . 0.0 110.954 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.951 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 89.2 t80 -58.56 -45.0 89.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.171 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 38.8 t -90.92 -32.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.963 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 mpp? -86.72 -69.67 0.66 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.777 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 9.6 m-85 -58.49 -27.2 64.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.59 -62.15 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 22.4 t -83.57 1.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.166 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.824 0.345 . . . . 0.0 111.225 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.777 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.2 mpp? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 6' ' ' MET . 16.9 tp10 -64.73 -44.81 88.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.903 0.383 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -58.32 -55.31 36.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.444 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.905 HD23 ' H ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -68.64 -35.86 77.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.771 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -73.06 -22.38 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.875 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 49.7 mtm -82.01 -51.54 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.537 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 53.1 p-10 -71.7 -37.84 70.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.098 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -65.27 -33.72 76.64 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.662 ' HG ' ' HG3' ' A' ' 75' ' ' MET . 3.4 tm? -70.91 -55.94 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.763 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -51.05 -53.45 33.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.742 0.782 . . . . 0.0 109.65 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -38.03 84.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.64 -33.7 75.55 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -66.93 -38.74 86.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.06 68.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 19' ' ' LEU . 46.8 t -64.27 -51.66 65.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.433 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -59.17 -55.51 33.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.773 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . 0.813 ' CG ' HG21 ' A' ' 68' ' ' VAL . 81.1 mtp -62.72 -41.3 99.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.387 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.24 -52.05 34.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -59.42 -44.99 92.76 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.625 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.05 -30.07 70.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.52 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.83 80.37 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.175 0.512 . . . . 0.0 109.664 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' GLY . 49.1 mm -62.83 -58.32 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.732 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.2 -47.4 90.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.31 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . . . -57.5 -38.73 75.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -67.14 -44.01 80.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.7 ' O ' HG13 ' A' ' 30' ' ' ILE . 32.9 mm -58.71 -52.32 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.306 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -66.9 -48.32 61.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.938 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 ' HA ' ' A' ' 57' ' ' MET . 38.5 pt -51.86 -46.78 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -62.24 -37.04 93.9 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 65.5 mt -58.17 -77.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.91 -47.6 74.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.127 0.489 . . . . 0.0 110.853 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -54.42 -48.73 63.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.365 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.06 90.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.662 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 44.8 mmtm -59.59 -64.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 110.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -62.28 -40.16 95.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 109.692 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 HD22 ' A' ' 49' ' ' LEU . 34.1 tp -57.61 -40.86 80.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.63 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.58 -56.58 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -58.22 -54.55 36.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.042 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -56.05 -25.6 45.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.534 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -83.34 -37.08 23.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.828 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 41.0 ptt180 -85.05 -6.28 59.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.432 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.947 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 58.8 tp60 -71.85 -108.57 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 71.7 Cg_endo -101.48 -68.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.737 0 CA-C-N 122.381 1.886 . . . . 0.0 112.835 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 46' ' ' ILE . 3.0 p30 -158.95 36.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.976 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 74.7 mt -74.77 16.13 0.31 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.506 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 37.9 mt -46.99 -44.31 46.99 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.306 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.3 Cg_endo -70.99 -29.25 18.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.08 1.187 . . . . 0.0 110.159 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 51.2 tp -64.0 -33.06 74.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 40' ' ' ALA . 26.4 mt -47.93 -67.52 0.27 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.759 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -61.69 -46.25 90.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.02 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.744 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.6 m -55.94 -39.57 71.91 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 66.1 mt-30 -85.32 -26.02 26.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 110.124 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -60.64 -54.01 50.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE1' ' O ' ' A' ' 51' ' ' THR . 2.9 p90 -68.29 -30.14 69.07 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.716 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 51' ' ' THR . 36.5 mm -66.45 -58.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.7 t -55.61 -46.39 79.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.222 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.69 ' HA ' HG21 ' A' ' 28' ' ' ILE . 62.4 ttp -69.47 -33.16 72.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -71.49 -42.67 55.25 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.978 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.4 pp -65.17 -29.13 69.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.142 0.471 . . . . 0.0 110.198 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 59' ' ' LEU . 98.1 t -78.01 -48.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 46.9 m-20 -73.27 -8.72 57.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.299 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -61.72 -30.69 70.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 56.2 mt -62.0 -62.21 6.25 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 31.0 Cg_exo -60.9 -25.42 81.33 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.044 1.051 . . . . 0.0 110.424 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -70.02 -31.1 68.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.29 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 62' ' ' ALA . 74.1 mt -78.24 -45.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.623 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -56.29 13.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.088 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.813 HG21 ' CG ' ' A' ' 17' ' ' MET . 43.8 t -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.034 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 72' ' ' LEU . . . -59.52 -45.43 95.58 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.127 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -65.04 -44.53 88.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 109.791 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -64.33 -45.78 92.48 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.525 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.0 pp -66.76 -32.71 74.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.371 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.942 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.7 t80 -54.98 -47.03 75.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 47.1 t -86.03 -30.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.445 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.662 ' HG3' ' HG ' ' A' ' 9' ' ' LEU . 20.9 mmt -73.21 -76.13 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.29 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 27.1 m-85 -60.78 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -92.96 -59.84 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 94.6 t -82.55 -6.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.062 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.117 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.843 0.354 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.13 -49.39 65.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -63.74 -30.61 71.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.55 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.531 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -76.68 -48.33 19.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.783 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -71.72 -15.69 62.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.05 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.458 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 27.3 ttt -82.05 -57.49 3.38 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.765 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 7.0 p-10 -68.68 -41.56 79.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.979 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 55.1 tp -60.1 -39.39 86.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 75' ' ' MET . 35.4 tp -67.48 -57.4 6.58 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.108 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 8.6 m-30 -50.85 -51.99 45.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 109.742 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.7 ttm -60.43 -38.98 85.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.07 -35.49 77.1 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.423 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -64.32 -37.32 87.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.03 -54.52 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 19' ' ' LEU . 52.6 t -61.29 -49.59 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.999 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -57.5 -46.02 84.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.081 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 85.5 mmm -65.24 -41.56 94.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.525 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -67.25 -54.33 20.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.868 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.6 pp -59.67 -42.65 93.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.611 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -68.89 -30.58 69.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.717 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.74 -41.89 82.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.893 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 26' ' ' ILE . 67.2 mt -64.45 -56.7 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.931 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.72 98.74 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.425 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.637 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -60.62 -45.26 94.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.65 -46.81 88.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.756 ' O ' HG13 ' A' ' 30' ' ' ILE . 40.8 mm -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.458 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -65.74 -48.3 68.34 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.113 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 24' ' ' ALA . 36.2 pt -49.48 -46.77 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 117.541 0.67 . . . . 0.0 109.331 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -65.43 -36.79 93.06 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.118 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.756 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.2 mt -59.73 -71.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 110.68 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 31' ' ' LEU . 5.9 tt -68.26 -30.94 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -59.71 -47.93 88.55 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.996 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.01 61.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.295 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 17.9 ptpt -60.51 -53.85 52.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 111.66 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.434 ' HB2' HD23 ' A' ' 31' ' ' LEU . 12.7 t80 -64.05 -48.33 76.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.29 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 36' ' ' LEU . 2.0 tm? -60.19 -37.68 80.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -61.01 -55.39 33.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.757 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.8 -56.01 27.68 Favored Glycine 0 C--O 1.235 0.196 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -55.8 -48.02 76.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.286 0.565 . . . . 0.0 110.418 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.626 ' CA ' HD21 ' A' ' 49' ' ' LEU . . . -70.66 -15.87 62.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.589 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 6.4 tpm_? -81.58 -28.41 33.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.633 ' CB ' HD13 ' A' ' 45' ' ' LEU . 90.9 mm-40 -101.85 106.93 49.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.63 ' O ' HG13 ' A' ' 46' ' ' ILE . 5.0 Cg_exo -44.83 -22.72 0.72 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.854 2.369 . . . . 0.0 113.974 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.606 ' C ' HD12 ' A' ' 45' ' ' LEU . 37.9 t70 -82.69 -7.2 59.66 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 42' ' ' GLN . 4.3 mp -108.45 19.36 19.9 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 43' ' ' PRO . 32.1 mt -54.8 -45.55 99.65 Favored Pre-proline 0 C--O 1.225 -0.229 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.145 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 15.4 Cg_exo -67.39 -20.83 47.97 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.803 1.669 . . . . 0.0 110.255 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 39' ' ' ALA . 27.4 tp -69.44 -38.64 77.92 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.626 HD21 ' CA ' ' A' ' 40' ' ' ALA . 51.9 mt -44.29 -62.9 1.0 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.679 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -67.4 -46.36 73.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.6 m -55.73 -46.06 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.77 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.736 ' HA ' HG22 ' A' ' 55' ' ' ILE . 16.4 pt20 -70.08 -36.31 74.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.19 -57.45 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.14 -41.64 99.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.202 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.736 HG22 ' HA ' ' A' ' 52' ' ' GLN . 11.0 tp -63.23 -50.17 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.698 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 60' ' ' VAL . 61.0 t -65.59 -42.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.4 ttm -71.83 -40.82 68.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.279 0.561 . . . . 0.0 110.327 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -68.7 -44.33 71.2 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.357 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 88.4 mt -63.56 -40.57 97.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.166 0.483 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 56' ' ' VAL . 73.4 t -71.45 -41.39 73.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.425 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 40.7 m-20 -81.19 -9.01 59.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.62 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -66.14 -27.55 68.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 72.4 mt -62.24 -59.66 12.33 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 16.3 Cg_exo -68.79 -26.38 32.5 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.264 1.309 . . . . 0.0 110.74 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.7 tpt -69.29 -31.7 70.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.494 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 62' ' ' ALA . 51.8 mt -79.15 -44.92 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.908 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.26 -53.13 32.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 110.306 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 97.1 t -64.71 -46.99 90.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -54.5 -50.77 55.67 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.702 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.6 pp -62.79 -42.33 99.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.301 0.572 . . . . 0.0 110.34 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -58.49 -56.38 25.57 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.845 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -71.59 -28.46 63.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.732 ' N ' HD12 ' A' ' 72' ' ' LEU . 21.4 t80 -57.91 -40.24 79.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 109.654 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 46.4 t -94.02 -32.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.817 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.845 ' HG3' HD23 ' A' ' 9' ' ' LEU . 88.3 mmm -75.03 -76.04 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.237 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 28.0 m-85 -63.93 -29.0 70.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.21 -51.85 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 78' ' ' VAL . 55.7 t -88.04 -6.49 10.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.66 0.267 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 6' ' ' MET . 42.7 tt0 -61.62 -53.9 50.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -65.68 -32.77 74.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -77.26 -31.14 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.688 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -77.43 -29.47 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.28 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 66.0 mtm -80.23 -49.16 11.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.561 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 57.5 p-10 -67.94 -40.13 83.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.255 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.1 tm? -64.13 -30.04 71.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.1 tm? -68.15 -61.62 1.77 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -50.53 -49.57 55.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.728 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.65 -43.04 99.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -55.25 -42.88 74.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.856 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' MET . . . -56.77 -44.33 81.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.974 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.63 44.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.132 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 HD23 ' A' ' 19' ' ' LEU . 48.9 t -58.38 -62.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.088 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.1 mpp? -47.57 -47.3 28.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.709 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -62.32 -45.09 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.935 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -66.69 -49.99 51.58 Favored Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.027 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 3.4 pp -60.61 -41.69 95.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.095 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -70.34 -32.14 69.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . -67.05 -44.14 80.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.1 mt -63.55 -57.61 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.408 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.22 -51.4 58.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.743 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.55 -41.32 89.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -62.01 -47.01 86.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.749 ' O ' HG12 ' A' ' 30' ' ' ILE . 36.7 mm -56.71 -60.02 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.29 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.42 -45.91 74.75 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.178 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.8 tp -51.37 -46.66 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.09 -39.39 97.55 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.739 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.9 mm -58.01 -69.61 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD22 ' HD3' ' A' ' 34' ' ' LYS . 2.5 tm? -76.31 -44.55 36.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -61.64 -38.35 95.73 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.458 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.21 -51.97 45.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.589 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.742 ' HD3' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -58.13 -50.07 74.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.36 0.6 . . . . 0.0 110.168 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 5.8 t80 -61.32 -41.54 97.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.754 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 49' ' ' LEU . 58.7 tp -63.79 -41.36 97.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.421 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 47.9 mt-10 -59.52 -53.48 57.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.601 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.97 -61.32 7.11 Favored Glycine 0 C--O 1.239 0.427 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.951 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -49.92 -46.14 51.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.636 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -72.44 -25.83 61.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.629 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 55.3 ttp180 -67.8 -25.24 65.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.59 ' CB ' HD13 ' A' ' 45' ' ' LEU . 72.6 mt-30 -96.85 95.54 2.26 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.098 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 99.4 Cg_exo -38.38 -25.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.46 2.773 . . . . 0.0 114.356 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.664 ' C ' HD12 ' A' ' 45' ' ' LEU . 58.2 m-20 -79.87 -1.42 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.772 HD23 ' CD2' ' A' ' 48' ' ' LEU . 5.4 mp -121.04 14.91 11.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 26.9 mm -52.48 -45.15 95.65 Favored Pre-proline 0 N--CA 1.464 0.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.308 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 9.4 Cg_exo -70.24 -21.0 31.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.813 1.675 . . . . 0.0 110.714 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.772 ' CD2' HD23 ' A' ' 45' ' ' LEU . 30.1 tp -67.31 -38.96 85.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 36' ' ' LEU . 38.9 mt -47.0 -64.59 0.74 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.829 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.017 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.689 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 46.8 m -58.58 -42.9 89.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.695 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -84.84 -34.79 22.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.949 0.404 . . . . 0.0 110.366 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.5 t80 -51.93 -50.6 60.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.908 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 1.2 p90 -63.41 -35.47 80.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.836 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 51' ' ' THR . 55.0 mt -66.21 -63.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.24 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.6 t -54.62 -40.45 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.638 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.7 ttt -71.2 -39.0 72.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 0.0 110.564 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -66.22 -45.91 83.28 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.343 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -57.08 -43.33 82.03 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 109.804 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 56' ' ' VAL . 50.6 t -66.28 -51.42 59.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.438 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.33 -13.68 62.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.58 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.77 -33.77 70.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.746 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 53.5 mt -60.69 -66.28 1.63 Allowed Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.598 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 22.0 Cg_exo -56.94 -25.31 61.69 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 120.055 1.055 . . . . 0.0 111.061 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.11 70.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 62' ' ' ALA . 70.2 mt -77.49 -43.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.26 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.546 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.32 -51.24 54.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.17 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.2 t -69.62 -30.53 45.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.269 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.52 -50.84 29.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.775 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 71' ' ' GLY . 3.7 pp -62.35 -42.61 99.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.993 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.854 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -61.55 -52.53 50.51 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.515 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.1 pp -64.04 -30.57 71.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 111.145 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 72' ' ' LEU . 89.2 t80 -53.03 -48.54 67.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.266 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.1 t -89.75 -31.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.397 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.893 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -80.5 -69.08 0.62 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -59.2 -23.04 61.93 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -79.04 -54.49 5.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 74' ' ' VAL . 13.8 p -115.67 -17.43 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.399 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.2 -45.9 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.693 0.282 . . . . 0.0 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.65 -45.84 90.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 8' ' ' LEU . 96.6 mt -66.19 -44.74 83.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.608 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 56.3 m-20 -63.2 -36.32 83.23 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.471 ' O ' ' HD1' ' A' ' 10' ' ' TYR . 56.4 ttm -64.22 -69.73 0.26 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.794 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -52.98 -40.65 63.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.526 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 54.7 tp -65.62 -31.01 71.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.762 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.591 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.3 tm? -68.6 -52.9 26.5 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.326 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 6' ' ' MET . 31.3 m-85 -59.69 -42.59 93.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.009 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 25.7 ttt -63.3 -37.76 88.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.08 -37.4 84.87 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.474 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -60.22 -46.24 90.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.57 72.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 19' ' ' LEU . 38.8 t -64.91 -51.52 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.733 ' CE ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.32 -51.61 66.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.684 ' CG ' HG21 ' A' ' 68' ' ' VAL . 84.6 mtp -62.5 -41.9 99.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.401 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -68.66 -53.85 18.2 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.567 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.5 pp -58.04 -45.39 87.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.241 0.544 . . . . 0.0 109.892 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.786 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.37 -32.18 73.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.371 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.86 -41.06 78.92 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.508 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 18' ' ' GLY . 92.6 mt -62.26 -57.79 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.777 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -47.76 89.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.446 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -56.42 -42.67 78.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.875 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -61.62 -58.08 9.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.197 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.854 ' O ' HG12 ' A' ' 30' ' ' ILE . 33.8 mm -44.4 -56.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.34 -38.33 87.12 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.766 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -56.13 -44.03 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.25 -36.4 89.66 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.546 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.854 HG12 ' O ' ' A' ' 26' ' ' ILE . 42.5 mm -59.63 -69.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.441 0.162 . . . . 0.0 110.81 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.0 tm? -74.59 -45.6 44.11 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.658 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -62.59 -44.11 98.03 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.3 -0.953 . . . . 0.0 110.886 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -60.75 -49.22 81.05 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.853 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.44 -53.98 49.42 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.058 0.456 . . . . 0.0 110.587 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.45 ' CE1' ' NE2' ' A' ' 52' ' ' GLN . 5.0 t80 -57.25 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 32' ' ' GLY . 6.8 mp -53.28 -34.65 58.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.925 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 16.3 tp10 -56.77 -61.28 2.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 109.944 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -54.32 -47.31 69.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.19 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.26 -34.97 77.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.148 0.499 . . . . 0.0 110.009 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.99 -22.87 62.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 4.5 tmm_? -92.34 -19.39 22.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.763 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.951 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 65.3 mt-30 -61.21 -177.01 0.12 Allowed Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 73.6 Cg_exo -48.81 -71.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.154 2.569 . . . . 0.0 113.375 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.6 t70 -146.09 46.94 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.893 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -84.56 13.22 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 111.131 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 29.4 mm -52.56 -45.51 95.9 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.635 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 35.3 Cg_endo -68.16 -23.43 39.47 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 120.874 1.05 . . . . 0.0 110.698 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 45' ' ' LEU . 35.6 tp -67.8 -38.72 83.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 40' ' ' ALA . 77.8 mt -43.91 -61.42 1.45 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.743 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.621 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 39.7 ptt180 -63.02 -49.53 74.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.148 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 55' ' ' ILE . 97.6 m -46.83 -48.8 20.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 28.3 mt-30 -69.3 -33.43 73.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.987 0.423 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.02 -54.19 47.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' HD1' ' O ' ' A' ' 50' ' ' ARG . 31.6 m-85 -65.15 -44.45 88.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.638 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 51' ' ' THR . 36.8 mm -63.86 -56.99 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 60' ' ' VAL . 39.1 t -60.78 -48.19 89.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.426 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 26.5 ttt -68.73 -35.53 77.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.216 0.532 . . . . 0.0 110.576 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -69.61 -45.08 60.8 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.07 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 80.2 mt -61.98 -42.5 99.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' VAL . 60.4 t -69.65 -50.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.391 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 57' ' ' MET . 28.6 m-20 -69.13 -16.04 63.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.636 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.73 -33.72 68.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.389 . . . . 0.0 110.506 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 70.9 mt -57.6 -66.11 1.45 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 17.4 Cg_endo -60.13 -24.94 78.53 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.261 1.307 . . . . 0.0 110.839 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 79.0 mmm -71.67 -31.6 66.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.495 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 58.4 mt -75.51 -46.47 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.513 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.55 -54.65 18.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.53 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG21 ' CG ' ' A' ' 17' ' ' MET . 58.1 t -67.13 -40.87 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.338 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.52 -41.61 99.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.876 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 70' ' ' LEU . 5.2 tt -67.89 -46.21 72.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -44.67 96.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.683 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 85.4 mt -73.68 -30.37 62.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.967 0.413 . . . . 0.0 110.273 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.867 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.8 t80 -58.27 -47.44 83.59 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG13 ' SD ' ' A' ' 75' ' ' MET . 6.4 p -78.64 -34.0 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.43 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.546 ' SD ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -70.07 -74.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.453 ' CE2' HD22 ' A' ' 72' ' ' LEU . 31.1 m-85 -56.89 -29.58 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.48 -54.3 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.8 t -92.08 -10.03 9.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.79 -55.78 13.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.04 -40.35 76.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.614 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.589 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 82.4 mt -70.32 -45.39 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 55.2 m-20 -71.19 -13.96 62.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.118 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.485 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 28.0 ttt -82.89 -59.05 2.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 10.5 p-10 -67.39 -42.38 83.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.099 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.97 -34.15 72.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 75' ' ' MET . 51.2 tp -68.43 -63.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.132 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 5.8 m-85 -53.64 -42.57 67.94 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.183 0.516 . . . . 0.0 109.935 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 15' ' ' VAL . 9.6 tmm? -66.31 -36.29 82.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.409 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -63.77 -31.25 72.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.743 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -68.08 -33.08 73.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -54.65 17.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 50.4 t -62.06 -41.94 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.762 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 15.2 mmt -62.03 -50.8 70.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.765 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.55 ' SD ' HG21 ' A' ' 68' ' ' VAL . 89.5 mmm -66.51 -39.65 88.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.566 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -69.65 -49.84 34.43 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -59.41 -47.28 86.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.793 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.58 -33.0 74.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.734 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.14 -42.26 84.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 18' ' ' GLY . 75.1 mt -62.25 -60.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.87 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.77 -45.88 90.53 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.808 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -62.32 -40.79 97.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.589 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -63.55 -43.88 95.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.212 0.53 . . . . 0.0 110.275 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.825 ' O ' HG13 ' A' ' 30' ' ' ILE . 79.4 mt -58.24 -61.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.174 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -67.16 -42.32 91.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.156 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.646 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.7 tp -54.87 -46.75 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.475 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.21 -36.43 92.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.65 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.825 HG13 ' O ' ' A' ' 26' ' ' ILE . 72.3 mt -61.88 -72.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.521 0.201 . . . . 0.0 110.856 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.3 tm? -71.39 -42.06 68.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -65.18 -44.05 94.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.793 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.59 -38.04 95.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.418 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 18.8 ptpt -71.99 -47.88 48.91 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.6 t80 -63.91 -49.44 72.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 49' ' ' LEU . 5.1 tt -56.24 -51.44 68.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.271 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' LYS . 12.6 pt-20 -57.26 -51.65 68.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.862 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -54.02 -53.7 35.54 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.77 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 45' ' ' LEU . . . -64.62 -42.32 95.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.093 0.473 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' HD23 ' A' ' 36' ' ' LEU . . . -57.0 -30.82 64.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.575 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 97.2 mtt180 -82.3 -37.82 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 109.706 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.793 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . 27.9 tp60 -44.86 127.97 5.27 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.352 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -32.78 -33.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 124.755 3.637 . . . . 0.0 115.879 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' C ' HD12 ' A' ' 45' ' ' LEU . 56.4 m-20 -141.02 29.3 1.86 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.793 ' HB2' ' HB3' ' A' ' 42' ' ' GLN . 8.6 mp -114.38 6.98 16.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 111.563 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.3 mp -48.61 -47.29 71.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.704 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 79.3 Cg_endo -78.92 -16.69 12.55 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.867 1.711 . . . . 0.0 111.174 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' HG ' HE21 ' A' ' 52' ' ' GLN . 40.4 tp -69.52 -30.74 68.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.711 HD13 HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -47.48 -59.21 3.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.556 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 86.7 mtm180 -72.06 -42.54 66.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 110.196 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 55' ' ' ILE . 28.0 m -52.74 -39.61 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.591 HE21 ' HG ' ' A' ' 48' ' ' LEU . 4.8 pt20 -84.59 -33.82 23.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.545 ' HD2' HD12 ' A' ' 36' ' ' LEU . 11.0 t80 -57.6 -49.7 75.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.231 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.564 ' CE1' HG12 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -73.2 -30.09 63.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 51' ' ' THR . 38.7 mm -69.69 -56.75 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.262 0.553 . . . . 0.0 109.843 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.646 HG12 ' CD1' ' A' ' 28' ' ' ILE . 41.1 t -61.57 -39.23 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.302 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.75 -34.26 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.537 . . . . 0.0 110.204 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.03 63.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.352 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.133 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.657 ' N ' HD12 ' A' ' 59' ' ' LEU . 99.7 t -78.16 -51.25 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -69.04 -12.77 61.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.51 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.48 -33.32 69.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.76 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 70.3 mt -60.85 -64.92 2.52 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.285 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 35.1 Cg_exo -55.71 -26.5 56.54 Favored 'Trans proline' 0 C--N 1.359 1.092 0 CA-C-N 120.123 1.08 . . . . 0.0 110.845 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.14 -30.85 66.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.633 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' ALA . 80.0 mt -76.73 -44.59 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.457 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.06 -58.42 4.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.55 HG21 ' SD ' ' A' ' 17' ' ' MET . 60.3 t -63.52 -39.53 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.192 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -64.67 -47.5 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.735 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.708 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.1 tm? -60.7 -44.74 96.19 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.37 58.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.172 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.2 pp -69.34 -26.06 64.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.943 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.7 t80 -54.68 -47.35 73.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 109.628 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 13.4 p -90.6 -28.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.675 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.659 ' HG3' HD21 ' A' ' 9' ' ' LEU . 94.2 mmm -82.14 -74.99 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 72' ' ' LEU . 15.5 m-30 -58.53 -28.79 65.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.378 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.943 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.96 -55.08 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 48.1 t -87.75 -2.75 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.158 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.94 -51.35 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.5 -38.28 86.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.7 -32.62 68.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.12 -30.94 62.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 10' ' ' TYR . 51.5 ttm -77.42 -46.22 23.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.746 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.41 -46.57 69.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.369 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.662 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.98 -32.26 70.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 61.2 tp -64.87 -58.23 6.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.778 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 6' ' ' MET . 9.1 m-30 -47.38 -54.3 11.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.521 0.676 . . . . 0.0 109.839 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -61.45 -38.56 87.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.721 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.82 -33.7 74.61 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.83 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.6 -52.57 51.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.078 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 43.6 t -60.48 -44.45 96.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.303 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.48 -55.42 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.773 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.2 mmm -58.68 -42.21 88.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.579 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -68.72 -53.98 17.32 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.695 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.4 pp -57.72 -44.07 85.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 110.196 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.89 -32.44 72.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -67.09 -40.45 86.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.838 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 18' ' ' GLY . 47.4 mm -62.37 -64.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.576 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.31 -50.51 46.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.677 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.22 -42.09 85.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.863 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -56.95 -59.52 4.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HD13 ' A' ' 30' ' ' ILE . 1.9 mp -53.72 -57.46 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.16 97.32 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.896 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 25' ' ' ALA . 6.0 tp -58.13 -43.67 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.03 -35.84 92.64 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.599 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 26' ' ' ILE . 1.5 mp -60.39 -72.3 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.611 0.244 . . . . 0.0 110.762 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 34' ' ' LYS . 3.2 tm? -69.02 -41.55 77.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.107 0.48 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -60.21 -43.24 98.64 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.834 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.87 -48.48 80.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.077 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.74 ' HD2' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -62.77 -50.87 69.33 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.893 0.377 . . . . 0.0 110.922 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 15.3 t80 -62.66 -49.23 75.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 49' ' ' LEU . 2.4 tm? -61.46 -37.18 82.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.796 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -58.79 -57.93 10.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.13 -56.78 18.51 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.245 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -50.29 -25.24 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.133 0.492 . . . . 0.0 111.255 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.656 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -92.86 -33.21 14.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.242 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 9.1 mmp_? -63.96 -25.04 67.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.26 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' CB ' HD23 ' A' ' 45' ' ' LEU . 10.9 mm100 -100.44 117.2 63.39 Favored Pre-proline 0 N--CA 1.435 -1.225 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.073 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 42' ' ' GLN . 9.7 Cg_endo -56.05 -7.44 1.74 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.008 2.472 . . . . 0.0 113.787 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -98.69 -25.39 14.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.53 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.863 HD12 HD22 ' A' ' 48' ' ' LEU . 2.8 mm? -92.16 11.56 25.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 13.9 mt -53.98 -44.24 97.97 Favored Pre-proline 0 C--O 1.225 -0.222 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.107 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 13.0 Cg_exo -68.83 -21.44 38.11 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.708 1.605 . . . . 0.0 110.694 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD22 HD12 ' A' ' 45' ' ' LEU . 48.4 tp -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 36' ' ' LEU . 69.1 mt -45.54 -63.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.449 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 47' ' ' PRO . 58.8 mtm-85 -67.6 -41.15 84.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.143 0.496 . . . . 0.0 110.305 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.843 ' O ' HG13 ' A' ' 55' ' ' ILE . 42.1 m -60.01 -39.68 86.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.076 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.701 ' OE1' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.25 -29.89 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.059 0.457 . . . . 0.0 110.155 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -61.22 -57.32 12.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.78 ' CE1' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -69.4 -34.58 74.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.843 HG13 ' O ' ' A' ' 51' ' ' THR . 33.6 mt -71.27 -56.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.658 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 60' ' ' VAL . 59.5 t -62.83 -37.34 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.499 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.434 ' CE ' HG12 ' A' ' 28' ' ' ILE . 61.3 tpp -73.69 -39.29 64.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.231 0.539 . . . . 0.0 110.386 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.96 -44.78 66.0 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.76 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 93.4 mt -60.21 -39.21 85.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.145 0.498 . . . . 0.0 110.071 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 56' ' ' VAL . 58.1 t -70.64 -42.3 77.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.745 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.687 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 41.0 m-20 -79.32 -13.09 59.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.648 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.712 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -67.12 -21.89 65.82 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.311 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 66.8 mt -65.13 -56.19 21.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.565 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 2.8 Cg_exo -77.94 -26.32 6.75 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.846 1.697 . . . . 0.0 110.979 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 50.6 tpp -70.69 -31.71 68.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 62' ' ' ALA . 1.2 mp -81.55 -44.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.771 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.8 48.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 109.984 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 74.6 t -67.98 -43.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.284 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.14 -43.08 99.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.989 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -63.87 -46.22 85.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 109.783 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.41 -55.52 30.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.493 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -68.2 -28.15 67.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.452 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.798 ' N ' HD12 ' A' ' 72' ' ' LEU . 87.4 t80 -52.54 -45.62 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.284 0.564 . . . . 0.0 109.711 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.6 p -93.0 -29.08 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.547 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 24.1 mmt -82.34 -70.04 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.321 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 10' ' ' TYR . 7.9 m-85 -61.21 -28.52 69.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.76 -58.9 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 111.839 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.7 t -83.82 -2.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.06 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.851 0.357 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.586 0.231 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.554 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 50.0 mt-10 -66.32 -53.44 36.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.203 0.525 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.416 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 75.2 m-20 -63.02 -31.73 72.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.792 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 79.7 mt -72.54 -50.86 22.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.35 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 2' ' ' GLU . 11.4 p-10 -69.67 -17.99 63.53 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.649 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 10' ' ' TYR . 10.3 tpt -85.9 -47.08 9.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.346 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.3 p30 -72.65 -40.68 66.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 60.3 mt -61.99 -32.7 73.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.688 HD13 ' HG3' ' A' ' 75' ' ' MET . 7.3 tt -70.26 -48.57 56.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 6' ' ' MET . 11.0 m-30 -48.58 -54.64 13.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.813 0.816 . . . . 0.0 109.105 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 ttm -63.61 -38.59 91.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.123 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -60.77 -33.07 72.4 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.915 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.68 80.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.04 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.38 55.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.499 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 19' ' ' LEU . 45.4 t -63.09 -47.1 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -59.08 -45.65 90.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.84 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.3 mmt -65.2 -42.75 93.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.7 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -70.14 -50.19 29.46 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.733 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.03 -44.88 94.32 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.095 0.474 . . . . 0.0 109.938 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.645 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -65.68 -38.42 89.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.332 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.19 94.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.1 mm -60.55 -61.6 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -52.93 42.63 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.933 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -56.8 -41.61 78.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.807 0.337 . . . . 0.0 110.693 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -61.95 -44.32 97.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HG13 ' A' ' 30' ' ' ILE . 66.0 mt -59.37 -55.76 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.756 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -64.66 -50.39 59.08 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.012 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 29' ' ' GLY . 2.9 pp -48.92 -46.86 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 28' ' ' ILE . . . -60.52 -39.3 96.21 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.3 mt -57.92 -72.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.635 0.255 . . . . 0.0 111.073 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.7 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.2 tp -73.51 -40.26 64.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -59.27 -39.44 94.63 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.62 -50.37 59.33 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.953 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.7 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.9 -52.41 65.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.169 0.509 . . . . 0.0 110.657 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.37 -52.88 63.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 47.6 tp -58.86 -36.04 73.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.151 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.83 -58.54 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -56.57 -56.31 25.29 Favored Glycine 0 C--O 1.242 0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.115 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.726 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -62.48 -16.16 53.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.335 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -95.94 -23.58 16.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.611 0.243 . . . . 0.0 110.831 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.608 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 16.0 ptm180 -86.31 -15.11 41.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.635 ' CB ' HD23 ' A' ' 45' ' ' LEU . 73.7 mt-30 -96.91 93.62 1.48 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.339 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 78.0 Cg_exo -38.06 -25.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.729 2.953 . . . . 0.0 114.729 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.633 ' C ' HD22 ' A' ' 45' ' ' LEU . 10.8 p-10 -85.28 2.81 42.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.901 HD12 HD22 ' A' ' 48' ' ' LEU . 3.4 mm? -116.02 18.97 15.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 22.8 mt -52.66 -45.92 96.23 Favored Pre-proline 0 C--O 1.224 -0.266 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.541 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 14.5 Cg_exo -67.82 -22.43 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.563 1.509 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.901 HD22 HD12 ' A' ' 45' ' ' LEU . 25.4 tp -68.74 -37.27 79.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 40' ' ' ALA . 63.9 mt -45.45 -65.45 0.54 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.34 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.07 -42.09 85.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.931 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 55' ' ' ILE . 50.6 m -58.58 -39.51 80.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.456 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.507 ' O ' HG23 ' A' ' 56' ' ' VAL . 14.4 pt20 -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.054 0.454 . . . . 0.0 110.218 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -59.16 -52.43 65.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.821 ' CE1' HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.09 -33.44 63.63 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.451 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.821 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.3 mm -69.76 -54.72 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.311 0.577 . . . . 0.0 110.063 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' HD12 ' A' ' 59' ' ' LEU . 59.8 t -64.53 -36.97 78.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.119 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.551 ' CE ' HD13 ' A' ' 28' ' ' ILE . 24.6 mmt -82.24 -29.51 31.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 0.0 110.433 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -81.21 -37.81 17.06 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.909 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -71.19 -21.41 62.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.829 0.814 . . . . 0.0 109.931 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 59' ' ' LEU . 78.3 t -88.19 -44.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.694 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -74.23 -22.15 59.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.74 -29.39 66.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.32 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.67 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 1.8 mp -58.15 -70.39 0.39 Allowed Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.114 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 25.6 Cg_exo -57.39 -27.38 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 120.787 0.992 . . . . 0.0 111.007 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.449 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 47.7 tpp -71.06 -30.33 66.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.166 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.804 ' O ' HD23 ' A' ' 70' ' ' LEU . 68.7 mt -79.31 -44.03 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.505 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.97 -56.8 6.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 0.0 109.947 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.816 HG12 HD22 ' A' ' 72' ' ' LEU . 86.2 t -63.12 -44.0 99.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.061 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -58.31 -46.69 92.59 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.339 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 66' ' ' ILE . 4.4 mm? -65.93 -46.18 79.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.842 0.321 . . . . 0.0 110.99 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -62.48 -52.71 47.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.807 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.816 HD22 HG12 ' A' ' 68' ' ' VAL . 5.7 mp -65.89 -32.26 73.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.945 0.402 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.835 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 94.1 t80 -54.2 -46.74 72.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.361 0.6 . . . . 0.0 109.727 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 49.1 t -86.3 -30.79 6.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.614 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.688 ' HG3' HD13 ' A' ' 9' ' ' LEU . 21.8 mmt -75.44 -74.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 20.2 m-85 -62.37 -27.64 69.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.78 -49.17 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 52.8 t -91.72 -6.24 10.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.047 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 111.242 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.952 0.406 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 6' ' ' MET . 56.0 mt-10 -62.09 -52.08 65.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.83 -46.23 85.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.699 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 84.3 mt -68.93 -33.29 73.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.775 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -70.7 -28.22 64.58 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.409 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 26.5 mmt -80.58 -53.11 6.85 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.092 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.9 p30 -64.13 -39.64 94.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.129 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 57.1 tp -63.4 -28.06 69.72 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.905 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 2.1 tm? -69.11 -65.5 0.7 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.158 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -51.83 -37.76 53.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.526 0.679 . . . . 0.0 109.451 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.39 73.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.672 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -65.29 -31.94 73.34 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.774 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.1 79.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.76 44.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 19' ' ' LEU . 42.4 t -61.6 -47.31 93.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.781 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -58.36 -47.46 83.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.145 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 21.1 mmt -67.72 -37.62 82.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.76 -53.37 16.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.051 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.06 -42.58 94.83 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.213 0.53 . . . . 0.0 109.767 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.84 -31.77 71.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.337 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.07 -40.02 82.81 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.178 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 18' ' ' GLY . 43.4 mm -63.93 -61.63 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.585 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.04 -49.72 61.69 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.514 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.5 -42.18 87.06 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 110.63 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.63 -61.6 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 30' ' ' ILE . 2.1 mp -51.29 -52.63 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.04 77.21 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.258 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.971 HD11 HG12 ' A' ' 56' ' ' VAL . 5.5 tp -57.13 -44.95 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.96 -40.23 95.22 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.96 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.701 HG12 ' O ' ' A' ' 26' ' ' ILE . 36.6 mm -55.03 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.565 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 35' ' ' PHE . 7.9 tt -68.2 -26.87 65.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.984 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -58.77 -45.08 95.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.257 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.86 -52.38 50.81 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.06 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 14.6 ptmm? -60.55 -51.1 70.87 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.195 0.521 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.62 ' HB2' HD23 ' A' ' 31' ' ' LEU . 15.4 t80 -63.01 -48.94 76.63 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.713 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.497 HD13 ' OE1' ' A' ' 52' ' ' GLN . 53.0 tp -65.07 -36.27 83.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.05 -63.09 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.069 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.82 -49.47 67.98 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.553 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.649 ' O ' HD23 ' A' ' 45' ' ' LEU . . . -53.8 -37.78 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.549 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . . . -81.91 -22.49 36.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -64.92 -34.06 77.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 36.3 mt-30 -57.81 123.38 63.16 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.12 1.71 0.58 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.73 2.287 . . . . 0.0 112.757 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.9 t0 -130.23 34.09 4.25 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 120.84 0.353 . . . . 0.0 110.334 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.923 HD22 ' HB3' ' A' ' 48' ' ' LEU . 2.6 tm? -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.51 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.862 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.4 mp -30.09 -58.64 0.29 Allowed Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 81.8 Cg_endo -77.66 -27.67 5.94 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.237 1.291 . . . . 0.0 110.938 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.923 ' HB3' HD22 ' A' ' 45' ' ' LEU . 23.0 tp -66.21 -21.52 66.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -56.41 -56.98 14.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.46 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 54.0 mtp85 -75.5 -34.88 60.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.141 0.496 . . . . 0.0 110.169 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.934 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 59.7 m -64.72 -33.33 75.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.45 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 2.8 pt20 -81.43 -36.91 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 12.2 t80 -55.52 -55.42 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.695 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.934 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 3.8 p90 -72.89 -38.5 66.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.493 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 54' ' ' PHE . 21.1 mm -61.25 -59.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 110.335 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.971 HG12 HD11 ' A' ' 28' ' ' ILE . 40.7 t -60.64 -50.0 82.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.124 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.67 -34.69 76.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.206 0.527 . . . . 0.0 110.571 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -72.31 -42.81 48.58 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.589 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.6 pp -66.88 -33.68 76.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.45 0.625 . . . . 0.0 109.881 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 56' ' ' VAL . 59.5 t -76.76 -49.8 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.039 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.43 -17.61 63.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.074 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.4 -34.26 68.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 52.0 mt -59.32 -69.02 0.59 Allowed Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.297 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 24.5 Cg_exo -53.49 -26.47 36.42 Favored 'Trans proline' 0 C--N 1.356 0.926 0 CA-C-N 119.845 0.98 . . . . 0.0 110.842 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.15 -30.69 66.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 62' ' ' ALA . 81.8 mt -77.99 -43.26 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.724 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.91 -58.49 3.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.858 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.512 HG12 HD12 ' A' ' 72' ' ' LEU . 59.8 t -62.33 -40.1 86.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.7 -49.72 75.51 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.064 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.83 -41.59 82.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.0 111.196 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.92 -48.01 69.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.173 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 76' ' ' PHE . 74.0 mt -70.76 -34.76 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.93 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 88.4 t80 -54.78 -46.77 74.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.198 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 75' ' ' MET . 8.3 p -84.27 -27.22 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.529 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.905 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -78.04 -74.71 0.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 72' ' ' LEU . 20.3 m-85 -58.53 -27.85 64.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.5 -56.57 2.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 27.1 t -87.63 -8.56 10.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 111.183 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -58.05 -67.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -59.65 -32.8 70.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 80.6 mt -67.99 -40.86 83.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.237 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 21.6 p30 -70.42 -33.79 71.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.568 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.448 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 60.7 mtm -68.82 -56.11 9.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.766 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -63.23 -44.11 96.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.2 tm? -60.7 -29.51 69.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.605 HD11 ' CA ' ' A' ' 71' ' ' GLY . 5.9 tt -69.23 -60.85 2.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.668 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -51.31 -45.31 62.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.303 0.573 . . . . 0.0 109.495 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.81 -40.21 91.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.698 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -57.99 -32.4 67.86 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.299 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -67.24 -37.8 84.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.28 50.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 19' ' ' LEU . 48.5 t -63.99 -41.17 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.01 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.7 mmm -61.03 -50.66 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.917 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 26.3 mmt -65.88 -39.58 90.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.646 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.66 -51.2 26.53 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -61.0 -44.76 96.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.14 -32.18 73.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.262 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -66.89 -42.03 86.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.6 mm -63.39 -60.52 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.771 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.1 92.88 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.617 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -59.62 -47.15 86.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 110.72 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.0 -53.12 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 110.932 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.804 ' O ' HG12 ' A' ' 30' ' ' ILE . 70.0 mt -51.78 -59.08 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.42 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.52 -44.44 92.95 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.393 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -49.25 -47.52 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.84 -40.44 98.4 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.911 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.804 HG12 ' O ' ' A' ' 26' ' ' ILE . 45.9 mm -56.45 -74.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 68.7 tp -67.21 -44.07 80.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -52.88 -43.76 61.06 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.557 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -62.04 -55.24 29.22 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.276 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 5.2 ptpp? -57.48 -52.06 66.93 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 120.965 0.412 . . . . 0.0 111.308 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.539 ' CD1' ' NE2' ' A' ' 52' ' ' GLN . 1.1 t80 -62.43 -54.38 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.703 ' CD1' HD11 ' A' ' 48' ' ' LEU . 53.5 tp -52.8 -39.58 62.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.316 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -57.96 -64.3 0.96 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.1 27.13 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.039 -1.076 . . . . 0.0 111.572 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -58.54 -31.21 67.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.591 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . . . -71.64 -29.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.981 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -87.62 -16.88 33.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.89 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 35.0 mt-30 -70.71 167.82 24.84 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.673 0.749 . . . . 0.0 111.229 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 58.4 Cg_endo -80.17 12.34 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.112 3.208 . . . . 0.0 113.081 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 p-10 -125.22 -83.87 0.64 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 45' ' ' LEU . 3.7 tt 69.87 -51.53 0.63 Allowed 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.55 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 6.8 mt -44.92 -50.29 26.27 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.344 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 57.9 Cg_endo -72.93 -23.74 18.34 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.444 1.429 . . . . 0.0 111.741 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.22 -37.38 85.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.027 ' N ' HD13 ' A' ' 48' ' ' LEU . 31.9 mt -48.61 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.82 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -74.95 -34.91 62.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 81.3 m -66.49 -31.76 72.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.13 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.581 ' OE1' HD23 ' A' ' 48' ' ' LEU . 23.6 mt-30 -98.43 -36.42 9.96 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.868 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.75 -46.3 90.2 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.37 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -76.08 -42.59 46.9 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.895 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD23 ' A' ' 59' ' ' LEU . 47.0 mm -69.41 -46.34 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 60' ' ' VAL . 95.7 t -67.19 -42.44 88.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.666 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -67.49 -40.86 85.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.432 0.634 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.29 68.7 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.639 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 55' ' ' ILE . 4.6 pp -65.87 -23.83 66.74 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.449 0.625 . . . . 0.0 110.649 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 56' ' ' VAL . 88.6 t -83.52 -53.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.41 0.624 . . . . 0.0 109.507 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 65' ' ' MET . 59.4 m-20 -62.97 -20.16 64.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.833 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -54.85 -35.41 63.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.578 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 60.8 mt -58.73 -66.56 1.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.888 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -59.5 -22.97 68.85 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.295 1.33 . . . . 0.0 111.08 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -72.7 -32.05 65.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 62' ' ' ALA . 65.5 mt -74.85 -46.65 40.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.741 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.92 -57.25 6.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.323 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG12 HD23 ' A' ' 72' ' ' LEU . 62.7 t -64.68 -34.39 69.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.382 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.11 -50.65 44.46 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.613 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.2 -43.21 96.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.494 0.664 . . . . 0.0 109.769 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.605 ' CA ' HD11 ' A' ' 9' ' ' LEU . . . -60.62 -59.46 10.2 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 68' ' ' VAL . 4.7 pp -61.02 -27.51 68.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.104 0.478 . . . . 0.0 110.954 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.951 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 89.2 t80 -58.56 -45.0 89.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.171 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 38.8 t -90.92 -32.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.963 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 mpp? -86.72 -69.67 0.66 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.777 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 9.6 m-85 -58.49 -27.2 64.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.59 -62.15 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 22.4 t -83.57 1.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.166 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.824 0.345 . . . . 0.0 111.225 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.777 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.2 mpp? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 6' ' ' MET . 16.9 tp10 -64.73 -44.81 88.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.903 0.383 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -58.32 -55.31 36.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.444 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.905 HD23 ' H ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -68.64 -35.86 77.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.771 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -73.06 -22.38 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.875 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 49.7 mtm -82.01 -51.54 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.537 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 53.1 p-10 -71.7 -37.84 70.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.098 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -65.27 -33.72 76.64 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' HG ' ' HG3' ' A' ' 75' ' ' MET . 3.4 tm? -70.91 -55.94 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.763 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -51.05 -53.45 33.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.742 0.782 . . . . 0.0 109.65 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -38.03 84.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.64 -33.7 75.55 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -66.93 -38.74 86.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.06 68.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 19' ' ' LEU . 46.8 t -64.27 -51.66 65.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.433 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -59.17 -55.51 33.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.773 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.813 ' CG ' HG21 ' A' ' 68' ' ' VAL . 81.1 mtp -62.72 -41.3 99.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.387 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.24 -52.05 34.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -59.42 -44.99 92.76 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.625 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.05 -30.07 70.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.52 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.83 80.37 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.175 0.512 . . . . 0.0 109.664 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' GLY . 49.1 mm -62.83 -58.32 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.732 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.2 -47.4 90.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.31 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . . . -57.5 -38.73 75.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -67.14 -44.01 80.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.7 ' O ' HG13 ' A' ' 30' ' ' ILE . 32.9 mm -58.71 -52.32 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.306 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -66.9 -48.32 61.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.938 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 ' HA ' ' A' ' 57' ' ' MET . 38.5 pt -51.86 -46.78 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -62.24 -37.04 93.9 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 65.5 mt -58.17 -77.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.91 -47.6 74.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.127 0.489 . . . . 0.0 110.853 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -54.42 -48.73 63.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.365 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.06 90.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.662 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 44.8 mmtm -59.59 -64.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 110.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -62.28 -40.16 95.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 109.692 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 HD22 ' A' ' 49' ' ' LEU . 34.1 tp -57.61 -40.86 80.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.63 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.58 -56.58 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -58.22 -54.55 36.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.042 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -56.05 -25.6 45.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.534 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -83.34 -37.08 23.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.828 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 41.0 ptt180 -85.05 -6.28 59.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.432 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.947 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 58.8 tp60 -71.85 -108.57 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 71.7 Cg_endo -101.48 -68.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.737 0 CA-C-N 122.381 1.886 . . . . 0.0 112.835 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 46' ' ' ILE . 3.0 p30 -158.95 36.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.976 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 74.7 mt -74.77 16.13 0.31 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.506 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 37.9 mt -46.99 -44.31 46.99 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.306 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.3 Cg_endo -70.99 -29.25 18.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.08 1.187 . . . . 0.0 110.159 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 51.2 tp -64.0 -33.06 74.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 40' ' ' ALA . 26.4 mt -47.93 -67.52 0.27 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.759 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -61.69 -46.25 90.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.02 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.744 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.6 m -55.94 -39.57 71.91 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 66.1 mt-30 -85.32 -26.02 26.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 110.124 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -60.64 -54.01 50.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE1' ' O ' ' A' ' 51' ' ' THR . 2.9 p90 -68.29 -30.14 69.07 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.716 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 51' ' ' THR . 36.5 mm -66.45 -58.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.7 t -55.61 -46.39 79.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.222 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.69 ' HA ' HG21 ' A' ' 28' ' ' ILE . 62.4 ttp -69.47 -33.16 72.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -71.49 -42.67 55.25 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.978 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.4 pp -65.17 -29.13 69.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.142 0.471 . . . . 0.0 110.198 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 59' ' ' LEU . 98.1 t -78.01 -48.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 46.9 m-20 -73.27 -8.72 57.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.299 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -61.72 -30.69 70.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 56.2 mt -62.0 -62.21 6.25 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 31.0 Cg_exo -60.9 -25.42 81.33 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.044 1.051 . . . . 0.0 110.424 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -70.02 -31.1 68.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.29 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 62' ' ' ALA . 74.1 mt -78.24 -45.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.623 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -56.29 13.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.088 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.813 HG21 ' CG ' ' A' ' 17' ' ' MET . 43.8 t -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.034 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 72' ' ' LEU . . . -59.52 -45.43 95.58 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.127 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -65.04 -44.53 88.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 109.791 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -64.33 -45.78 92.48 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.525 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.0 pp -66.76 -32.71 74.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.371 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.942 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.7 t80 -54.98 -47.03 75.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 47.1 t -86.03 -30.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.445 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.662 ' HG3' ' HG ' ' A' ' 9' ' ' LEU . 20.9 mmt -73.21 -76.13 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.29 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 27.1 m-85 -60.78 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -92.96 -59.84 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 94.6 t -82.55 -6.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.062 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.117 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.843 0.354 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.13 -49.39 65.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -63.74 -30.61 71.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.55 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.531 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -76.68 -48.33 19.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.783 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.72 -15.69 62.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.05 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.458 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 27.3 ttt -82.05 -57.49 3.38 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.765 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.531 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 7.0 p-10 -68.68 -41.56 79.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.979 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 55.1 tp -60.1 -39.39 86.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 75' ' ' MET . 35.4 tp -67.48 -57.4 6.58 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.108 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 8.6 m-30 -50.85 -51.99 45.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 109.742 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.7 ttm -60.43 -38.98 85.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.07 -35.49 77.1 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.423 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -64.32 -37.32 87.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.03 -54.52 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 19' ' ' LEU . 52.6 t -61.29 -49.59 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.999 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -57.5 -46.02 84.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.081 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 85.5 mmm -65.24 -41.56 94.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.525 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -67.25 -54.33 20.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.868 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.6 pp -59.67 -42.65 93.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.611 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -68.89 -30.58 69.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.717 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.74 -41.89 82.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.893 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 26' ' ' ILE . 67.2 mt -64.45 -56.7 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.931 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.72 98.74 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.425 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.637 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -60.62 -45.26 94.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.65 -46.81 88.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.756 ' O ' HG13 ' A' ' 30' ' ' ILE . 40.8 mm -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.458 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.492 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -65.74 -48.3 68.34 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.113 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 24' ' ' ALA . 36.2 pt -49.48 -46.77 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 117.541 0.67 . . . . 0.0 109.331 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.526 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -65.43 -36.79 93.06 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.118 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.756 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.2 mt -59.73 -71.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 110.68 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 31' ' ' LEU . 5.9 tt -68.26 -30.94 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -59.71 -47.93 88.55 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.996 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.01 61.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.295 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 17.9 ptpt -60.51 -53.85 52.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 111.66 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.434 ' HB2' HD23 ' A' ' 31' ' ' LEU . 12.7 t80 -64.05 -48.33 76.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.29 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 36' ' ' LEU . 2.0 tm? -60.19 -37.68 80.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -61.01 -55.39 33.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.757 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.8 -56.01 27.68 Favored Glycine 0 C--O 1.235 0.196 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -55.8 -48.02 76.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.286 0.565 . . . . 0.0 110.418 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.626 ' CA ' HD21 ' A' ' 49' ' ' LEU . . . -70.66 -15.87 62.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.589 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 6.4 tpm_? -81.58 -28.41 33.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.633 ' CB ' HD13 ' A' ' 45' ' ' LEU . 90.9 mm-40 -101.85 106.93 49.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.63 ' O ' HG13 ' A' ' 46' ' ' ILE . 5.0 Cg_exo -44.83 -22.72 0.72 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.854 2.369 . . . . 0.0 113.974 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.606 ' C ' HD12 ' A' ' 45' ' ' LEU . 37.9 t70 -82.69 -7.2 59.66 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 42' ' ' GLN . 4.3 mp -108.45 19.36 19.9 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 43' ' ' PRO . 32.1 mt -54.8 -45.55 99.65 Favored Pre-proline 0 C--O 1.225 -0.229 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.145 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 15.4 Cg_exo -67.39 -20.83 47.97 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.803 1.669 . . . . 0.0 110.255 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 39' ' ' ALA . 27.4 tp -69.44 -38.64 77.92 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.626 HD21 ' CA ' ' A' ' 40' ' ' ALA . 51.9 mt -44.29 -62.9 1.0 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.679 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -67.4 -46.36 73.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.6 m -55.73 -46.06 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.77 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.736 ' HA ' HG22 ' A' ' 55' ' ' ILE . 16.4 pt20 -70.08 -36.31 74.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.19 -57.45 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.14 -41.64 99.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.202 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.736 HG22 ' HA ' ' A' ' 52' ' ' GLN . 11.0 tp -63.23 -50.17 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.698 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 60' ' ' VAL . 61.0 t -65.59 -42.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.4 ttm -71.83 -40.82 68.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.279 0.561 . . . . 0.0 110.327 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -68.7 -44.33 71.2 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.357 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 88.4 mt -63.56 -40.57 97.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.166 0.483 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 56' ' ' VAL . 73.4 t -71.45 -41.39 73.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.425 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 40.7 m-20 -81.19 -9.01 59.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.62 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -66.14 -27.55 68.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 72.4 mt -62.24 -59.66 12.33 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 16.3 Cg_exo -68.79 -26.38 32.5 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.264 1.309 . . . . 0.0 110.74 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.7 tpt -69.29 -31.7 70.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.494 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 62' ' ' ALA . 51.8 mt -79.15 -44.92 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.908 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.26 -53.13 32.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 110.306 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 97.1 t -64.71 -46.99 90.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -54.5 -50.77 55.67 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.702 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.6 pp -62.79 -42.33 99.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.301 0.572 . . . . 0.0 110.34 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -58.49 -56.38 25.57 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.845 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -71.59 -28.46 63.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.732 ' N ' HD12 ' A' ' 72' ' ' LEU . 21.4 t80 -57.91 -40.24 79.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 109.654 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 46.4 t -94.02 -32.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.817 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.845 ' HG3' HD23 ' A' ' 9' ' ' LEU . 88.3 mmm -75.03 -76.04 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.237 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 28.0 m-85 -63.93 -29.0 70.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.21 -51.85 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 78' ' ' VAL . 55.7 t -88.04 -6.49 10.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.66 0.267 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 6' ' ' MET . 42.7 tt0 -61.62 -53.9 50.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -65.68 -32.77 74.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -77.26 -31.14 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.688 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.43 -29.47 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.28 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 66.0 mtm -80.23 -49.16 11.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.561 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 57.5 p-10 -67.94 -40.13 83.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.255 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.1 tm? -64.13 -30.04 71.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.1 tm? -68.15 -61.62 1.77 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -50.53 -49.57 55.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.728 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.65 -43.04 99.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -55.25 -42.88 74.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.856 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' MET . . . -56.77 -44.33 81.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.974 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.63 44.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.132 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 HD23 ' A' ' 19' ' ' LEU . 48.9 t -58.38 -62.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.088 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.1 mpp? -47.57 -47.3 28.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.709 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -62.32 -45.09 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.935 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -66.69 -49.99 51.58 Favored Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.027 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 3.4 pp -60.61 -41.69 95.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.095 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -70.34 -32.14 69.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . -67.05 -44.14 80.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.1 mt -63.55 -57.61 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.408 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.22 -51.4 58.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.743 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.55 -41.32 89.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -62.01 -47.01 86.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.749 ' O ' HG12 ' A' ' 30' ' ' ILE . 36.7 mm -56.71 -60.02 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.29 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.42 -45.91 74.75 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.178 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.8 tp -51.37 -46.66 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.09 -39.39 97.55 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.739 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.9 mm -58.01 -69.61 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.742 HD22 ' HD3' ' A' ' 34' ' ' LYS . 2.5 tm? -76.31 -44.55 36.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -61.64 -38.35 95.73 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.458 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.21 -51.97 45.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.589 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.742 ' HD3' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -58.13 -50.07 74.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.36 0.6 . . . . 0.0 110.168 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 5.8 t80 -61.32 -41.54 97.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.754 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 49' ' ' LEU . 58.7 tp -63.79 -41.36 97.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.421 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 47.9 mt-10 -59.52 -53.48 57.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.601 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.97 -61.32 7.11 Favored Glycine 0 C--O 1.239 0.427 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.951 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -49.92 -46.14 51.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.636 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -72.44 -25.83 61.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.629 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 55.3 ttp180 -67.8 -25.24 65.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.59 ' CB ' HD13 ' A' ' 45' ' ' LEU . 72.6 mt-30 -96.85 95.54 2.26 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.098 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 99.4 Cg_exo -38.38 -25.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.46 2.773 . . . . 0.0 114.356 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.664 ' C ' HD12 ' A' ' 45' ' ' LEU . 58.2 m-20 -79.87 -1.42 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.772 HD23 ' CD2' ' A' ' 48' ' ' LEU . 5.4 mp -121.04 14.91 11.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 26.9 mm -52.48 -45.15 95.65 Favored Pre-proline 0 N--CA 1.464 0.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.308 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 9.4 Cg_exo -70.24 -21.0 31.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.813 1.675 . . . . 0.0 110.714 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.772 ' CD2' HD23 ' A' ' 45' ' ' LEU . 30.1 tp -67.31 -38.96 85.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 36' ' ' LEU . 38.9 mt -47.0 -64.59 0.74 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.829 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.017 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.689 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 46.8 m -58.58 -42.9 89.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.695 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -84.84 -34.79 22.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.949 0.404 . . . . 0.0 110.366 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.5 t80 -51.93 -50.6 60.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.908 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 1.2 p90 -63.41 -35.47 80.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.836 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 51' ' ' THR . 55.0 mt -66.21 -63.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.24 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.6 t -54.62 -40.45 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.638 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.7 ttt -71.2 -39.0 72.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 0.0 110.564 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -66.22 -45.91 83.28 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.343 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -57.08 -43.33 82.03 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 109.804 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 56' ' ' VAL . 50.6 t -66.28 -51.42 59.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.438 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.33 -13.68 62.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.58 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.77 -33.77 70.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.746 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 53.5 mt -60.69 -66.28 1.63 Allowed Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.598 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 22.0 Cg_exo -56.94 -25.31 61.69 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 120.055 1.055 . . . . 0.0 111.061 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.11 70.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 62' ' ' ALA . 70.2 mt -77.49 -43.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.26 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.546 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.32 -51.24 54.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.17 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.2 t -69.62 -30.53 45.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.269 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.52 -50.84 29.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.775 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 71' ' ' GLY . 3.7 pp -62.35 -42.61 99.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.993 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.854 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -61.55 -52.53 50.51 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.515 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.1 pp -64.04 -30.57 71.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 111.145 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 72' ' ' LEU . 89.2 t80 -53.03 -48.54 67.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.266 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.1 t -89.75 -31.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.397 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.893 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -80.5 -69.08 0.62 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -59.2 -23.04 61.93 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -79.04 -54.49 5.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 74' ' ' VAL . 13.8 p -115.67 -17.43 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.399 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.2 -45.9 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.693 0.282 . . . . 0.0 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.65 -45.84 90.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 8' ' ' LEU . 96.6 mt -66.19 -44.74 83.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.608 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 4.3 m120 -63.2 -36.32 83.23 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.471 ' O ' ' HD1' ' A' ' 10' ' ' TYR . 56.4 ttm -64.22 -69.73 0.26 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.794 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -52.98 -40.65 63.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.526 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 54.7 tp -65.62 -31.01 71.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.762 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.591 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.3 tm? -68.6 -52.9 26.5 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.326 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 6' ' ' MET . 31.3 m-85 -59.69 -42.59 93.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.009 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 25.7 ttt -63.3 -37.76 88.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.08 -37.4 84.87 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.474 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -60.22 -46.24 90.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.57 72.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 19' ' ' LEU . 38.8 t -64.91 -51.52 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.733 ' CE ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.32 -51.61 66.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.684 ' CG ' HG21 ' A' ' 68' ' ' VAL . 84.6 mtp -62.5 -41.9 99.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.401 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -68.66 -53.85 18.2 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.567 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.5 pp -58.04 -45.39 87.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.241 0.544 . . . . 0.0 109.892 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.786 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.37 -32.18 73.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.371 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.86 -41.06 78.92 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.508 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 18' ' ' GLY . 92.6 mt -62.26 -57.79 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.777 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -47.76 89.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.446 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -56.42 -42.67 78.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.875 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -61.62 -58.08 9.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.197 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.854 ' O ' HG12 ' A' ' 30' ' ' ILE . 33.8 mm -44.4 -56.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.34 -38.33 87.12 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.766 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -56.13 -44.03 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.25 -36.4 89.66 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.546 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.854 HG12 ' O ' ' A' ' 26' ' ' ILE . 42.5 mm -59.63 -69.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.441 0.162 . . . . 0.0 110.81 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.0 tm? -74.59 -45.6 44.11 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.658 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -62.59 -44.11 98.03 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.3 -0.953 . . . . 0.0 110.886 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -60.75 -49.22 81.05 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.853 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.44 -53.98 49.42 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.058 0.456 . . . . 0.0 110.587 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 5.0 t80 -57.25 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 32' ' ' GLY . 6.8 mp -53.28 -34.65 58.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.925 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 16.3 tp10 -56.77 -61.28 2.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 109.944 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -54.32 -47.31 69.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.19 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.26 -34.97 77.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.148 0.499 . . . . 0.0 110.009 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.99 -22.87 62.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 4.5 tmm_? -92.34 -19.39 22.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.763 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.951 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 65.3 mt-30 -61.21 -177.01 0.12 Allowed Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 73.6 Cg_exo -48.81 -71.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.154 2.569 . . . . 0.0 113.375 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.6 t70 -146.09 46.94 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.893 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -84.56 13.22 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 111.131 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 29.4 mm -52.56 -45.51 95.9 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.635 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 35.3 Cg_endo -68.16 -23.43 39.47 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 120.874 1.05 . . . . 0.0 110.698 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 45' ' ' LEU . 35.6 tp -67.8 -38.72 83.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 40' ' ' ALA . 77.8 mt -43.91 -61.42 1.45 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.743 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.621 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 39.7 ptt180 -63.02 -49.53 74.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.148 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 55' ' ' ILE . 97.6 m -46.83 -48.8 20.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 40.7 mt-30 -69.3 -33.43 73.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.987 0.423 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.02 -54.19 47.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' HD1' ' O ' ' A' ' 50' ' ' ARG . 31.6 m-85 -65.15 -44.45 88.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.638 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 51' ' ' THR . 36.8 mm -63.86 -56.99 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 60' ' ' VAL . 39.1 t -60.78 -48.19 89.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.426 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 26.5 ttt -68.73 -35.53 77.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.216 0.532 . . . . 0.0 110.576 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -69.61 -45.08 60.8 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.07 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 80.2 mt -61.98 -42.5 99.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' VAL . 60.4 t -69.65 -50.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.391 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 57' ' ' MET . 28.6 m-20 -69.13 -16.04 63.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.636 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.73 -33.72 68.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.389 . . . . 0.0 110.506 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 70.9 mt -57.6 -66.11 1.45 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 17.4 Cg_endo -60.13 -24.94 78.53 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.261 1.307 . . . . 0.0 110.839 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 79.0 mmm -71.67 -31.6 66.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.495 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 58.4 mt -75.51 -46.47 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.513 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.55 -54.65 18.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.53 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.684 HG21 ' CG ' ' A' ' 17' ' ' MET . 58.1 t -67.13 -40.87 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.338 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.52 -41.61 99.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.876 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 70' ' ' LEU . 5.2 tt -67.89 -46.21 72.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -44.67 96.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.683 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 85.4 mt -73.68 -30.37 62.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.967 0.413 . . . . 0.0 110.273 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.867 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.8 t80 -58.27 -47.44 83.59 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG13 ' SD ' ' A' ' 75' ' ' MET . 6.4 p -78.64 -34.0 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.43 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.546 ' SD ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -70.07 -74.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.453 ' CE2' HD22 ' A' ' 72' ' ' LEU . 31.1 m-85 -56.89 -29.58 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.48 -54.3 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.8 t -92.08 -10.03 9.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.79 -55.78 13.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.04 -40.35 76.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.614 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.589 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 82.4 mt -70.32 -45.39 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 3.9 m120 -71.19 -13.96 62.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.118 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.485 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 28.0 ttt -82.89 -59.05 2.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 10.5 p-10 -67.39 -42.38 83.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.099 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.97 -34.15 72.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 75' ' ' MET . 51.2 tp -68.43 -63.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.132 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 5.8 m-85 -53.64 -42.57 67.94 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.183 0.516 . . . . 0.0 109.935 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 15' ' ' VAL . 9.6 tmm? -66.31 -36.29 82.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.409 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -63.77 -31.25 72.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.743 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -68.08 -33.08 73.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -54.65 17.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 50.4 t -62.06 -41.94 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.762 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 15.2 mmt -62.03 -50.8 70.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.765 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.55 ' SD ' HG21 ' A' ' 68' ' ' VAL . 89.5 mmm -66.51 -39.65 88.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.566 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -69.65 -49.84 34.43 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -59.41 -47.28 86.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.793 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.58 -33.0 74.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.734 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.14 -42.26 84.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 18' ' ' GLY . 75.1 mt -62.25 -60.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.87 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.77 -45.88 90.53 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.808 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -62.32 -40.79 97.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.589 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -63.55 -43.88 95.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.212 0.53 . . . . 0.0 110.275 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.825 ' O ' HG13 ' A' ' 30' ' ' ILE . 79.4 mt -58.24 -61.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.174 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -67.16 -42.32 91.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.156 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.646 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.7 tp -54.87 -46.75 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.475 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.21 -36.43 92.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.65 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.825 HG13 ' O ' ' A' ' 26' ' ' ILE . 72.3 mt -61.88 -72.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.521 0.201 . . . . 0.0 110.856 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.3 tm? -71.39 -42.06 68.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -65.18 -44.05 94.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.793 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.59 -38.04 95.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.418 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 18.8 ptpt -71.99 -47.88 48.91 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.6 t80 -63.91 -49.44 72.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 49' ' ' LEU . 5.1 tt -56.24 -51.44 68.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.271 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' LYS . 12.6 pt-20 -57.26 -51.65 68.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.862 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -54.02 -53.7 35.54 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.77 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 45' ' ' LEU . . . -64.62 -42.32 95.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.093 0.473 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' HD23 ' A' ' 36' ' ' LEU . . . -57.0 -30.82 64.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.575 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 97.2 mtt180 -82.3 -37.82 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 109.706 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.793 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . 3.1 tp-100 -44.86 127.97 5.27 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.352 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -32.78 -33.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 124.755 3.637 . . . . 0.0 115.879 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' C ' HD12 ' A' ' 45' ' ' LEU . 56.4 m-20 -141.02 29.3 1.86 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.793 ' HB2' ' HB3' ' A' ' 42' ' ' GLN . 8.6 mp -114.38 6.98 16.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 111.563 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.3 mp -48.61 -47.29 71.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.704 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 79.3 Cg_endo -78.92 -16.69 12.55 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.867 1.711 . . . . 0.0 111.174 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.556 HD22 ' HG ' ' A' ' 45' ' ' LEU . 40.4 tp -69.52 -30.74 68.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.711 HD13 HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -47.48 -59.21 3.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.556 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 86.7 mtm180 -72.06 -42.54 66.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 110.196 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 55' ' ' ILE . 28.0 m -52.74 -39.61 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 18.3 pt20 -84.59 -33.82 23.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.545 ' HD2' HD12 ' A' ' 36' ' ' LEU . 11.0 t80 -57.6 -49.7 75.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.231 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.564 ' CE1' HG12 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -73.2 -30.09 63.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 51' ' ' THR . 38.7 mm -69.69 -56.75 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.262 0.553 . . . . 0.0 109.843 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.646 HG12 ' CD1' ' A' ' 28' ' ' ILE . 41.1 t -61.57 -39.23 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.302 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.75 -34.26 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.537 . . . . 0.0 110.204 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.03 63.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.352 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.133 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.657 ' N ' HD12 ' A' ' 59' ' ' LEU . 99.7 t -78.16 -51.25 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -69.04 -12.77 61.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.51 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.48 -33.32 69.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.76 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 70.3 mt -60.85 -64.92 2.52 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.285 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 35.1 Cg_exo -55.71 -26.5 56.54 Favored 'Trans proline' 0 C--N 1.359 1.092 0 CA-C-N 120.123 1.08 . . . . 0.0 110.845 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.14 -30.85 66.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.633 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' ALA . 80.0 mt -76.73 -44.59 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.457 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.06 -58.42 4.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.55 HG21 ' SD ' ' A' ' 17' ' ' MET . 60.3 t -63.52 -39.53 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.192 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -64.67 -47.5 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.735 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.708 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.1 tm? -60.7 -44.74 96.19 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.37 58.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.172 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.2 pp -69.34 -26.06 64.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.943 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.7 t80 -54.68 -47.35 73.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 109.628 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.62 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 13.4 p -90.6 -28.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.675 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.659 ' HG3' HD21 ' A' ' 9' ' ' LEU . 94.2 mmm -82.14 -74.99 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 72' ' ' LEU . 15.5 m-30 -58.53 -28.79 65.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.378 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.943 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.96 -55.08 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 48.1 t -87.75 -2.75 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.158 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.94 -51.35 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.5 -38.28 86.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.7 -32.62 68.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.12 -30.94 62.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 10' ' ' TYR . 51.5 ttm -77.42 -46.22 23.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.746 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.41 -46.57 69.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.369 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.662 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.98 -32.26 70.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 61.2 tp -64.87 -58.23 6.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.778 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 6' ' ' MET . 9.1 m-30 -47.38 -54.3 11.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.521 0.676 . . . . 0.0 109.839 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -61.45 -38.56 87.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.721 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.82 -33.7 74.61 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.83 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.6 -52.57 51.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.078 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 43.6 t -60.48 -44.45 96.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.303 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.48 -55.42 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.773 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.2 mmm -58.68 -42.21 88.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.579 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -68.72 -53.98 17.32 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.695 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.4 pp -57.72 -44.07 85.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 110.196 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.89 -32.44 72.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -67.09 -40.45 86.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.838 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 18' ' ' GLY . 47.4 mm -62.37 -64.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.576 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.31 -50.51 46.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.677 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.22 -42.09 85.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.863 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -56.95 -59.52 4.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HD13 ' A' ' 30' ' ' ILE . 1.9 mp -53.72 -57.46 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.16 97.32 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.896 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 25' ' ' ALA . 6.0 tp -58.13 -43.67 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.03 -35.84 92.64 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.599 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 26' ' ' ILE . 1.5 mp -60.39 -72.3 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.611 0.244 . . . . 0.0 110.762 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 34' ' ' LYS . 3.2 tm? -69.02 -41.55 77.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.107 0.48 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -60.21 -43.24 98.64 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.834 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.87 -48.48 80.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.077 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.74 ' HD2' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -62.77 -50.87 69.33 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.893 0.377 . . . . 0.0 110.922 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 15.3 t80 -62.66 -49.23 75.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 49' ' ' LEU . 2.4 tm? -61.46 -37.18 82.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.796 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -58.79 -57.93 10.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.13 -56.78 18.51 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.245 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -50.29 -25.24 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.133 0.492 . . . . 0.0 111.255 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.656 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -92.86 -33.21 14.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.242 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 9.1 mmp_? -63.96 -25.04 67.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.26 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.597 ' CB ' HD23 ' A' ' 45' ' ' LEU . 10.9 mm100 -100.44 117.2 63.39 Favored Pre-proline 0 N--CA 1.435 -1.225 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.073 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 42' ' ' GLN . 9.7 Cg_endo -56.05 -7.44 1.74 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.008 2.472 . . . . 0.0 113.787 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -98.69 -25.39 14.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.53 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.863 HD12 HD22 ' A' ' 48' ' ' LEU . 2.8 mm? -92.16 11.56 25.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 13.9 mt -53.98 -44.24 97.97 Favored Pre-proline 0 C--O 1.225 -0.222 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.107 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 13.0 Cg_exo -68.83 -21.44 38.11 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.708 1.605 . . . . 0.0 110.694 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.863 HD22 HD12 ' A' ' 45' ' ' LEU . 48.4 tp -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 36' ' ' LEU . 69.1 mt -45.54 -63.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.449 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 47' ' ' PRO . 58.8 mtm-85 -67.6 -41.15 84.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.143 0.496 . . . . 0.0 110.305 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.843 ' O ' HG13 ' A' ' 55' ' ' ILE . 42.1 m -60.01 -39.68 86.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.076 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.701 ' OE1' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.25 -29.89 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.059 0.457 . . . . 0.0 110.155 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -61.22 -57.32 12.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.78 ' CE1' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -69.4 -34.58 74.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.843 HG13 ' O ' ' A' ' 51' ' ' THR . 33.6 mt -71.27 -56.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.658 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 60' ' ' VAL . 59.5 t -62.83 -37.34 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.499 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.434 ' CE ' HG12 ' A' ' 28' ' ' ILE . 61.3 tpp -73.69 -39.29 64.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.231 0.539 . . . . 0.0 110.386 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.96 -44.78 66.0 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.76 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 93.4 mt -60.21 -39.21 85.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.145 0.498 . . . . 0.0 110.071 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 56' ' ' VAL . 58.1 t -70.64 -42.3 77.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.745 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.687 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 41.0 m-20 -79.32 -13.09 59.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.648 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.712 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -67.12 -21.89 65.82 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.311 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 66.8 mt -65.13 -56.19 21.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.565 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 2.8 Cg_exo -77.94 -26.32 6.75 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.846 1.697 . . . . 0.0 110.979 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 50.6 tpp -70.69 -31.71 68.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 62' ' ' ALA . 1.2 mp -81.55 -44.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.771 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.8 48.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 109.984 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 74.6 t -67.98 -43.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.284 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.14 -43.08 99.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.989 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -63.87 -46.22 85.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 109.783 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.41 -55.52 30.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.493 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -68.2 -28.15 67.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.452 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.798 ' N ' HD12 ' A' ' 72' ' ' LEU . 87.4 t80 -52.54 -45.62 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.284 0.564 . . . . 0.0 109.711 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.6 p -93.0 -29.08 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.547 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 24.1 mmt -82.34 -70.04 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.321 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 10' ' ' TYR . 7.9 m-85 -61.21 -28.52 69.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.76 -58.9 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 111.839 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.7 t -83.82 -2.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.06 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.851 0.357 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.586 0.231 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.554 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 50.0 mt-10 -66.32 -53.44 36.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.203 0.525 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.416 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 75.2 m-20 -63.02 -31.73 72.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.792 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 79.7 mt -72.54 -50.86 22.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.35 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 2' ' ' GLU . 11.4 p-10 -69.67 -17.99 63.53 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.649 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 10' ' ' TYR . 10.3 tpt -85.9 -47.08 9.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.346 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.3 p30 -72.65 -40.68 66.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 60.3 mt -61.99 -32.7 73.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.688 HD13 ' HG3' ' A' ' 75' ' ' MET . 7.3 tt -70.26 -48.57 56.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 6' ' ' MET . 11.0 m-30 -48.58 -54.64 13.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.813 0.816 . . . . 0.0 109.105 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 ttm -63.61 -38.59 91.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.123 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -60.77 -33.07 72.4 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.915 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.68 80.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.04 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.38 55.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.499 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 19' ' ' LEU . 45.4 t -63.09 -47.1 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -59.08 -45.65 90.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.84 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.3 mmt -65.2 -42.75 93.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.7 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -70.14 -50.19 29.46 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.733 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.03 -44.88 94.32 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.095 0.474 . . . . 0.0 109.938 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.645 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -65.68 -38.42 89.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.332 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.19 94.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.1 mm -60.55 -61.6 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -52.93 42.63 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.933 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -56.8 -41.61 78.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.807 0.337 . . . . 0.0 110.693 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -61.95 -44.32 97.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HG13 ' A' ' 30' ' ' ILE . 66.0 mt -59.37 -55.76 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.756 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.569 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -64.66 -50.39 59.08 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.012 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 29' ' ' GLY . 2.9 pp -48.92 -46.86 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 28' ' ' ILE . . . -60.52 -39.3 96.21 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.3 mt -57.92 -72.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.635 0.255 . . . . 0.0 111.073 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.7 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.2 tp -73.51 -40.26 64.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -59.27 -39.44 94.63 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.62 -50.37 59.33 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.953 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.7 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.9 -52.41 65.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.169 0.509 . . . . 0.0 110.657 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.37 -52.88 63.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 47.6 tp -58.86 -36.04 73.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.151 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.83 -58.54 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -56.57 -56.31 25.29 Favored Glycine 0 C--O 1.242 0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.115 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.726 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -62.48 -16.16 53.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.335 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -95.94 -23.58 16.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.611 0.243 . . . . 0.0 110.831 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.608 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 16.0 ptm180 -86.31 -15.11 41.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.635 ' CB ' HD23 ' A' ' 45' ' ' LEU . 73.7 mt-30 -96.91 93.62 1.48 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.339 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 78.0 Cg_exo -38.06 -25.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.729 2.953 . . . . 0.0 114.729 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.633 ' C ' HD22 ' A' ' 45' ' ' LEU . 10.8 p-10 -85.28 2.81 42.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.901 HD12 HD22 ' A' ' 48' ' ' LEU . 3.4 mm? -116.02 18.97 15.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 22.8 mt -52.66 -45.92 96.23 Favored Pre-proline 0 C--O 1.224 -0.266 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.541 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 14.5 Cg_exo -67.82 -22.43 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.563 1.509 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.901 HD22 HD12 ' A' ' 45' ' ' LEU . 25.4 tp -68.74 -37.27 79.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 40' ' ' ALA . 63.9 mt -45.45 -65.45 0.54 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.34 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.07 -42.09 85.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.931 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 55' ' ' ILE . 50.6 m -58.58 -39.51 80.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.456 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.667 HE22 ' HB3' ' A' ' 39' ' ' ALA . 20.7 pt20 -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.054 0.454 . . . . 0.0 110.218 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -59.16 -52.43 65.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.821 ' CE1' HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.09 -33.44 63.63 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.451 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.821 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.3 mm -69.76 -54.72 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.311 0.577 . . . . 0.0 110.063 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' HD12 ' A' ' 59' ' ' LEU . 59.8 t -64.53 -36.97 78.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.119 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.551 ' CE ' HD13 ' A' ' 28' ' ' ILE . 24.6 mmt -82.24 -29.51 31.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 0.0 110.433 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -81.21 -37.81 17.06 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.909 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -71.19 -21.41 62.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.829 0.814 . . . . 0.0 109.931 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 59' ' ' LEU . 78.3 t -88.19 -44.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.694 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -74.23 -22.15 59.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.74 -29.39 66.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.32 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.67 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 1.8 mp -58.15 -70.39 0.39 Allowed Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.114 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 25.6 Cg_exo -57.39 -27.38 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 120.787 0.992 . . . . 0.0 111.007 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.449 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 47.7 tpp -71.06 -30.33 66.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.166 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.804 ' O ' HD23 ' A' ' 70' ' ' LEU . 68.7 mt -79.31 -44.03 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.505 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.97 -56.8 6.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 0.0 109.947 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.816 HG12 HD22 ' A' ' 72' ' ' LEU . 86.2 t -63.12 -44.0 99.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.061 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -58.31 -46.69 92.59 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.339 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 66' ' ' ILE . 4.4 mm? -65.93 -46.18 79.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.842 0.321 . . . . 0.0 110.99 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -62.48 -52.71 47.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.807 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.816 HD22 HG12 ' A' ' 68' ' ' VAL . 5.7 mp -65.89 -32.26 73.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.945 0.402 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.835 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 94.1 t80 -54.2 -46.74 72.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.361 0.6 . . . . 0.0 109.727 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 49.1 t -86.3 -30.79 6.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.614 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.688 ' HG3' HD13 ' A' ' 9' ' ' LEU . 21.8 mmt -75.44 -74.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.514 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 20.2 m-85 -62.37 -27.64 69.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.78 -49.17 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 52.8 t -91.72 -6.24 10.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.047 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 111.242 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.952 0.406 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 6' ' ' MET . 56.0 mt-10 -62.09 -52.08 65.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.83 -46.23 85.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.699 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 84.3 mt -68.93 -33.29 73.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.775 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -70.7 -28.22 64.58 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.409 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 26.5 mmt -80.58 -53.11 6.85 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.092 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.9 p30 -64.13 -39.64 94.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.129 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 57.1 tp -63.4 -28.06 69.72 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.905 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 2.1 tm? -69.11 -65.5 0.7 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.158 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -51.83 -37.76 53.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.526 0.679 . . . . 0.0 109.451 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.39 73.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.672 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -65.29 -31.94 73.34 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.774 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.1 79.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.76 44.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 19' ' ' LEU . 42.4 t -61.6 -47.31 93.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.781 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -58.36 -47.46 83.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.145 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 21.1 mmt -67.72 -37.62 82.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.76 -53.37 16.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.051 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.06 -42.58 94.83 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.213 0.53 . . . . 0.0 109.767 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.618 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.84 -31.77 71.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.337 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.07 -40.02 82.81 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.178 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 18' ' ' GLY . 43.4 mm -63.93 -61.63 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.585 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.04 -49.72 61.69 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.514 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.5 -42.18 87.06 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 110.63 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.63 -61.6 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 30' ' ' ILE . 2.1 mp -51.29 -52.63 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.04 77.21 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.258 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.971 HD11 HG12 ' A' ' 56' ' ' VAL . 5.5 tp -57.13 -44.95 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.96 -40.23 95.22 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.96 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.701 HG12 ' O ' ' A' ' 26' ' ' ILE . 36.6 mm -55.03 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.565 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 35' ' ' PHE . 7.9 tt -68.2 -26.87 65.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.984 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -58.77 -45.08 95.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.257 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.86 -52.38 50.81 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.06 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 14.6 ptmm? -60.55 -51.1 70.87 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.195 0.521 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.62 ' HB2' HD23 ' A' ' 31' ' ' LEU . 15.4 t80 -63.01 -48.94 76.63 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.713 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.497 HD13 ' OE1' ' A' ' 52' ' ' GLN . 53.0 tp -65.07 -36.27 83.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.05 -63.09 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.069 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.82 -49.47 67.98 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.553 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.649 ' O ' HD23 ' A' ' 45' ' ' LEU . . . -53.8 -37.78 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.549 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . . . -81.91 -22.49 36.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -64.92 -34.06 77.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 68.1 mt-30 -57.81 123.38 63.16 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.12 1.71 0.58 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.73 2.287 . . . . 0.0 112.757 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.9 t0 -130.23 34.09 4.25 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 120.84 0.353 . . . . 0.0 110.334 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.923 HD22 ' HB3' ' A' ' 48' ' ' LEU . 2.6 tm? -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.51 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.862 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.4 mp -30.09 -58.64 0.29 Allowed Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 81.8 Cg_endo -77.66 -27.67 5.94 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.237 1.291 . . . . 0.0 110.938 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.923 ' HB3' HD22 ' A' ' 45' ' ' LEU . 23.0 tp -66.21 -21.52 66.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -56.41 -56.98 14.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.46 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 54.0 mtp85 -75.5 -34.88 60.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.141 0.496 . . . . 0.0 110.169 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.934 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 59.7 m -64.72 -33.33 75.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.45 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 2.8 pt20 -81.43 -36.91 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.422 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 12.2 t80 -55.52 -55.42 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.695 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.934 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 3.8 p90 -72.89 -38.5 66.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.493 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 54' ' ' PHE . 21.1 mm -61.25 -59.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 110.335 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.971 HG12 HD11 ' A' ' 28' ' ' ILE . 40.7 t -60.64 -50.0 82.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.124 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.67 -34.69 76.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.206 0.527 . . . . 0.0 110.571 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -72.31 -42.81 48.58 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.589 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.6 pp -66.88 -33.68 76.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.45 0.625 . . . . 0.0 109.881 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 56' ' ' VAL . 59.5 t -76.76 -49.8 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.039 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.43 -17.61 63.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.074 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.4 -34.26 68.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 52.0 mt -59.32 -69.02 0.59 Allowed Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.297 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 24.5 Cg_exo -53.49 -26.47 36.42 Favored 'Trans proline' 0 C--N 1.356 0.926 0 CA-C-N 119.845 0.98 . . . . 0.0 110.842 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.15 -30.69 66.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 62' ' ' ALA . 81.8 mt -77.99 -43.26 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.724 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.91 -58.49 3.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.858 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.512 HG12 HD12 ' A' ' 72' ' ' LEU . 59.8 t -62.33 -40.1 86.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.7 -49.72 75.51 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.064 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.83 -41.59 82.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.0 111.196 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.92 -48.01 69.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.173 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 76' ' ' PHE . 74.0 mt -70.76 -34.76 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.93 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 88.4 t80 -54.78 -46.77 74.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.198 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 75' ' ' MET . 8.3 p -84.27 -27.22 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.529 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.905 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -78.04 -74.71 0.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 72' ' ' LEU . 20.3 m-85 -58.53 -27.85 64.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.5 -56.57 2.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 27.1 t -87.63 -8.56 10.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 111.183 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -58.05 -67.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -59.65 -32.8 70.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.441 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 80.6 mt -67.99 -40.86 83.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.237 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 21.6 p30 -70.42 -33.79 71.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.568 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.448 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 60.7 mtm -68.82 -56.11 9.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.766 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -63.23 -44.11 96.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.2 tm? -60.7 -29.51 69.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.605 HD11 ' CA ' ' A' ' 71' ' ' GLY . 5.9 tt -69.23 -60.85 2.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.668 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -51.31 -45.31 62.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.303 0.573 . . . . 0.0 109.495 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.81 -40.21 91.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.698 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -57.99 -32.4 67.86 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.299 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -67.24 -37.8 84.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.28 50.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 19' ' ' LEU . 48.5 t -63.99 -41.17 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.01 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.7 mmm -61.03 -50.66 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.917 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 26.3 mmt -65.88 -39.58 90.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.646 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.66 -51.2 26.53 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -61.0 -44.76 96.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.14 -32.18 73.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.262 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -66.89 -42.03 86.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.6 mm -63.39 -60.52 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.771 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.1 92.88 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.617 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.627 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -59.62 -47.15 86.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 110.72 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.0 -53.12 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 110.932 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.804 ' O ' HG12 ' A' ' 30' ' ' ILE . 70.0 mt -51.78 -59.08 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.42 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.52 -44.44 92.95 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.393 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -49.25 -47.52 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.84 -40.44 98.4 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.911 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.804 HG12 ' O ' ' A' ' 26' ' ' ILE . 45.9 mm -56.45 -74.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 68.7 tp -67.21 -44.07 80.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -52.88 -43.76 61.06 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.557 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -62.04 -55.24 29.22 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.276 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 5.2 ptpp? -57.48 -52.06 66.93 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 120.965 0.412 . . . . 0.0 111.308 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.458 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 t80 -62.43 -54.38 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.703 ' CD1' HD11 ' A' ' 48' ' ' LEU . 53.5 tp -52.8 -39.58 62.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.316 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -57.96 -64.3 0.96 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.1 27.13 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.039 -1.076 . . . . 0.0 111.572 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -58.54 -31.21 67.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.591 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . . . -71.64 -29.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.981 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -87.62 -16.88 33.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.89 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 60.9 mt-30 -70.71 167.82 24.84 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.673 0.749 . . . . 0.0 111.229 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 58.4 Cg_endo -80.17 12.34 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.112 3.208 . . . . 0.0 113.081 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 p-10 -125.22 -83.87 0.64 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 45' ' ' LEU . 3.7 tt 69.87 -51.53 0.63 Allowed 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.55 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 6.8 mt -44.92 -50.29 26.27 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.344 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 57.9 Cg_endo -72.93 -23.74 18.34 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.444 1.429 . . . . 0.0 111.741 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.22 -37.38 85.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.027 ' N ' HD13 ' A' ' 48' ' ' LEU . 31.9 mt -48.61 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.82 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -74.95 -34.91 62.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 81.3 m -66.49 -31.76 72.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.13 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.731 ' NE2' HD23 ' A' ' 48' ' ' LEU . 62.1 mt-30 -98.43 -36.42 9.96 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.868 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.75 -46.3 90.2 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.37 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -76.08 -42.59 46.9 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.895 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD23 ' A' ' 59' ' ' LEU . 47.0 mm -69.41 -46.34 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 60' ' ' VAL . 95.7 t -67.19 -42.44 88.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.666 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -67.49 -40.86 85.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.432 0.634 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.29 68.7 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.639 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 55' ' ' ILE . 4.6 pp -65.87 -23.83 66.74 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.449 0.625 . . . . 0.0 110.649 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 56' ' ' VAL . 88.6 t -83.52 -53.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.41 0.624 . . . . 0.0 109.507 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 65' ' ' MET . 59.4 m-20 -62.97 -20.16 64.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.833 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -54.85 -35.41 63.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.578 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 60.8 mt -58.73 -66.56 1.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.888 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -59.5 -22.97 68.85 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.295 1.33 . . . . 0.0 111.08 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -72.7 -32.05 65.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 62' ' ' ALA . 65.5 mt -74.85 -46.65 40.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.741 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.92 -57.25 6.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.323 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.667 HG12 HD23 ' A' ' 72' ' ' LEU . 62.7 t -64.68 -34.39 69.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.382 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.11 -50.65 44.46 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.613 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.2 -43.21 96.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.494 0.664 . . . . 0.0 109.769 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.605 ' CA ' HD11 ' A' ' 9' ' ' LEU . . . -60.62 -59.46 10.2 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 68' ' ' VAL . 4.7 pp -61.02 -27.51 68.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.104 0.478 . . . . 0.0 110.954 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.951 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 89.2 t80 -58.56 -45.0 89.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.171 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 38.8 t -90.92 -32.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.963 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 mpp? -86.72 -69.67 0.66 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.777 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 9.6 m-85 -58.49 -27.2 64.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.59 -62.15 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 22.4 t -83.57 1.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.166 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.824 0.345 . . . . 0.0 111.225 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.777 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.2 mpp? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 6' ' ' MET . 16.9 tp10 -64.73 -44.81 88.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.903 0.383 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -58.32 -55.31 36.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.444 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.905 HD23 ' H ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -68.64 -35.86 77.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.771 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 1' ' ' MET . 63.4 m-20 -73.06 -22.38 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.875 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 49.7 mtm -82.01 -51.54 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.537 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 53.1 p-10 -71.7 -37.84 70.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.098 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -65.27 -33.72 76.64 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.662 ' HG ' ' HG3' ' A' ' 75' ' ' MET . 3.4 tm? -70.91 -55.94 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.763 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -51.05 -53.45 33.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.742 0.782 . . . . 0.0 109.65 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -38.03 84.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.64 -33.7 75.55 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -66.93 -38.74 86.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.06 68.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 19' ' ' LEU . 46.8 t -64.27 -51.66 65.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.433 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -59.17 -55.51 33.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.773 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . 0.813 ' CG ' HG21 ' A' ' 68' ' ' VAL . 81.1 mtp -62.72 -41.3 99.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.387 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.24 -52.05 34.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -59.42 -44.99 92.76 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.625 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.05 -30.07 70.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.52 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.83 80.37 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.175 0.512 . . . . 0.0 109.664 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' GLY . 49.1 mm -62.83 -58.32 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.732 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.2 -47.4 90.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.31 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . . . -57.5 -38.73 75.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -67.14 -44.01 80.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.7 ' O ' HG13 ' A' ' 30' ' ' ILE . 32.9 mm -58.71 -52.32 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.306 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -66.9 -48.32 61.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.938 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 ' HA ' ' A' ' 57' ' ' MET . 38.5 pt -51.86 -46.78 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -62.24 -37.04 93.9 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 65.5 mt -58.17 -77.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.91 -47.6 74.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.127 0.489 . . . . 0.0 110.853 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -54.42 -48.73 63.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.365 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.06 90.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.662 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 44.8 mmtm -59.59 -64.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 110.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -62.28 -40.16 95.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 109.692 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 HD22 ' A' ' 49' ' ' LEU . 34.1 tp -57.61 -40.86 80.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.63 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.58 -56.58 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -58.22 -54.55 36.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.042 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -56.05 -25.6 45.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.534 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -83.34 -37.08 23.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.828 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 41.0 ptt180 -85.05 -6.28 59.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.432 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.947 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 58.8 tp60 -71.85 -108.57 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 71.7 Cg_endo -101.48 -68.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.737 0 CA-C-N 122.381 1.886 . . . . 0.0 112.835 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 46' ' ' ILE . 3.0 p30 -158.95 36.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.976 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 74.7 mt -74.77 16.13 0.31 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.506 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 37.9 mt -46.99 -44.31 46.99 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.306 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.3 Cg_endo -70.99 -29.25 18.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.08 1.187 . . . . 0.0 110.159 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 51.2 tp -64.0 -33.06 74.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 40' ' ' ALA . 26.4 mt -47.93 -67.52 0.27 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.759 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -61.69 -46.25 90.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.02 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.744 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.6 m -55.94 -39.57 71.91 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 66.1 mt-30 -85.32 -26.02 26.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 110.124 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -60.64 -54.01 50.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE1' ' O ' ' A' ' 51' ' ' THR . 2.9 p90 -68.29 -30.14 69.07 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.716 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 51' ' ' THR . 36.5 mm -66.45 -58.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.7 t -55.61 -46.39 79.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.222 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.69 ' HA ' HG21 ' A' ' 28' ' ' ILE . 62.4 ttp -69.47 -33.16 72.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -71.49 -42.67 55.25 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.978 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.4 pp -65.17 -29.13 69.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.142 0.471 . . . . 0.0 110.198 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 59' ' ' LEU . 98.1 t -78.01 -48.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 46.9 m-20 -73.27 -8.72 57.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.299 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -61.72 -30.69 70.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 56.2 mt -62.0 -62.21 6.25 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 31.0 Cg_exo -60.9 -25.42 81.33 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.044 1.051 . . . . 0.0 110.424 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -70.02 -31.1 68.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.29 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 62' ' ' ALA . 74.1 mt -78.24 -45.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.623 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -56.29 13.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.088 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.813 HG21 ' CG ' ' A' ' 17' ' ' MET . 43.8 t -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.034 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 72' ' ' LEU . . . -59.52 -45.43 95.58 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.127 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -65.04 -44.53 88.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 109.791 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -64.33 -45.78 92.48 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.525 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.0 pp -66.76 -32.71 74.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.371 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.942 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.7 t80 -54.98 -47.03 75.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 47.1 t -86.03 -30.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.445 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.662 ' HG3' ' HG ' ' A' ' 9' ' ' LEU . 20.9 mmt -73.21 -76.13 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.29 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 27.1 m-85 -60.78 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -92.96 -59.84 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 94.6 t -82.55 -6.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.062 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.117 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptt? . . . . . 0 N--CA 1.488 1.467 0 CA-C-O 120.843 0.354 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 63.3 mm-40 -67.13 -49.39 65.02 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.849 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -63.74 -30.61 71.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.55 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.531 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -76.68 -48.33 19.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.783 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -71.72 -15.69 62.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.05 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.458 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 27.3 ttt -82.05 -57.49 3.38 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.765 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.531 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 7.0 p-10 -68.68 -41.56 79.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.979 179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.433 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 55.1 tp -60.1 -39.39 86.0 Favored 'General case' 0 C--O 1.232 0.147 0 C-N-CA 120.606 -0.437 . . . . 0.0 110.594 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 75' ' ' MET . 35.4 tp -67.48 -57.4 6.58 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.856 -0.338 . . . . 0.0 110.108 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.458 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 8.6 m-30 -50.85 -51.99 45.94 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.629 0.728 . . . . 0.0 109.742 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.7 ttm -60.43 -38.98 85.81 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.897 -1.047 . . . . 0.0 109.817 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.564 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.07 -35.49 77.1 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.423 178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.506 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -64.32 -37.32 87.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 178.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.03 -54.52 32.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.449 HG12 HD23 ' A' ' 19' ' ' LEU . 52.6 t -61.29 -49.59 83.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.999 178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -57.5 -46.02 84.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.081 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.506 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 85.5 mmm -65.24 -41.56 94.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.525 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.537 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -67.25 -54.33 20.99 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.726 -0.749 . . . . 0.0 111.868 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.6 pp -59.67 -42.65 93.36 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.611 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -68.89 -30.58 69.1 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.717 178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.74 -41.89 82.72 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.893 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.618 ' O ' HG12 ' A' ' 26' ' ' ILE . 67.2 mt -64.45 -56.7 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.931 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.7 -43.72 98.74 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.425 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.637 ' O ' HG12 ' A' ' 28' ' ' ILE . . . -60.62 -45.26 94.71 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.587 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -60.65 -46.81 88.9 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.375 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.756 ' O ' HG13 ' A' ' 30' ' ' ILE . 40.8 mm -55.0 -55.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.458 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.492 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -65.74 -48.3 68.34 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.206 -0.997 . . . . 0.0 113.113 -179.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 24' ' ' ALA . 36.2 pt -49.48 -46.77 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.393 0 CA-C-N 117.541 0.67 . . . . 0.0 109.331 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.526 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -65.43 -36.79 93.06 Favored Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.118 177.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.756 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.2 mt -59.73 -71.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.111 0 CA-C-O 120.86 0.362 . . . . 0.0 110.68 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.816 HD23 ' O ' ' A' ' 31' ' ' LEU . 5.9 tt -68.26 -30.94 70.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.163 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' A' ' 36' ' ' LEU . . . -59.71 -47.93 88.55 Favored Glycine 0 C--O 1.222 -0.625 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.996 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -59.79 -51.01 61.56 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.295 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 17.9 ptpt -60.51 -53.85 52.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 0.0 111.66 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.434 ' HB2' HD23 ' A' ' 31' ' ' LEU . 12.7 t80 -64.05 -48.33 76.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.257 0.551 . . . . 0.0 110.29 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 36' ' ' LEU . 2.0 tm? -60.19 -37.68 80.96 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.73 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -61.01 -55.39 33.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.757 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.8 -56.01 27.68 Favored Glycine 0 C--O 1.235 0.196 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.085 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.64 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -55.8 -48.02 76.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.286 0.565 . . . . 0.0 110.418 179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.626 ' CA ' HD21 ' A' ' 49' ' ' LEU . . . -70.66 -15.87 62.76 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.589 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 6.4 tpm_? -81.58 -28.41 33.81 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.633 ' CB ' HD13 ' A' ' 45' ' ' LEU . 90.9 mm-40 -101.85 106.93 49.9 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.837 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.63 ' O ' HG13 ' A' ' 46' ' ' ILE . 5.0 Cg_exo -44.83 -22.72 0.72 Allowed 'Trans proline' 0 CA--C 1.532 0.401 0 C-N-CA 122.854 2.369 . . . . 0.0 113.974 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.606 ' C ' HD12 ' A' ' 45' ' ' LEU . 37.9 t70 -82.69 -7.2 59.66 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.633 HD13 ' CB ' ' A' ' 42' ' ' GLN . 4.3 mp -108.45 19.36 19.9 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.63 HG13 ' O ' ' A' ' 43' ' ' PRO . 32.1 mt -54.8 -45.55 99.65 Favored Pre-proline 0 C--O 1.225 -0.229 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.145 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 15.4 Cg_exo -67.39 -20.83 47.97 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.803 1.669 . . . . 0.0 110.255 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 39' ' ' ALA . 27.4 tp -69.44 -38.64 77.92 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.626 HD21 ' CA ' ' A' ' 40' ' ' ALA . 51.9 mt -44.29 -62.9 1.0 Allowed 'General case' 0 C--O 1.233 0.203 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.679 178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 26.4 mmm180 -67.4 -46.36 73.45 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.704 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.6 m -55.73 -46.06 77.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.77 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.736 ' HA ' HG22 ' A' ' 55' ' ' ILE . 16.4 pt20 -70.08 -36.31 74.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.775 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -56.19 -57.45 12.14 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.1 0.476 . . . . 0.0 109.745 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -63.14 -41.64 99.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.202 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.736 HG22 ' HA ' ' A' ' 52' ' ' GLN . 11.0 tp -63.23 -50.17 80.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.698 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.653 ' O ' HG23 ' A' ' 60' ' ' VAL . 61.0 t -65.59 -42.76 93.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 51.4 ttm -71.83 -40.82 68.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.279 0.561 . . . . 0.0 110.327 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -68.7 -44.33 71.2 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.357 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 88.4 mt -63.56 -40.57 97.33 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 117.166 0.483 . . . . 0.0 109.918 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 56' ' ' VAL . 73.4 t -71.45 -41.39 73.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.425 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 40.7 m-20 -81.19 -9.01 59.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.62 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.56 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -66.14 -27.55 68.11 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 72.4 mt -62.24 -59.66 12.33 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.804 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 16.3 Cg_exo -68.79 -26.38 32.5 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.264 1.309 . . . . 0.0 110.74 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 15.7 tpt -69.29 -31.7 70.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.494 178.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 62' ' ' ALA . 51.8 mt -79.15 -44.92 24.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.908 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.656 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.26 -53.13 32.75 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 121.2 0.524 . . . . 0.0 110.306 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.612 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 97.1 t -64.71 -46.99 90.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -54.5 -50.77 55.67 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.702 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.656 ' HG ' ' O ' ' A' ' 67' ' ' ALA . 3.6 pp -62.79 -42.33 99.65 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.301 0.572 . . . . 0.0 110.34 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.584 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -58.49 -56.38 25.57 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.845 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.732 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -71.59 -28.46 63.83 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.732 ' N ' HD12 ' A' ' 72' ' ' LEU . 21.4 t80 -57.91 -40.24 79.88 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.221 0.534 . . . . 0.0 109.654 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.53 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 46.4 t -94.02 -32.0 4.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.817 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.845 ' HG3' HD23 ' A' ' 9' ' ' LEU . 88.3 mmm -75.03 -76.04 0.15 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.237 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.483 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 28.0 m-85 -63.93 -29.0 70.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -178.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.21 -51.85 4.24 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.533 ' O ' HG12 ' A' ' 78' ' ' VAL . 55.7 t -88.04 -6.49 10.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.186 0 CA-C-O 120.827 0.346 . . . . 0.0 111.143 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.66 0.267 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 6' ' ' MET . 42.7 tt0 -61.62 -53.9 50.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.906 0.384 . . . . 0.0 111.025 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -65.68 -32.77 74.51 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.864 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.549 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 81.8 mt -77.26 -31.14 54.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.688 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.43 -29.47 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.28 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 66.0 mtm -80.23 -49.16 11.99 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.561 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 57.5 p-10 -67.94 -40.13 83.35 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.941 -0.304 . . . . 0.0 110.255 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.871 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.1 tm? -64.13 -30.04 71.12 Favored 'General case' 0 CA--C 1.521 -0.14 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.671 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.1 tm? -68.15 -61.62 1.77 Allowed 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.799 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -50.53 -49.57 55.49 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 121.33 0.586 . . . . 0.0 109.728 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.1 tpp -62.65 -43.04 99.81 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.347 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -55.25 -42.88 74.05 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.856 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' A' ' 17' ' ' MET . . . -56.77 -44.33 81.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.974 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.69 -54.63 44.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.132 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 HD23 ' A' ' 19' ' ' LEU . 48.9 t -58.38 -62.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.088 179.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.527 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.1 mpp? -47.57 -47.3 28.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.709 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 17' ' ' MET . 0.0 OUTLIER -62.32 -45.09 94.78 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.935 179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -66.69 -49.99 51.58 Favored Glycine 0 C--O 1.228 -0.222 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.027 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.507 ' CD2' ' HA ' ' A' ' 16' ' ' MET . 3.4 pp -60.61 -41.69 95.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 110.095 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -70.34 -32.14 69.74 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 178.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.415 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . -67.05 -44.14 80.92 Favored 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.521 ' O ' HG12 ' A' ' 26' ' ' ILE . 83.1 mt -63.55 -57.61 11.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.408 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.22 -51.4 58.71 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.743 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 60' ' ' VAL . . . -59.55 -41.32 89.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.507 179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.466 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -62.01 -47.01 86.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 0.0 110.6 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.749 ' O ' HG12 ' A' ' 30' ' ' ILE . 36.7 mm -56.71 -60.02 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.29 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -67.42 -45.91 74.75 Favored Glycine 0 C--N 1.335 0.479 0 C-N-CA 120.265 -0.969 . . . . 0.0 113.178 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.616 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.8 tp -51.37 -46.66 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.09 -39.39 97.55 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.739 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.749 HG12 ' O ' ' A' ' 26' ' ' ILE . 29.9 mm -58.01 -69.61 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-O 120.605 0.241 . . . . 0.0 111.087 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.742 HD22 ' HD3' ' A' ' 34' ' ' LYS . 2.5 tm? -76.31 -44.55 36.39 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -61.64 -38.35 95.73 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.372 -0.918 . . . . 0.0 111.458 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 37' ' ' GLU . . . -65.21 -51.97 45.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.589 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.742 ' HD3' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -58.13 -50.07 74.78 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 121.36 0.6 . . . . 0.0 110.168 179.311 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.401 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 5.8 t80 -61.32 -41.54 97.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.415 -0.812 . . . . 0.0 109.754 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.919 HD12 HD22 ' A' ' 49' ' ' LEU . 58.7 tp -63.79 -41.36 97.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.421 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 33' ' ' GLY . 47.9 mt-10 -59.52 -53.48 57.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.601 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.97 -61.32 7.11 Favored Glycine 0 C--O 1.239 0.427 0 C-N-CA 120.066 -1.064 . . . . 0.0 111.951 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -49.92 -46.14 51.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.636 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -72.44 -25.83 61.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.629 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.56 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 55.3 ttp180 -67.8 -25.24 65.49 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.59 ' CB ' HD13 ' A' ' 45' ' ' LEU . 72.6 mt-30 -96.85 95.54 2.26 Favored Pre-proline 0 N--CA 1.448 -0.573 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.098 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.56 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 99.4 Cg_exo -38.38 -25.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.46 2.773 . . . . 0.0 114.356 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.664 ' C ' HD12 ' A' ' 45' ' ' LEU . 58.2 m-20 -79.87 -1.42 39.05 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.772 HD23 ' CD2' ' A' ' 48' ' ' LEU . 5.4 mp -121.04 14.91 11.53 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.52 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 26.9 mm -52.48 -45.15 95.65 Favored Pre-proline 0 N--CA 1.464 0.229 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.308 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 9.4 Cg_exo -70.24 -21.0 31.85 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 121.813 1.675 . . . . 0.0 110.714 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.772 ' CD2' HD23 ' A' ' 45' ' ' LEU . 30.1 tp -67.31 -38.96 85.81 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.919 HD22 HD12 ' A' ' 36' ' ' LEU . 38.9 mt -47.0 -64.59 0.74 Allowed 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.663 -1.608 . . . . 0.0 111.829 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 79.1 mtt-85 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.017 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.689 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 46.8 m -58.58 -42.9 89.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.695 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -84.84 -34.79 22.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.949 0.404 . . . . 0.0 110.366 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' A' ' 49' ' ' LEU . 1.5 t80 -51.93 -50.6 60.81 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.908 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 1.2 p90 -63.41 -35.47 80.54 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.836 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.569 HG13 ' O ' ' A' ' 51' ' ' THR . 55.0 mt -66.21 -63.76 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 120.922 0.392 . . . . 0.0 111.24 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.722 ' O ' HG23 ' A' ' 60' ' ' VAL . 22.6 t -54.62 -40.45 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.638 -178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.7 ttt -71.2 -39.0 72.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 0.0 110.564 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -66.22 -45.91 83.28 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.343 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 99.1 mt -57.08 -43.33 82.03 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.154 0.502 . . . . 0.0 109.804 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 56' ' ' VAL . 50.6 t -66.28 -51.42 59.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.438 178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -69.33 -13.68 62.51 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.58 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.77 -33.77 70.67 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.746 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 53.5 mt -60.69 -66.28 1.63 Allowed Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.598 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.746 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 22.0 Cg_exo -56.94 -25.31 61.69 Favored 'Trans proline' 0 C--N 1.355 0.894 0 CA-C-N 120.055 1.055 . . . . 0.0 111.061 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.54 -33.11 70.77 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 62' ' ' ALA . 70.2 mt -77.49 -43.58 30.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.26 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.546 ' O ' ' HG ' ' A' ' 70' ' ' LEU . . . -67.32 -51.24 54.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.3 0.571 . . . . 0.0 110.17 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 60.2 t -69.62 -30.53 45.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.269 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -69.52 -50.84 29.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.775 179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 71' ' ' GLY . 3.7 pp -62.35 -42.61 99.54 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.993 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.854 ' N ' HD12 ' A' ' 70' ' ' LEU . . . -61.55 -52.53 50.51 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.515 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.844 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.1 pp -64.04 -30.57 71.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.92 0.391 . . . . 0.0 111.145 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.844 ' N ' HD12 ' A' ' 72' ' ' LEU . 89.2 t80 -53.03 -48.54 67.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.266 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.618 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.1 t -89.75 -31.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.397 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.893 ' HA ' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -80.5 -69.08 0.62 Allowed 'General case' 0 C--O 1.223 -0.335 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.493 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -59.2 -23.04 61.93 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -79.04 -54.49 5.97 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 74' ' ' VAL . 13.8 p -115.67 -17.43 8.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.399 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.893 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.326 -0.441 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.585 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.2 -45.9 79.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.693 0.282 . . . . 0.0 110.812 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -62.65 -45.84 90.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.837 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' O ' ' CB ' ' A' ' 8' ' ' LEU . 96.6 mt -66.19 -44.74 83.1 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.608 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 4.3 m120 -63.2 -36.32 83.23 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.471 ' O ' ' HD1' ' A' ' 10' ' ' TYR . 56.4 ttm -64.22 -69.73 0.26 Allowed 'General case' 0 C--O 1.241 0.62 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.794 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.435 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -52.98 -40.65 63.91 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.526 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.472 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 54.7 tp -65.62 -31.01 71.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.762 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.591 HD13 ' C ' ' A' ' 9' ' ' LEU . 2.3 tm? -68.6 -52.9 26.5 Favored 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.326 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.471 ' HD1' ' O ' ' A' ' 6' ' ' MET . 31.3 m-85 -59.69 -42.59 93.3 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.009 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.461 ' O ' HG23 ' A' ' 15' ' ' VAL . 25.7 ttt -63.3 -37.76 88.5 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.292 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.08 -37.4 84.87 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.474 178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -60.22 -46.24 90.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.104 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.66 -50.57 72.98 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.794 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.548 HG12 HD23 ' A' ' 19' ' ' LEU . 38.8 t -64.91 -51.52 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.319 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.733 ' CE ' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -62.32 -51.61 66.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.988 -179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.684 ' CG ' HG21 ' A' ' 68' ' ' VAL . 84.6 mtp -62.5 -41.9 99.13 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.401 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -68.66 -53.85 18.2 Favored Glycine 0 C--O 1.226 -0.358 0 C-N-CA 120.939 -0.648 . . . . 0.0 112.567 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.786 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.5 pp -58.04 -45.39 87.08 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.241 0.544 . . . . 0.0 109.892 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.786 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.37 -32.18 73.41 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.371 178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.86 -41.06 78.92 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.508 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 18' ' ' GLY . 92.6 mt -62.26 -57.79 10.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.777 179.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.96 -47.76 89.66 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.312 -0.947 . . . . 0.0 111.446 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.525 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -56.42 -42.67 78.43 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.875 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -61.62 -58.08 9.5 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.197 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.854 ' O ' HG12 ' A' ' 30' ' ' ILE . 33.8 mm -44.4 -56.73 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.454 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.34 -38.33 87.12 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.766 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.875 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -56.13 -44.03 77.71 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.453 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -67.25 -36.4 89.66 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.546 177.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.854 HG12 ' O ' ' A' ' 26' ' ' ILE . 42.5 mm -59.63 -69.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.441 0.162 . . . . 0.0 110.81 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.619 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.0 tm? -74.59 -45.6 44.11 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.658 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -62.59 -44.11 98.03 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.3 -0.953 . . . . 0.0 110.886 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -60.75 -49.22 81.05 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.853 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HD3' ' HA ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -61.44 -53.98 49.42 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-O 121.058 0.456 . . . . 0.0 110.587 179.53 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.408 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 5.0 t80 -57.25 -62.64 1.62 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.57 HD13 ' O ' ' A' ' 32' ' ' GLY . 6.8 mp -53.28 -34.65 58.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.925 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.507 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 16.3 tp10 -56.77 -61.28 2.54 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.031 0.444 . . . . 0.0 109.944 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.536 ' O ' ' HG3' ' A' ' 42' ' ' GLN . . . -54.32 -47.31 69.08 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.19 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.837 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -62.26 -34.97 77.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.148 0.499 . . . . 0.0 110.009 178.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.99 -22.87 62.12 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.044 179.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.617 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 4.5 tmm_? -92.34 -19.39 22.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.763 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.951 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 65.3 mt-30 -61.21 -177.01 0.12 Allowed Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.756 178.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.951 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 73.6 Cg_exo -48.81 -71.58 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 123.154 2.569 . . . . 0.0 113.375 -179.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.413 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.6 t70 -146.09 46.94 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.509 -0.476 . . . . 0.0 111.893 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.837 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 3.4 mm? -84.56 13.22 5.81 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.952 0.406 . . . . 0.0 111.131 178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.603 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 29.4 mm -52.56 -45.51 95.9 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.635 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 35.3 Cg_endo -68.16 -23.43 39.47 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 120.874 1.05 . . . . 0.0 110.698 179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 45' ' ' LEU . 35.6 tp -67.8 -38.72 83.67 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.962 HD21 ' HB2' ' A' ' 40' ' ' ALA . 77.8 mt -43.91 -61.42 1.45 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.743 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.621 ' O ' ' HD1' ' A' ' 54' ' ' PHE . 39.7 ptt180 -63.02 -49.53 74.29 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.148 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 55' ' ' ILE . 97.6 m -46.83 -48.8 20.79 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.839 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 48' ' ' LEU . 40.7 mt-30 -69.3 -33.43 73.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.987 0.423 . . . . 0.0 110.581 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.02 -54.19 47.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.567 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' HD1' ' O ' ' A' ' 50' ' ' ARG . 31.6 m-85 -65.15 -44.45 88.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.638 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 51' ' ' THR . 36.8 mm -63.86 -56.99 13.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.797 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.616 ' O ' HG23 ' A' ' 60' ' ' VAL . 39.1 t -60.78 -48.19 89.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 -179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.426 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 26.5 ttt -68.73 -35.53 77.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.216 0.532 . . . . 0.0 110.576 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -69.61 -45.08 60.8 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.503 -0.772 . . . . 0.0 113.07 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 80.2 mt -61.98 -42.5 99.2 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.993 0.425 . . . . 0.0 110.084 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 56' ' ' VAL . 60.4 t -69.65 -50.67 48.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.391 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.426 ' OD2' ' HG2' ' A' ' 57' ' ' MET . 28.6 m-20 -69.13 -16.04 63.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.636 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.558 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.73 -33.72 68.74 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.389 . . . . 0.0 110.506 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.582 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 70.9 mt -57.6 -66.11 1.45 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.587 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HB2' ' HG2' ' A' ' 17' ' ' MET . 17.4 Cg_endo -60.13 -24.94 78.53 Favored 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 121.261 1.307 . . . . 0.0 110.839 179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' A' ' 62' ' ' ALA . 79.0 mmm -71.67 -31.6 66.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.495 177.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.558 HG13 ' O ' ' A' ' 62' ' ' ALA . 58.4 mt -75.51 -46.47 37.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.513 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.55 -54.65 18.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.53 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.684 HG21 ' CG ' ' A' ' 17' ' ' MET . 58.1 t -67.13 -40.87 86.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.338 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.52 -41.61 99.16 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.876 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 70' ' ' LEU . 5.2 tt -67.89 -46.21 72.26 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -63.4 -44.67 96.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.683 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 68' ' ' VAL . 85.4 mt -73.68 -30.37 62.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.967 0.413 . . . . 0.0 110.273 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.867 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.8 t80 -58.27 -47.44 83.59 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG13 ' SD ' ' A' ' 75' ' ' MET . 6.4 p -78.64 -34.0 17.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.43 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.546 ' SD ' HG13 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -70.07 -74.57 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.235 0.458 . . . . 0.0 112.235 179.893 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.453 ' CE2' HD22 ' A' ' 72' ' ' LEU . 31.1 m-85 -56.89 -29.58 63.12 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.867 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.48 -54.3 3.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 14.8 t -92.08 -10.03 9.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.77 0.319 . . . . 0.0 111.074 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.494 1.772 0 N-CA-C 112.938 0.718 . . . . 0.0 112.938 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -66.79 -55.78 13.4 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.028 0.442 . . . . 0.0 111.01 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -57.04 -40.35 76.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.614 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.589 ' HA ' ' OD1' ' A' ' 7' ' ' ASP . 82.4 mt -70.32 -45.39 66.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.697 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.537 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 3.9 m120 -71.19 -13.96 62.1 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.118 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.485 ' HG2' ' CE2' ' A' ' 10' ' ' TYR . 28.0 ttt -82.89 -59.05 2.62 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 10.5 p-10 -67.39 -42.38 83.43 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.099 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.97 -34.15 72.91 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.659 HD21 ' HG3' ' A' ' 75' ' ' MET . 51.2 tp -68.43 -63.63 1.02 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.132 179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 6' ' ' MET . 5.8 m-85 -53.64 -42.57 67.94 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.183 0.516 . . . . 0.0 109.935 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' HG23 ' A' ' 15' ' ' VAL . 9.6 tmm? -66.31 -36.29 82.55 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.409 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.502 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -63.77 -31.25 72.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.743 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.429 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -68.08 -33.08 73.87 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.63 -54.65 17.91 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 50.4 t -62.06 -41.94 93.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.762 178.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.456 ' O ' ' HG ' ' A' ' 19' ' ' LEU . 15.2 mmt -62.03 -50.8 70.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.765 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.55 ' SD ' HG21 ' A' ' 68' ' ' VAL . 89.5 mmm -66.51 -39.65 88.8 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.566 -179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' O ' HG13 ' A' ' 22' ' ' ILE . . . -69.65 -49.84 34.43 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.4 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -59.41 -47.28 86.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.913 0.387 . . . . 0.0 110.08 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.793 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.58 -33.0 74.7 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.734 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -67.14 -42.26 84.7 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.645 HG13 ' O ' ' A' ' 18' ' ' GLY . 75.1 mt -62.25 -60.59 2.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.87 178.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.77 -45.88 90.53 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.808 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -62.32 -40.79 97.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.944 0.402 . . . . 0.0 110.589 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.504 ' HA ' HG22 ' A' ' 28' ' ' ILE . . . -63.55 -43.88 95.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.212 0.53 . . . . 0.0 110.275 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.825 ' O ' HG13 ' A' ' 30' ' ' ILE . 79.4 mt -58.24 -61.33 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.174 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -67.16 -42.32 91.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.153 -1.023 . . . . 0.0 113.156 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.646 ' CD1' HG12 ' A' ' 56' ' ' VAL . 8.7 tp -54.87 -46.75 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.475 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -62.21 -36.43 92.99 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 114.393 -1.276 . . . . 0.0 110.65 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.825 HG13 ' O ' ' A' ' 26' ' ' ILE . 72.3 mt -61.88 -72.54 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.521 0.201 . . . . 0.0 110.856 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD13 ' C ' ' A' ' 31' ' ' LEU . 3.3 tm? -71.39 -42.06 68.84 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.816 0.341 . . . . 0.0 110.888 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -65.18 -44.05 94.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.52 -0.848 . . . . 0.0 111.793 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.59 -38.04 95.18 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.545 -0.835 . . . . 0.0 112.418 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 37' ' ' GLU . 18.8 ptpt -71.99 -47.88 48.91 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.05 0.452 . . . . 0.0 110.513 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.6 t80 -63.91 -49.44 72.64 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.711 HD21 HD13 ' A' ' 49' ' ' LEU . 5.1 tt -56.24 -51.44 68.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.271 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 34' ' ' LYS . 12.6 pt-20 -57.26 -51.65 68.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.862 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 37' ' ' GLU . . . -54.02 -53.7 35.54 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.77 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.68 ' HB1' ' HB3' ' A' ' 45' ' ' LEU . . . -64.62 -42.32 95.59 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.093 0.473 . . . . 0.0 110.965 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' HB2' HD23 ' A' ' 36' ' ' LEU . . . -57.0 -30.82 64.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.575 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.503 ' HG3' ' O ' ' A' ' 37' ' ' GLU . 97.2 mtt180 -82.3 -37.82 25.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.451 0.643 . . . . 0.0 109.706 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.793 ' HB3' ' HB2' ' A' ' 45' ' ' LEU . 3.1 tp-100 -44.86 127.97 5.27 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.352 -179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -32.78 -33.21 0.05 OUTLIER 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 124.755 3.637 . . . . 0.0 115.879 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' C ' HD12 ' A' ' 45' ' ' LEU . 56.4 m-20 -141.02 29.3 1.86 Allowed 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.793 ' HB2' ' HB3' ' A' ' 42' ' ' GLN . 8.6 mp -114.38 6.98 16.21 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.778 0.323 . . . . 0.0 111.563 178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.807 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.3 mp -48.61 -47.29 71.07 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.704 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.445 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 79.3 Cg_endo -78.92 -16.69 12.55 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 121.867 1.711 . . . . 0.0 111.174 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.556 HD22 ' HG ' ' A' ' 45' ' ' LEU . 40.4 tp -69.52 -30.74 68.64 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 176.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.711 HD13 HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -47.48 -59.21 3.4 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.556 179.241 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.533 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 86.7 mtm180 -72.06 -42.54 66.14 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.328 0.585 . . . . 0.0 110.196 179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.677 ' O ' HG12 ' A' ' 55' ' ' ILE . 28.0 m -52.74 -39.61 62.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.13 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.549 ' HG2' ' O ' ' A' ' 48' ' ' LEU . 18.3 pt20 -84.59 -33.82 23.29 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.995 0.426 . . . . 0.0 110.139 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.545 ' HD2' HD12 ' A' ' 36' ' ' LEU . 11.0 t80 -57.6 -49.7 75.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.231 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.564 ' CE1' HG12 ' A' ' 55' ' ' ILE . 1.0 OUTLIER -73.2 -30.09 63.27 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -178.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.677 HG12 ' O ' ' A' ' 51' ' ' THR . 38.7 mm -69.69 -56.75 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.262 0.553 . . . . 0.0 109.843 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.646 HG12 ' CD1' ' A' ' 28' ' ' ILE . 41.1 t -61.57 -39.23 82.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.302 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.7 tpt -71.75 -34.26 69.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.227 0.537 . . . . 0.0 110.204 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.67 -42.03 63.26 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.352 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 60' ' ' VAL . 3.7 pp -65.12 -26.93 68.41 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.133 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.657 ' N ' HD12 ' A' ' 59' ' ' LEU . 99.7 t -78.16 -51.25 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.088 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' C ' ' HD2' ' A' ' 64' ' ' PRO . 1.2 m-20 -69.04 -12.77 61.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.51 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.594 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.48 -33.32 69.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.76 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 70.3 mt -60.85 -64.92 2.52 Favored Pre-proline 0 N--CA 1.453 -0.322 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.285 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.76 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 35.1 Cg_exo -55.71 -26.5 56.54 Favored 'Trans proline' 0 C--N 1.359 1.092 0 CA-C-N 120.123 1.08 . . . . 0.0 110.845 178.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -71.14 -30.85 66.99 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.633 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.594 HG13 ' O ' ' A' ' 62' ' ' ALA . 80.0 mt -76.73 -44.59 33.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.457 178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.06 -58.42 4.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.302 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.55 HG21 ' SD ' ' A' ' 17' ' ' MET . 60.3 t -63.52 -39.53 85.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.192 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -64.67 -47.5 82.87 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.735 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.708 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.1 tm? -60.7 -44.74 96.19 Favored 'General case' 0 CA--C 1.52 -0.21 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.15 -51.37 58.77 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.172 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.722 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.2 pp -69.34 -26.06 64.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.676 0.274 . . . . 0.0 111.099 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.943 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.7 t80 -54.68 -47.35 73.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 109.628 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.62 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 13.4 p -90.6 -28.5 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.675 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.659 ' HG3' HD21 ' A' ' 9' ' ' LEU . 94.2 mmm -82.14 -74.99 0.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.217 0.532 . . . . 0.0 111.756 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 72' ' ' LEU . 15.5 m-30 -58.53 -28.79 65.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.378 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.943 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -96.96 -55.08 2.98 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.62 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 48.1 t -87.75 -2.75 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.169 -0.469 . . . . 0.0 112.158 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.164 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' A' ' 1' ' ' MET . 28.1 ttt . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -62.94 -51.35 67.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.942 0.401 . . . . 0.0 111.072 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.5 -38.28 86.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.591 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 82.6 mt -71.7 -32.62 68.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.395 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -74.12 -30.94 62.56 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.602 ' HG2' ' CZ ' ' A' ' 10' ' ' TYR . 51.5 ttm -77.42 -46.22 23.34 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.746 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -68.41 -46.57 69.57 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.369 178.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.662 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.4 tm? -59.98 -32.26 70.67 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.486 ' CD2' ' HG3' ' A' ' 75' ' ' MET . 61.2 tp -64.87 -58.23 6.74 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.778 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.602 ' CZ ' ' HG2' ' A' ' 6' ' ' MET . 9.1 m-30 -47.38 -54.3 11.59 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.521 0.676 . . . . 0.0 109.839 178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -61.45 -38.56 87.65 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.721 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.635 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -61.82 -33.7 74.61 Favored 'General case' 0 C--O 1.22 -0.49 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.83 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -62.49 -40.84 97.99 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.738 -0.468 . . . . 0.0 109.738 178.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.6 -52.57 51.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.078 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.477 HG12 HD23 ' A' ' 19' ' ' LEU . 43.6 t -60.48 -44.45 96.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.204 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.303 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.635 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -62.48 -55.42 27.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.212 0.529 . . . . 0.0 110.773 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.458 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 89.2 mmm -58.68 -42.21 88.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.579 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.67 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -68.72 -53.98 17.32 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.695 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.752 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.4 pp -57.72 -44.07 85.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.953 0.406 . . . . 0.0 110.196 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.752 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.89 -32.44 72.92 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -67.09 -40.45 86.96 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.838 178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.67 HG12 ' O ' ' A' ' 18' ' ' GLY . 47.4 mm -62.37 -64.45 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.576 178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.31 -50.51 46.6 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.677 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.636 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.22 -42.09 85.51 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 110.384 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.863 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -56.95 -59.52 4.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.046 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HD13 ' A' ' 30' ' ' ILE . 1.9 mp -53.72 -57.46 5.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.779 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.19 -39.16 97.32 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.896 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.863 HG22 ' O ' ' A' ' 25' ' ' ALA . 6.0 tp -58.13 -43.67 85.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.03 -35.84 92.64 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.599 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.731 HD13 ' O ' ' A' ' 26' ' ' ILE . 1.5 mp -60.39 -72.3 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-O 120.611 0.244 . . . . 0.0 110.762 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 34' ' ' LYS . 3.2 tm? -69.02 -41.55 77.58 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.107 0.48 . . . . 0.0 110.308 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -60.21 -43.24 98.64 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.834 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -62.87 -48.48 80.54 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.077 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.74 ' HD2' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -62.77 -50.87 69.33 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.893 0.377 . . . . 0.0 110.922 179.999 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 15.3 t80 -62.66 -49.23 75.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.33 0.586 . . . . 0.0 110.015 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 49' ' ' LEU . 2.4 tm? -61.46 -37.18 82.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.796 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -58.79 -57.93 10.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.909 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.13 -56.78 18.51 Favored Glycine 0 C--O 1.237 0.331 0 C-N-CA 120.386 -0.911 . . . . 0.0 112.245 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.762 ' HB2' HD23 ' A' ' 48' ' ' LEU . . . -50.29 -25.24 3.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.133 0.492 . . . . 0.0 111.255 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.656 ' N ' HD21 ' A' ' 49' ' ' LEU . . . -92.86 -33.21 14.32 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.242 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.674 ' HA ' ' NE ' ' A' ' 41' ' ' ARG . 9.1 mmp_? -63.96 -25.04 67.96 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.26 178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.597 ' CB ' HD23 ' A' ' 45' ' ' LEU . 10.9 mm100 -100.44 117.2 63.39 Favored Pre-proline 0 N--CA 1.435 -1.225 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.073 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 42' ' ' GLN . 9.7 Cg_endo -56.05 -7.44 1.74 Allowed 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.008 2.472 . . . . 0.0 113.787 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -98.69 -25.39 14.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 0.0 111.53 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.863 HD12 HD22 ' A' ' 48' ' ' LEU . 2.8 mm? -92.16 11.56 25.15 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.553 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 13.9 mt -53.98 -44.24 97.97 Favored Pre-proline 0 C--O 1.225 -0.222 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.107 179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.515 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 13.0 Cg_exo -68.83 -21.44 38.11 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 121.708 1.605 . . . . 0.0 110.694 179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.863 HD22 HD12 ' A' ' 45' ' ' LEU . 48.4 tp -65.98 -40.98 91.67 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.995 HD22 HD22 ' A' ' 36' ' ' LEU . 69.1 mt -45.54 -63.38 0.97 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.449 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 47' ' ' PRO . 58.8 mtm-85 -67.6 -41.15 84.51 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.143 0.496 . . . . 0.0 110.305 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.843 ' O ' HG13 ' A' ' 55' ' ' ILE . 42.1 m -60.01 -39.68 86.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.076 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.701 ' OE1' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -81.25 -29.89 34.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.059 0.457 . . . . 0.0 110.155 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -61.22 -57.32 12.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.336 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.78 ' CE1' HG13 ' A' ' 55' ' ' ILE . 0.4 OUTLIER -69.4 -34.58 74.71 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.843 HG13 ' O ' ' A' ' 51' ' ' THR . 33.6 mt -71.27 -56.75 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.658 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.743 ' O ' HG23 ' A' ' 60' ' ' VAL . 59.5 t -62.83 -37.34 78.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.499 -178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.434 ' CE ' HG12 ' A' ' 28' ' ' ILE . 61.3 tpp -73.69 -39.29 64.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.231 0.539 . . . . 0.0 110.386 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.96 -44.78 66.0 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.76 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 55' ' ' ILE . 93.4 mt -60.21 -39.21 85.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.145 0.498 . . . . 0.0 110.071 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 56' ' ' VAL . 58.1 t -70.64 -42.3 77.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.745 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.687 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 41.0 m-20 -79.32 -13.09 59.87 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.648 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.712 ' O ' HD13 ' A' ' 66' ' ' ILE . . . -67.12 -21.89 65.82 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.424 -0.511 . . . . 0.0 110.311 178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.65 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 66.8 mt -65.13 -56.19 21.79 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.581 -0.282 . . . . 0.0 111.565 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 61' ' ' ASP . 2.8 Cg_exo -77.94 -26.32 6.75 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 121.846 1.697 . . . . 0.0 110.979 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 50.6 tpp -70.69 -31.71 68.7 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.712 HD13 ' O ' ' A' ' 62' ' ' ALA . 1.2 mp -81.55 -44.36 20.37 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.771 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.67 -52.8 48.73 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 120.975 0.417 . . . . 0.0 109.984 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.624 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 74.6 t -67.98 -43.51 85.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.284 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -63.14 -43.08 99.21 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.989 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.635 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -63.87 -46.22 85.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.097 0.475 . . . . 0.0 109.783 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -58.41 -55.52 30.28 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.493 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.798 HD12 ' N ' ' A' ' 73' ' ' TYR . 3.9 pp -68.2 -28.15 67.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.754 0.311 . . . . 0.0 111.452 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.798 ' N ' HD12 ' A' ' 72' ' ' LEU . 87.4 t80 -52.54 -45.62 66.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.284 0.564 . . . . 0.0 109.711 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.527 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 11.6 p -93.0 -29.08 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.547 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.535 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 24.1 mmt -82.34 -70.04 0.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.321 -178.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.534 ' CZ ' ' CD1' ' A' ' 10' ' ' TYR . 7.9 m-85 -61.21 -28.52 69.21 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.76 -58.9 1.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.029 0.442 . . . . 0.0 111.839 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 78' ' ' VAL . 49.7 t -83.82 -2.24 6.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.813 -0.631 . . . . 0.0 112.06 -179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 120.851 0.357 . . . . 0.0 111.132 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 120.586 0.231 . . . . 0.0 111.544 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.554 ' HA ' ' OD1' ' A' ' 5' ' ' ASN . 50.0 mt-10 -66.32 -53.44 36.44 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.203 0.525 . . . . 0.0 111.143 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.416 ' O ' ' OD2' ' A' ' 7' ' ' ASP . 75.2 m-20 -63.02 -31.73 72.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.792 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 79.7 mt -72.54 -50.86 22.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.35 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 2' ' ' GLU . 11.4 p-10 -69.67 -17.99 63.53 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.649 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.541 ' HG3' ' CZ ' ' A' ' 10' ' ' TYR . 10.3 tpt -85.9 -47.08 9.98 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.346 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.3 p30 -72.65 -40.68 66.16 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 7' ' ' ASP . 60.3 mt -61.99 -32.7 73.19 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.688 HD13 ' HG3' ' A' ' 75' ' ' MET . 7.3 tt -70.26 -48.57 56.23 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.541 ' CZ ' ' HG3' ' A' ' 6' ' ' MET . 11.0 m-30 -48.58 -54.64 13.74 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.813 0.816 . . . . 0.0 109.105 177.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 ttm -63.61 -38.59 91.71 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 114.257 -1.338 . . . . 0.0 110.123 -179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.59 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -60.77 -33.07 72.4 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.915 178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.98 -36.68 80.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.856 0.36 . . . . 0.0 110.04 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.99 -51.38 55.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.499 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.511 HG12 HD23 ' A' ' 19' ' ' LEU . 45.4 t -63.09 -47.1 94.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.548 178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.59 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -59.08 -45.65 90.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.84 178.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 15.3 mmt -65.2 -42.75 93.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.7 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -70.14 -50.19 29.46 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.733 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.03 -44.88 94.32 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.095 0.474 . . . . 0.0 109.938 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.645 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -65.68 -38.42 89.22 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.332 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.19 94.97 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.537 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.7 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.1 mm -60.55 -61.6 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.209 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.77 -52.93 42.63 Favored Glycine 0 C--O 1.236 0.273 0 C-N-CA 120.306 -0.949 . . . . 0.0 111.933 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.707 ' HB1' ' CG1' ' A' ' 60' ' ' VAL . . . -56.8 -41.61 78.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.807 0.337 . . . . 0.0 110.693 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.512 ' O ' HG13 ' A' ' 28' ' ' ILE . . . -61.95 -44.32 97.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.713 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.731 ' O ' HG13 ' A' ' 30' ' ' ILE . 66.0 mt -59.37 -55.76 21.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.756 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -64.66 -50.39 59.08 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.088 -1.053 . . . . 0.0 113.012 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.88 HD12 ' N ' ' A' ' 29' ' ' GLY . 2.9 pp -48.92 -46.86 16.66 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.88 ' N ' HD12 ' A' ' 28' ' ' ILE . . . -60.52 -39.3 96.21 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 177.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 26' ' ' ILE . 83.3 mt -57.92 -72.94 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-O 120.635 0.255 . . . . 0.0 111.073 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.7 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.2 tp -73.51 -40.26 64.19 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.929 0.395 . . . . 0.0 110.991 -179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -59.27 -39.44 94.63 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.513 -0.851 . . . . 0.0 111.559 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.62 -50.37 59.33 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.953 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.7 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -60.9 -52.41 65.16 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.169 0.509 . . . . 0.0 110.657 179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.37 -52.88 63.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 40' ' ' ALA . 47.6 tp -58.86 -36.04 73.95 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.151 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.83 -58.54 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.238 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.573 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -56.57 -56.31 25.29 Favored Glycine 0 C--O 1.242 0.63 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.115 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.726 ' HB1' HD23 ' A' ' 48' ' ' LEU . . . -62.48 -16.16 53.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.529 -0.335 . . . . 0.0 111.419 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 49' ' ' LEU . . . -95.94 -23.58 16.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.611 0.243 . . . . 0.0 110.831 179.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.608 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 16.0 ptm180 -86.31 -15.11 41.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.635 ' CB ' HD23 ' A' ' 45' ' ' LEU . 73.7 mt-30 -96.91 93.62 1.48 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.339 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' A' ' 41' ' ' ARG . 78.0 Cg_exo -38.06 -25.2 0.08 OUTLIER 'Trans proline' 0 CA--C 1.534 0.505 0 C-N-CA 123.729 2.953 . . . . 0.0 114.729 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.633 ' C ' HD22 ' A' ' 45' ' ' LEU . 10.8 p-10 -85.28 2.81 42.38 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.901 HD12 HD22 ' A' ' 48' ' ' LEU . 3.4 mm? -116.02 18.97 15.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 22.8 mt -52.66 -45.92 96.23 Favored Pre-proline 0 C--O 1.224 -0.266 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.541 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 46' ' ' ILE . 14.5 Cg_exo -67.82 -22.43 42.91 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 121.563 1.509 . . . . 0.0 110.513 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.901 HD22 HD12 ' A' ' 45' ' ' LEU . 25.4 tp -68.74 -37.27 79.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 40' ' ' ALA . 63.9 mt -45.45 -65.45 0.54 Allowed 'General case' 0 C--O 1.232 0.161 0 CA-C-N 114.515 -1.22 . . . . 0.0 111.34 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -67.07 -42.09 85.3 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.931 -179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HG12 ' A' ' 55' ' ' ILE . 50.6 m -58.58 -39.51 80.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.456 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.667 HE22 ' HB3' ' A' ' 39' ' ' ALA . 20.7 pt20 -82.75 -32.37 27.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.054 0.454 . . . . 0.0 110.218 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -59.16 -52.43 65.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.648 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.821 ' CE1' HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -74.09 -33.44 63.63 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.451 -178.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.821 HG12 ' CE1' ' A' ' 54' ' ' PHE . 23.3 mm -69.76 -54.72 17.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 121.311 0.577 . . . . 0.0 110.063 178.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.663 ' HA ' HD12 ' A' ' 59' ' ' LEU . 59.8 t -64.53 -36.97 78.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.119 -178.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.551 ' CE ' HD13 ' A' ' 28' ' ' ILE . 24.6 mmt -82.24 -29.51 31.28 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 0.0 110.433 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -81.21 -37.81 17.06 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.748 -0.66 . . . . 0.0 113.909 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.713 HD13 ' N ' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -71.19 -21.41 62.15 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 117.829 0.814 . . . . 0.0 109.931 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.713 ' N ' HD13 ' A' ' 59' ' ' LEU . 78.3 t -88.19 -44.76 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.694 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -74.23 -22.15 59.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -58.74 -29.39 66.69 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.32 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.67 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 1.8 mp -58.15 -70.39 0.39 Allowed Pre-proline 0 N--CA 1.452 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.114 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.67 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 25.6 Cg_exo -57.39 -27.38 75.55 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 120.787 0.992 . . . . 0.0 111.007 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.449 ' HB3' ' HA ' ' A' ' 62' ' ' ALA . 47.7 tpp -71.06 -30.33 66.45 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.166 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.804 ' O ' HD23 ' A' ' 70' ' ' LEU . 68.7 mt -79.31 -44.03 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.505 179.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.97 -56.8 6.69 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 0.0 109.947 179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.816 HG12 HD22 ' A' ' 72' ' ' LEU . 86.2 t -63.12 -44.0 99.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.061 178.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -58.31 -46.69 92.59 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.339 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.804 HD23 ' O ' ' A' ' 66' ' ' ILE . 4.4 mm? -65.93 -46.18 79.15 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.842 0.321 . . . . 0.0 110.99 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -62.48 -52.71 47.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.219 -0.991 . . . . 0.0 111.807 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.816 HD22 HG12 ' A' ' 68' ' ' VAL . 5.7 mp -65.89 -32.26 73.67 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.945 0.402 . . . . 0.0 111.014 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.835 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 94.1 t80 -54.2 -46.74 72.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.361 0.6 . . . . 0.0 109.727 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.626 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 49.1 t -86.3 -30.79 6.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.614 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.688 ' HG3' HD13 ' A' ' 9' ' ' LEU . 21.8 mmt -75.44 -74.97 0.19 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.514 ' CD2' ' HG ' ' A' ' 72' ' ' LEU . 20.2 m-85 -62.37 -27.64 69.21 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.835 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.78 -49.17 4.67 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.532 0.567 . . . . 0.0 112.532 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 52.8 t -91.72 -6.24 10.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.188 -0.46 . . . . 0.0 112.047 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 120.962 0.411 . . . . 0.0 111.242 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 120.952 0.406 . . . . 0.0 111.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.582 ' O ' ' HG2' ' A' ' 6' ' ' MET . 56.0 mt-10 -62.09 -52.08 65.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.627 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -57.83 -46.23 85.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.699 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 84.3 mt -68.93 -33.29 73.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.775 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -70.7 -28.22 64.58 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.409 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.582 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 26.5 mmt -80.58 -53.11 6.85 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.092 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.479 ' OD2' ' HA ' ' A' ' 4' ' ' LEU . 2.9 p30 -64.13 -39.64 94.45 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.129 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' CB ' ' O ' ' A' ' 4' ' ' LEU . 57.1 tp -63.4 -28.06 69.72 Favored 'General case' 0 CA--C 1.522 -0.109 0 N-CA-C 109.379 -0.601 . . . . 0.0 109.379 178.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.905 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 2.1 tm? -69.11 -65.5 0.7 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.158 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -51.83 -37.76 53.12 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.526 0.679 . . . . 0.0 109.451 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.39 73.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.672 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -65.29 -31.94 73.34 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.774 178.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.87 -35.1 79.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.24 -52.76 44.63 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.354 178.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.587 HG12 HD23 ' A' ' 19' ' ' LEU . 42.4 t -61.6 -47.31 93.96 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.781 178.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -58.36 -47.46 83.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.145 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.459 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 21.1 mmt -67.72 -37.62 82.47 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.76 -53.37 16.06 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.051 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -60.06 -42.58 94.83 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.213 0.53 . . . . 0.0 109.767 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.618 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.84 -31.77 71.84 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.337 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -68.07 -40.02 82.81 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.178 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 18' ' ' GLY . 43.4 mm -63.93 -61.63 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.585 178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.04 -49.72 61.69 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.265 -0.969 . . . . 0.0 111.514 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.647 ' O ' ' HB ' ' A' ' 28' ' ' ILE . . . -58.5 -42.18 87.06 Favored 'General case' 0 C--O 1.224 -0.277 0 CA-C-O 120.692 0.282 . . . . 0.0 110.63 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.792 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.63 -61.6 2.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.378 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.701 ' O ' HG12 ' A' ' 30' ' ' ILE . 2.1 mp -51.29 -52.63 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.252 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.72 -34.04 77.21 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.258 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.971 HD11 HG12 ' A' ' 56' ' ' VAL . 5.5 tp -57.13 -44.95 84.16 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.47 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -65.96 -40.23 95.22 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.96 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.701 HG12 ' O ' ' A' ' 26' ' ' ILE . 36.6 mm -55.03 -70.9 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-O 120.916 0.389 . . . . 0.0 110.565 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.62 HD23 ' HB2' ' A' ' 35' ' ' PHE . 7.9 tt -68.2 -26.87 65.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.984 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . -58.77 -45.08 95.38 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.257 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.86 -52.38 50.81 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.06 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 14.6 ptmm? -60.55 -51.1 70.87 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 121.195 0.521 . . . . 0.0 111.135 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.62 ' HB2' HD23 ' A' ' 31' ' ' LEU . 15.4 t80 -63.01 -48.94 76.63 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.713 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.497 HD13 ' OE1' ' A' ' 52' ' ' GLN . 53.0 tp -65.07 -36.27 83.78 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.088 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -58.05 -63.09 1.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.069 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.82 -49.47 67.98 Favored Glycine 0 C--O 1.238 0.375 0 C-N-CA 120.184 -1.008 . . . . 0.0 111.553 179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.649 ' O ' HD23 ' A' ' 45' ' ' LEU . . . -53.8 -37.78 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.549 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HA ' ' HG ' ' A' ' 45' ' ' LEU . . . -81.91 -22.49 36.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.618 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 57.9 ttt-85 -64.92 -34.06 77.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 68.1 mt-30 -57.81 123.38 63.16 Favored Pre-proline 0 N--CA 1.444 -0.764 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.735 178.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -61.12 1.71 0.58 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.73 2.287 . . . . 0.0 112.757 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 47' ' ' PRO . 8.9 t0 -130.23 34.09 4.25 Favored 'General case' 0 C--O 1.226 -0.143 0 CA-C-O 120.84 0.353 . . . . 0.0 110.334 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.923 HD22 ' HB3' ' A' ' 48' ' ' LEU . 2.6 tm? -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.51 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.862 ' H ' HD12 ' A' ' 46' ' ' ILE . 4.4 mp -30.09 -58.64 0.29 Allowed Pre-proline 0 N--CA 1.469 0.519 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.594 ' HD3' ' HB ' ' A' ' 46' ' ' ILE . 81.8 Cg_endo -77.66 -27.67 5.94 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 121.237 1.291 . . . . 0.0 110.938 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.923 ' HB3' HD22 ' A' ' 45' ' ' LEU . 23.0 tp -66.21 -21.52 66.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.577 ' HB3' ' O ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -56.41 -56.98 14.45 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.46 179.335 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.55 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 54.0 mtp85 -75.5 -34.88 60.87 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.141 0.496 . . . . 0.0 110.169 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.934 ' HA ' ' CE2' ' A' ' 54' ' ' PHE . 59.7 m -64.72 -33.33 75.7 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.45 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.57 ' O ' HG23 ' A' ' 56' ' ' VAL . 2.8 pt20 -81.43 -36.91 28.87 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.422 ' N ' ' HG3' ' A' ' 52' ' ' GLN . 12.2 t80 -55.52 -55.42 32.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.695 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.934 ' CE2' ' HA ' ' A' ' 51' ' ' THR . 3.8 p90 -72.89 -38.5 66.93 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.493 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 54' ' ' PHE . 21.1 mm -61.25 -59.65 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.117 0.484 . . . . 0.0 110.335 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.971 HG12 HD11 ' A' ' 28' ' ' ILE . 40.7 t -60.64 -50.0 82.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.124 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 27.1 ttt -68.67 -34.69 76.13 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.206 0.527 . . . . 0.0 110.571 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 62' ' ' ALA . . . -72.31 -42.81 48.58 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.414 -0.812 . . . . 0.0 113.589 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.6 pp -66.88 -33.68 76.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 117.45 0.625 . . . . 0.0 109.881 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 56' ' ' VAL . 59.5 t -76.76 -49.8 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.039 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.43 -17.61 63.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.074 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.602 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -57.4 -34.26 68.7 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.69 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 52.0 mt -59.32 -69.02 0.59 Allowed Pre-proline 0 N--CA 1.451 -0.405 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.297 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 24.5 Cg_exo -53.49 -26.47 36.42 Favored 'Trans proline' 0 C--N 1.356 0.926 0 CA-C-N 119.845 0.98 . . . . 0.0 110.842 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.3 tpt -71.15 -30.69 66.79 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.959 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 62' ' ' ALA . 81.8 mt -77.99 -43.26 28.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.724 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.91 -58.49 3.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.858 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.512 HG12 HD12 ' A' ' 72' ' ' LEU . 59.8 t -62.33 -40.1 86.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.218 178.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 73' ' ' TYR . . . -60.7 -49.72 75.51 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.223 -0.989 . . . . 0.0 112.064 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 92.6 mt -67.83 -41.59 82.77 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 120.77 0.319 . . . . 0.0 111.196 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -65.92 -48.01 69.77 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.526 -0.845 . . . . 0.0 112.173 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' A' ' 76' ' ' PHE . 74.0 mt -70.76 -34.76 72.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.851 0.358 . . . . 0.0 110.842 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.93 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 88.4 t80 -54.78 -46.77 74.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.198 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.781 HG13 ' SD ' ' A' ' 75' ' ' MET . 8.3 p -84.27 -27.22 7.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.529 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.905 ' HG2' ' HG ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -78.04 -74.71 0.25 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.67 ' CE2' HD22 ' A' ' 72' ' ' LEU . 20.3 m-85 -58.53 -27.85 64.91 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -93.5 -56.57 2.87 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 27.1 t -87.63 -8.56 10.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.168 0 CA-C-O 120.964 0.412 . . . . 0.0 111.183 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.4 mtp . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -58.05 -67.09 0.38 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.125 0.488 . . . . 0.0 110.811 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -59.65 -32.8 70.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.88 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.441 ' HA ' ' OD2' ' A' ' 7' ' ' ASP . 80.6 mt -67.99 -40.86 83.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.237 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 9' ' ' LEU . 21.6 p30 -70.42 -33.79 71.75 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 119.924 -0.711 . . . . 0.0 109.568 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.448 ' N ' ' OD1' ' A' ' 5' ' ' ASN . 60.7 mtm -68.82 -56.11 9.03 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.766 179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 8' ' ' LEU . 3.0 p30 -63.23 -44.11 96.16 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.843 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.2 tm? -60.7 -29.51 69.38 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.605 HD11 ' CA ' ' A' ' 71' ' ' GLY . 5.9 tt -69.23 -60.85 2.07 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.668 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -51.31 -45.31 62.18 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.303 0.573 . . . . 0.0 109.495 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.81 -40.21 91.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.698 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 8' ' ' LEU . . . -57.99 -32.4 67.86 Favored 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.299 179.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 17' ' ' MET . . . -67.24 -37.8 84.15 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.4 -53.28 50.91 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 19' ' ' LEU . 48.5 t -63.99 -41.17 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.01 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 61.7 mmm -61.03 -50.66 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.917 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.466 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 26.3 mmt -65.88 -39.58 90.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.646 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.582 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -69.66 -51.2 26.53 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.187 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.813 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.9 pp -61.0 -44.76 96.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.194 0.521 . . . . 0.0 109.812 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.813 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -66.14 -32.18 73.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.262 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 17' ' ' MET . . . -66.89 -42.03 86.21 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.392 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.582 HG12 ' O ' ' A' ' 18' ' ' GLY . 50.6 mm -63.39 -60.52 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.771 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.13 -45.1 92.88 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.32 -0.943 . . . . 0.0 111.617 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.627 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -59.62 -47.15 86.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.717 0.294 . . . . 0.0 110.72 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' O ' HG22 ' A' ' 28' ' ' ILE . . . -59.0 -53.12 61.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.974 0.416 . . . . 0.0 110.932 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.804 ' O ' HG12 ' A' ' 30' ' ' ILE . 70.0 mt -51.78 -59.08 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.42 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.52 -44.44 92.95 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.393 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -49.25 -47.52 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.33 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.481 ' N ' ' CG2' ' A' ' 28' ' ' ILE . . . -63.84 -40.44 98.4 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.911 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.804 HG12 ' O ' ' A' ' 26' ' ' ILE . 45.9 mm -56.45 -74.22 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.812 0.339 . . . . 0.0 110.907 179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 68.7 tp -67.21 -44.07 80.49 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.907 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -52.88 -43.76 61.06 Favored Glycine 0 C--O 1.226 -0.349 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.557 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' GLU . . . -62.04 -55.24 29.22 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.276 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.511 ' HG2' ' HA ' ' A' ' 31' ' ' LEU . 5.2 ptpp? -57.48 -52.06 66.93 Favored 'General case' 0 C--O 1.239 0.553 0 CA-C-O 120.965 0.412 . . . . 0.0 111.308 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.458 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 1.1 t80 -62.43 -54.38 41.02 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.703 ' CD1' HD11 ' A' ' 48' ' ' LEU . 53.5 tp -52.8 -39.58 62.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.316 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -57.96 -64.3 0.96 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.566 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -51.93 -54.1 27.13 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.039 -1.076 . . . . 0.0 111.572 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.461 ' HB3' ' HG ' ' A' ' 48' ' ' LEU . . . -58.54 -31.21 67.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.952 0.406 . . . . 0.0 110.591 179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 45' ' ' LEU . . . -71.64 -29.03 64.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.981 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 61.0 ttt-85 -87.62 -16.88 33.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.89 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.66 ' HB3' ' HD2' ' A' ' 43' ' ' PRO . 60.9 mt-30 -70.71 167.82 24.84 Favored Pre-proline 0 N--CA 1.441 -0.904 0 CA-C-O 121.673 0.749 . . . . 0.0 111.229 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.66 ' HD2' ' HB3' ' A' ' 42' ' ' GLN . 58.4 Cg_endo -80.17 12.34 2.53 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 124.112 3.208 . . . . 0.0 113.081 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 45' ' ' LEU . 1.4 p-10 -125.22 -83.87 0.64 Allowed 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 45' ' ' LEU . 3.7 tt 69.87 -51.53 0.63 Allowed 'General case' 0 C--N 1.335 -0.044 0 CA-C-O 120.975 0.417 . . . . 0.0 109.99 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.55 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 6.8 mt -44.92 -50.29 26.27 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.344 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 57.9 Cg_endo -72.93 -23.74 18.34 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.444 1.429 . . . . 0.0 111.741 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.027 HD13 ' N ' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -66.22 -37.38 85.41 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.027 ' N ' HD13 ' A' ' 48' ' ' LEU . 31.9 mt -48.61 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.004 -1.453 . . . . 0.0 111.82 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.7 mtt85 -74.95 -34.91 62.12 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.44 ' O ' ' CG1' ' A' ' 55' ' ' ILE . 81.3 m -66.49 -31.76 72.69 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.541 -0.464 . . . . 0.0 112.13 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.731 ' NE2' HD23 ' A' ' 48' ' ' LEU . 62.1 mt-30 -98.43 -36.42 9.96 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.868 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.75 -46.3 90.2 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.37 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -76.08 -42.59 46.9 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.895 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.531 HG22 HD23 ' A' ' 59' ' ' LEU . 47.0 mm -69.41 -46.34 76.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.981 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 60' ' ' VAL . 95.7 t -67.19 -42.44 88.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.666 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 24.6 ptt? -67.49 -40.86 85.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.432 0.634 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.49 -45.29 68.7 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.639 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.531 HD23 HG22 ' A' ' 55' ' ' ILE . 4.6 pp -65.87 -23.83 66.74 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 117.449 0.625 . . . . 0.0 110.649 -179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 56' ' ' VAL . 88.6 t -83.52 -53.6 10.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.41 0.624 . . . . 0.0 109.507 177.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 65' ' ' MET . 59.4 m-20 -62.97 -20.16 64.99 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.833 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.552 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -54.85 -35.41 63.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.005 0.431 . . . . 0.0 110.212 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.578 ' HB ' ' CD ' ' A' ' 64' ' ' PRO . 60.8 mt -58.73 -66.56 1.33 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.888 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.578 ' CD ' ' HB ' ' A' ' 63' ' ' ILE . 17.4 Cg_endo -59.5 -22.97 68.85 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 121.295 1.33 . . . . 0.0 111.08 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.512 ' HE2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -72.7 -32.05 65.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 178.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 62' ' ' ALA . 65.5 mt -74.85 -46.65 40.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.741 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.92 -57.25 6.53 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.323 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.667 HG12 HD23 ' A' ' 72' ' ' LEU . 62.7 t -64.68 -34.39 69.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.382 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.11 -50.65 44.46 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.481 -0.866 . . . . 0.0 111.613 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 60.6 tp -60.2 -43.21 96.13 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.494 0.664 . . . . 0.0 109.769 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.605 ' CA ' HD11 ' A' ' 9' ' ' LEU . . . -60.62 -59.46 10.2 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 114.93 -1.032 . . . . 0.0 112.541 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.667 HD23 HG12 ' A' ' 68' ' ' VAL . 4.7 pp -61.02 -27.51 68.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.104 0.478 . . . . 0.0 110.954 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.951 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 89.2 t80 -58.56 -45.0 89.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.171 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.559 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 38.8 t -90.92 -32.55 5.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.963 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.512 ' O ' ' HA ' ' A' ' 79' ' ' ALA . 1.6 mpp? -86.72 -69.67 0.66 Allowed 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 120.729 -0.389 . . . . 0.0 111.777 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.503 ' HB2' ' HB2' ' A' ' 72' ' ' LEU . 9.6 m-85 -58.49 -27.2 64.23 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.951 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -98.59 -62.15 1.28 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.993 0.425 . . . . 0.0 111.771 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 22.4 t -83.57 1.65 3.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.166 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.824 0.345 . . . . 0.0 111.225 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.777 ' HA ' HD21 ' A' ' 4' ' ' LEU . 4.2 mpp? . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' A' ' 6' ' ' MET . 16.9 tp10 -64.73 -44.81 88.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.903 0.383 . . . . 0.0 111.138 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -58.32 -55.31 36.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.444 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.905 HD23 ' H ' ' A' ' 4' ' ' LEU . 0.4 OUTLIER -68.64 -35.86 77.83 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.771 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.499 ' ND2' ' HB3' ' A' ' 1' ' ' MET . 63.4 m-20 -73.06 -22.38 60.62 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.875 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.55 ' HG3' ' O ' ' A' ' 2' ' ' GLU . 49.7 mtm -82.01 -51.54 7.93 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.537 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' OD1' ' HA ' ' A' ' 4' ' ' LEU . 53.1 p-10 -71.7 -37.84 70.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.098 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.753 ' O ' HD13 ' A' ' 8' ' ' LEU . 3.0 tm? -65.27 -33.72 76.64 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' HG ' ' HG3' ' A' ' 75' ' ' MET . 3.4 tm? -70.91 -55.94 7.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.763 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 10.5 m-30 -51.05 -53.45 33.6 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.742 0.782 . . . . 0.0 109.65 178.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -61.0 -38.03 84.59 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.677 -1.147 . . . . 0.0 110.174 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.588 ' O ' ' HB2' ' A' ' 16' ' ' MET . . . -62.64 -33.7 75.55 Favored 'General case' 0 C--O 1.219 -0.532 0 N-CA-C 109.662 -0.495 . . . . 0.0 109.662 178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' ' HG3' ' A' ' 17' ' ' MET . . . -66.93 -38.74 86.75 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.06 68.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 19' ' ' LEU . 46.8 t -64.27 -51.66 65.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.433 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.588 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -59.17 -55.51 33.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.773 179.672 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.813 ' CG ' HG21 ' A' ' 68' ' ' VAL . 81.1 mtp -62.72 -41.3 99.09 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.387 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.604 ' O ' HG12 ' A' ' 22' ' ' ILE . . . -67.24 -52.05 34.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.564 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.744 HD12 ' N ' ' A' ' 20' ' ' ALA . 4.0 pp -59.42 -44.99 92.76 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 121.351 0.596 . . . . 0.0 109.625 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -67.05 -30.07 70.04 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.52 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.76 -38.83 80.37 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 121.175 0.512 . . . . 0.0 109.664 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 18' ' ' GLY . 49.1 mm -62.83 -58.32 8.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.732 178.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -62.2 -47.4 90.02 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.31 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' O ' HG23 ' A' ' 28' ' ' ILE . . . -57.5 -38.73 75.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 115.585 -0.308 . . . . 0.0 110.585 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . . . -67.14 -44.01 80.91 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.733 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.7 ' O ' HG13 ' A' ' 30' ' ' ILE . 32.9 mm -58.71 -52.32 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.306 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' HA2' HD12 ' A' ' 30' ' ' ILE . . . -66.9 -48.32 61.43 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.938 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.69 HG21 ' HA ' ' A' ' 57' ' ' MET . 38.5 pt -51.86 -46.78 40.84 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.555 ' N ' HG13 ' A' ' 28' ' ' ILE . . . -62.24 -37.04 93.9 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.709 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 65.5 mt -58.17 -77.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 178.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.3 tp -65.91 -47.6 74.21 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.127 0.489 . . . . 0.0 110.853 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' A' ' 36' ' ' LEU . . . -54.42 -48.73 63.4 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.365 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.35 -36.06 90.02 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.662 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.709 ' HG2' ' O ' ' A' ' 30' ' ' ILE . 44.8 mmtm -59.59 -64.57 0.9 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.908 0.385 . . . . 0.0 110.63 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -62.28 -40.16 95.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.475 0.655 . . . . 0.0 109.692 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.679 HD12 HD22 ' A' ' 49' ' ' LEU . 34.1 tp -57.61 -40.86 80.07 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.966 -1.015 . . . . 0.0 110.63 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -69.58 -56.58 6.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.155 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' HA2' ' HG2' ' A' ' 41' ' ' ARG . . . -58.22 -54.55 36.73 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.042 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 45' ' ' LEU . . . -56.05 -25.6 45.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.777 0.322 . . . . 0.0 111.534 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -83.34 -37.08 23.85 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.828 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.416 ' HG2' ' HA2' ' A' ' 38' ' ' GLY . 41.0 ptt180 -85.05 -6.28 59.32 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.432 179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.947 ' HB3' ' HD3' ' A' ' 43' ' ' PRO . 58.8 tp60 -71.85 -108.57 0.0 OUTLIER Pre-proline 0 CA--C 1.55 0.952 0 CA-C-O 118.273 -0.87 . . . . 0.0 110.611 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 42' ' ' GLN . 71.7 Cg_endo -101.48 -68.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.737 0 CA-C-N 122.381 1.886 . . . . 0.0 112.835 -179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 46' ' ' ILE . 3.0 p30 -158.95 36.36 0.21 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.976 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.656 ' HB2' ' O ' ' A' ' 39' ' ' ALA . 74.7 mt -74.77 16.13 0.31 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.115 0.483 . . . . 0.0 110.506 179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.589 ' O ' ' HB2' ' A' ' 49' ' ' LEU . 37.9 mt -46.99 -44.31 46.99 Favored Pre-proline 0 C--O 1.224 -0.238 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.306 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 46' ' ' ILE . 44.3 Cg_endo -70.99 -29.25 18.29 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.08 1.187 . . . . 0.0 110.159 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.529 ' HB3' ' O ' ' A' ' 45' ' ' LEU . 51.2 tp -64.0 -33.06 74.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 ' HB2' ' A' ' 40' ' ' ALA . 26.4 mt -47.93 -67.52 0.27 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.563 -1.198 . . . . 0.0 110.759 178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -61.69 -46.25 90.51 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.02 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.744 ' O ' HG12 ' A' ' 55' ' ' ILE . 98.6 m -55.94 -39.57 71.91 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-O 120.809 0.337 . . . . 0.0 110.996 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 66.1 mt-30 -85.32 -26.02 26.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.853 0.359 . . . . 0.0 110.124 179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -60.64 -54.01 50.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.364 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.523 ' CE1' ' O ' ' A' ' 51' ' ' THR . 2.9 p90 -68.29 -30.14 69.07 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 121.03 -0.268 . . . . 0.0 110.716 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 ' O ' ' A' ' 51' ' ' THR . 36.5 mm -66.45 -58.74 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 52' ' ' GLN . 78.7 t -55.61 -46.39 79.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.222 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.69 ' HA ' HG21 ' A' ' 28' ' ' ILE . 62.4 ttp -69.47 -33.16 72.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.106 0.479 . . . . 0.0 110.612 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' A' ' 62' ' ' ALA . . . -71.49 -42.67 55.25 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.978 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.629 HD12 ' N ' ' A' ' 60' ' ' VAL . 4.4 pp -65.17 -29.13 69.94 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 117.142 0.471 . . . . 0.0 110.198 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.629 ' N ' HD12 ' A' ' 59' ' ' LEU . 98.1 t -78.01 -48.83 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.492 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 46.9 m-20 -73.27 -8.72 57.02 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.299 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.589 ' O ' HG13 ' A' ' 66' ' ' ILE . . . -61.72 -30.69 70.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.742 ' HB ' ' HD3' ' A' ' 64' ' ' PRO . 56.2 mt -62.0 -62.21 6.25 Favored Pre-proline 0 N--CA 1.452 -0.354 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.488 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.742 ' HD3' ' HB ' ' A' ' 63' ' ' ILE . 31.0 Cg_exo -60.9 -25.42 81.33 Favored 'Trans proline' 0 C--N 1.357 0.976 0 CA-C-N 120.044 1.051 . . . . 0.0 110.424 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 16.2 tpt -70.02 -31.1 68.59 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.29 178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.589 HG13 ' O ' ' A' ' 62' ' ' ALA . 74.1 mt -78.24 -45.61 26.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.623 178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.05 -56.29 13.91 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.088 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.813 HG21 ' CG ' ' A' ' 17' ' ' MET . 43.8 t -63.57 -44.66 98.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.034 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.476 ' HA2' HD21 ' A' ' 72' ' ' LEU . . . -59.52 -45.43 95.58 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.127 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.599 ' O ' HD13 ' A' ' 70' ' ' LEU . 2.5 tm? -65.04 -44.53 88.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.053 0.454 . . . . 0.0 109.791 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' O ' ' HG2' ' A' ' 75' ' ' MET . . . -64.33 -45.78 92.48 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.525 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.871 HD12 ' N ' ' A' ' 73' ' ' TYR . 4.0 pp -66.76 -32.71 74.18 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.88 0.371 . . . . 0.0 110.64 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.942 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 92.7 t80 -54.98 -47.03 75.12 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.249 0.547 . . . . 0.0 110.003 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.529 ' O ' ' HB ' ' A' ' 78' ' ' VAL . 47.1 t -86.03 -30.94 6.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.445 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.662 ' HG3' ' HG ' ' A' ' 9' ' ' LEU . 20.9 mmt -73.21 -76.13 0.13 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.29 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.499 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 27.1 m-85 -60.78 -30.35 69.98 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 73' ' ' TYR . . . -92.96 -59.84 1.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 74' ' ' VAL . 94.6 t -82.55 -6.13 9.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.062 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' A' ' 75' ' ' MET . . . . . . . . 0 N--CA 1.463 0.184 0 CA-C-O 120.838 0.351 . . . . 0.0 111.117 179.253 . . . . . . . . 1 1 . 1 stop_ save_